caba-10k_20201231.htm

0001564590-21-013329.txt : 20210316 0001564590-21-013329.hdr.sgml : 20210316 20210316081540 ACCESSION NUMBER: 0001564590-21-013329 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 92 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cabaletta Bio, Inc. CENTRAL INDEX KEY: 0001759138 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39103 FILM NUMBER: 21743703 BUSINESS ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (267) 759-3100 MAIL ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 10-K 1 caba-10k_20201231.htm 10-K caba-10k_20201231.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO

Commission File Number 001-39103

CABALETTA BIO, INC.

(Exact name of Registrant as specified in its Charter)

Delaware	82-1685768
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
2929 Arch Street, Suite 600 Philadelphia, PA	19104
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (267) 759-3100

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.00001 per share

CABA

The Nasdaq Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
.
Non-accelerated filer	☒	Smaller reporting company	☒

		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of June 30, 2020 (the last business day of the registrant's most recently completed second fiscal quarter), the aggregate market value of the registrant's common stock held by non-affiliates was approximately $214 million based on the last reported sale price of the registrant's common stock on the Nasdaq Global Select Market on June 30, 2020.

The number of shares of registrant’s Common Stock outstanding as of March 10, 2021 was 24,062,775.

DOCUMENTS INCORPORATED BY REFERENCE

Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant’s definitive Proxy Statement for its 2021 annual meeting of shareholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year end of December 31, 2020. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.

Table of Contents

		Page
PART I		3
Item 1.	Business	4
Item 1A.	Risk Factors	54
Item 1B.	Unresolved Staff Comments	123
Item 2.	Properties	123
Item 3.	Legal Proceedings	123
Item 4.	Mine Safety Disclosures	123

PART II		124
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	124
Item 6.	Selected Financial Data	126
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	127
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	139
Item 8.	Financial Statements and Supplementary Data	139
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	139
Item 9A.	Controls and Procedures	140
Item 9B.	Other Information	141

PART III		142
Item 10.	Directors, Executive Officers and Corporate Governance	142
Item 11.	Executive Compensation	142
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	142
Item 13.	Certain Relationships and Related Transactions, and Director Independence	142
Item 14.	Principal Accounting Fees and Services	142

PART IV		143
Item 15.	Exhibits, Financial Statement Schedules	143
Item 16	Form 10-K Summary	143
	Signatures	147

Summary of the Material and Other Risks Associated with Our Business

•

We are a clinical-stage company with a limited operating history, have incurred significant losses since our inception, and anticipate that we will continue to incur significant losses for the foreseeable future.

•

We are highly dependent on our relationship with University of Pennsylvania, or Penn, for our preclinical research and development activities, key technology and our current manufacturing needs for our clinical trial of DSG3-CAART, or the DesCAARTes^TM trial, and if Penn’s manufacturing capacity is reduced or otherwise delayed or limited, this could adversely impact enrollment in our DesCAARTes^TM trial.

•

We are reliant on intellectual property licensed to us by Penn and termination of our license agreement with Penn would result in the loss of significant rights, which would have a material adverse effect on our business.

•

If we are unable to obtain and maintain sufficient intellectual property protection for DSG3-CAART, our other product candidates and technologies or any future product candidates, we may not be able to compete effectively in our markets.

•

We will need to raise substantial additional funding before we can expect to complete development of any of our product candidates or generate any revenues from product sales.

•

Our limited operating history may make it difficult for you to evaluate the success of our business to date and to assess our future viability.

•

If we are unable to successfully develop our current programs into a portfolio of product candidates, or experience significant delays in doing so, we may not realize the full commercial potential of our current and future product candidates.

•

If we encounter difficulties enrolling patients in our DesCAARTes^TM trial or future clinical trials, these clinical development activities could be delayed or otherwise adversely affected.

•

If we are unable to advance our product candidates through clinical development, obtain regulatory approval and ultimately commercialize our product candidates, or experience significant delays in doing so, our business will be materially harmed.

•

Results of earlier studies may not be predictive of future study or trial results, and we may fail to establish an adequate safety and efficacy profile to conduct clinical trials or obtain regulatory approval for our product candidates.

•

If serious adverse events, undesirable side effects or unexpected characteristics are identified during the development of any of our product candidates, we may need to delay, abandon or limit our further clinical development of those product candidates.

•

The COVID-19 pandemic and the future outbreak of other highly infectious or contagious diseases could seriously harm our research, development and potential future commercialization efforts, increase our costs and expenses and have a material adverse effect on our business, financial condition and results of operations.

•

Manufacturing and administering our product candidates is complex and we may encounter difficulties in technology transfer from Penn to a contract manufacturing organization.

•

We face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than we do.

•

We may establish our own manufacturing facility and infrastructure in addition to or in lieu of relying on third parties for the manufacture of our product candidates, which will be costly and time-consuming, and which may not be successful.

•

Our future success depends in part upon our ability to retain our key employees, consultants and advisors and to attract, retain and motivate other qualified personnel.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K, including the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains express or implied forward-looking statements that are based on our management’s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this Annual Report on Form 10-K include, but are not limited to, statements about:

•

the success, cost and timing and conduct of our clinical trial program, including our clinical trial of DSG3-CAART, or the DesCAARTes^TM trial, and our other product candidates, including statements regarding the timing of initiation and completion of the clinical trials and the period during which the results of the clinical trials will become available;

•

the timing of and our ability to obtain and maintain regulatory approval of our product candidates, including DSG3-CAART, MuSK-CAART, FVIII-CAART and DSG3/1-CAART, in any of the indications for which we plan to develop them, and any related restrictions, limitations, and/or warnings in the label of an approved product candidate;

•

the impact of any business interruptions to our operations, including the timing and enrollment of patients in our ongoing and planned clinical trials and our planned Investigational New Drug application submissions, or to those of our clinical sites, manufacturers, suppliers, or other vendors resulting from the coronavirus disease (COVID-19) pandemic or similar public health crisis;

•

our expected use of proceeds from the initial public offering and the period over which such proceeds, together with cash, will be sufficient to meet our operating needs;

•

our plans to pursue research and development of other product candidates;

•

our plan to infuse our DSG3-CAART product candidate without lymphodepletion or other preconditioning agents initially in our DesCAARTes^TM trial;

•

the potential advantages of our proprietary Cabaletta Approach for selective B cell Ablation platform, called our CABA platform, and our product candidates;

•

the extent to which our scientific approach and CABA platform may potentially address a broad range of diseases;

•

the potential benefits and success of our arrangements and our expanded sponsored research agreement with the Trustees of the University of Pennsylvania, or Penn, and the Children’s Hospital of Philadelphia, or CHOP, and our scientific co-founders, Drs. Milone and Payne;

•

our ability to successfully commercialize our product candidates, including DSG3-CAART and our other product candidates;

•

the potential receipt of revenue from future sales of DSG3-CAART and our other product candidates;

•

the rate and degree of market acceptance and clinical utility of DSG3-CAART and our other product candidates;

•

our estimates regarding the potential market opportunity for DSG3-CAART and our other product candidates, and our ability to serve those markets;

•

our sales, marketing and distribution capabilities and strategy, whether alone or with potential future collaborators;

•

our ability to establish and maintain arrangements or a facility for manufacture of DSG3-CAART and our other product candidates;

•

our ability to obtain funding for our operations, including funding necessary to initiate and complete our DesCAARTes^TM trial and our ongoing preclinical studies of MuSK-CAART, DSG3/1-CAART and FVIII-CAART;

•

the potential achievement of milestones and receipt of payments under our collaborations;

•

our ability to enter into additional collaborations with existing collaborators or other third parties;

•

our expectations regarding our ability to obtain and maintain intellectual property protection for our product candidates and our ability to operate our business without infringing on the intellectual property rights of others;

•

the success of competing therapies that are or become available, and our competitive position;

•

the accuracy of our estimates regarding expenses, future revenues, capital requirements and needs for additional financing;

•

the impact of government laws and regulations in the United States and foreign countries; and

•

our ability to attract and retain key scientific or management personnel.

These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this Annual Report on Form 10-K. The forward-looking statements contained in this Annual Report on Form 10-K are made as of the date of this Annual Report on Form 10-K, and we undertake no obligations to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

PART I

Item 1. Business.

Overview

B cell-mediated autoimmune diseases occur when certain populations of B cells mistakenly produce autoantibodies, which are directed against specific healthy tissue or cells in the body. The presence of autoantibodies can manifest in a variety of autoimmune diseases and result in the destruction of healthy tissue in the body. Current treatment options for B cell-mediated autoimmune diseases are generally limited to corticosteroids and other generalized immunosuppressants that offer only temporary disease suppression, may require chronic, in-hospital administration and are associated with potentially life-threatening side effects. We believe the ideal therapy for B cell-mediated autoimmune diseases would selectively and completely eliminate the pathogenic B cells while sparing the body’s normal B cells.

We are pioneering the development of a new class of engineered T cell therapies that express CAARs to selectively engage and eliminate pathogenic B cells. Our CAARs build upon the scientific foundation of CARs, differing primarily in the use of the antigen rather than an antibody fragment, which enables the CAAR T cells to serve as a “decoy” for specific autoantibodies expressed on the surface of B cells. This allows these pathogenic B cells to engage with the CAAR T cells instead of benign antigens, resulting in their elimination. We have developed our CABA platform to inform product candidate development from scientific, clinical and commercial assessment through CAAR design. Using our CABA platform, we have identified and thoroughly evaluated over two dozen B cell-mediated autoimmune diseases that we believe will be amenable to treatment with the Cabaletta approach and have advanced several of our highest priority targets into discovery and preclinical testing.

Our current product candidate pipeline is illustrated below.

*	In our discovery stage, we perform epitope mapping and optimize CAAR construct and design.

**	May not be required if Phase 2 is a registrational clinical trial, subject to discussion with the FDA.

Our initial therapeutic focus is on pemphigus vulgaris, or PV, a chronic, autoimmune blistering skin disease. Despite a current standard of care that includes corticosteroids and adjunctive immunosuppressive agents, PV remains associated with frequent recurrences as well as substantial morbidity and mortality. Our lead product candidate, DSG3-CAART, is being evaluated for the treatment of mPV, a subtype of PV that affects mucosal surfaces. mPV is caused by autoantibodies against the cell adhesion protein desmoglein 3, or DSG3. DSG3-CAART is designed to selectively target B cells expressing autoantibodies specific for DSG3, which may prevent these B cells from producing DSG3 antibodies that are the cause of mPV while preserving general B cell immune function. In January 2020, the U.S. Food and Drug Administration, or the FDA, granted orphan drug designation to DSG3-CAART for the treatment of PV. In May 2020, DSG3-CAART received fast track designation from the FDA for improving healing of mucosal blisters in patients with mPV. In December 2020, we announced that the first patient had been dosed in the DesCAARTes™ trial. Our next PV-directed product candidate, DSG3/1-CAART, is being designed to target B cells expressing autoantibodies against DSG3 and desmoglein 1, or DSG1. It is being developed for the treatment of mucocutaneous PV, or mcPV, another subtype of PV that affects both mucosal and skin surfaces and is caused by autoantibodies against DSG3 and DSG1, respectively.

Our lead preclinical product candidate, MuSK-CAART, is designed to treat a subset of patients with myasthenia gravis, or MG. MG is an autoimmune disease induced by autoantibodies targeting the neuromuscular junction, or NMJ, which can lead to life-threatening muscle weakness. Our product candidate targets B cells expressing autoantibodies against a transmembrane protein, muscle-specific kinase, or MuSK, and is being developed for the treatment of MuSK MG. Data from our initial in vitro and in vivo studies of MuSK-CAART was presented at the American Academy of Neurology’s Science Highlights Virtual Platform in May 2020. The efficacy and safety of MuSK CAAR T cells were investigated using in vitro cytotoxicity assays, in vitro screens for off-target toxicity and a mouse model to evaluate the efficacy of human MuSK CAAR T cells against MuSK antibody expressing B cells in vivo. In preclinical studies, MuSK CAAR T cells demonstrated in vitro cytotoxicity towards a B cell line expressing anti-MuSK antibodies, but we did not observe any cytotoxicity when the anti-MuSK antibody was not expressed. In addition, MuSK CAAR T cells also targeted and eliminated a panel of B cells targeting different MuSK epitopes. In an in vivo mouse model, MuSK CAAR T cells, but not control CAAR T cells, showed biological activity by blocking the growth of B cell lines expressing an anti-MuSK antibody. Based in part on these results, IND-enabling studies have been initiated and an IND submission is anticipated in the second half of 2021.

We are also pursuing development of an additional product candidate, FVIII-CAART, which is being designed to treat a subset of patients with Hemophilia A, an X-linked bleeding disorder caused by mutations in the FVIII gene. While our CABA platform is primarily focused on the treatment of B cell-mediated autoimmune diseases, we believe our approach may be applicable in other instances where B cell antibody production is

implicated in response to exogenous FVIII, which is administered for the treatment of Hemophilia A. Specifically, we have identified an unmet need in cases where the immune system produces antibodies against exogenous antigens, which is known as an alloimmune response. Some patients receiving repeated administrations of exogenous FVIII will develop alloantibodies against the treatment, also known as inhibitors, neutralizing its therapeutic potential. Patients with FVIII alloantibodies may often require high-dose FVIII, immune tolerance induction with FVIII, agents that mimic FVIII or plasmapheresis to remove the FVIII alloantibodies. FVIII-CAART leverages a CAAR designed to target B cells expressing alloantibodies against FVIII, and it is initially being developed as an adjunctive therapy for Hemophilia A patients who develop FVIII alloantibodies.

Our manufacturing strategy is a three-stage process designed to initially leverage the extensive early-stage manufacturing expertise of our academic partners while migrating to contract manufacturing organization, or CMO, partnerships and ultimately aiming to achieve full manufacturing independence. We believe partnering with proven and reputable manufacturing partners has allowed us to efficiently deploy financial and personnel resources. Stage 1 leverages the expertise in cell and vector manufacturing of our partners at the Children’s Hospital of Philadelphia, or CHOP, and the University of Pennsylvania, or Penn. This stage included early development work, support of the DSG3-CAART IND, and cell and vector product manufacturing for our DesCAARTes^TM trial. We believe these partnerships and use of these established facilities have allowed us to move efficiently into clinical trials, but are not sufficient to support a commercial license. Stage 2, which is ongoing, is designed to engage partners who are qualified for manufacturing of vectors at commercial grade and scale and who have experience with cell processing. In January 2021, we initiated a collaboration with WuXi Advanced Therapies, Inc. or WuXi, to serve as our cell processing manufacturing partner for the anticipated MuSK-CAART Phase 1 clinical trial. Contingent on sufficient clinical evidence from the DesCAARTes^TM trial, we plan to advance the third stage of our manufacturing strategy which will include building, qualifying and operating our own manufacturing facility. We believe this additional stage will enable full control of product development and commercial supply for products arising from our CABA platform, enabling us to achieve continuous improvement of our product candidates. Our Chief Executive Officer and Executive Vice President, Science and Technology, have both, in prior roles, built and led organizations that have constructed and commissioned cell therapy facilities which we hope will enable us to smoothly transition to stage 3 when feasible.

We plan to build upon our first mover advantage in the field of targeted cell therapy for B cell-mediated autoimmune diseases and further advance the discovery, development and commercialization of our CAAR T portfolio. Our extensive correlative study program has been designed to inform clinical observations from the DesCAARTes^TM trial in order to preserve and expand our industry leading insights into the impact of CAAR T therapies in patients. Our scientific founders are leading experts in B cell-mediated autoimmune diseases and CAR T technology, and we are led by an experienced team with demonstrated success in discovering, developing, manufacturing, and evaluating novel cell therapy products in clinical trials. In addition, we have partnered our discovery and initial development efforts with Penn, a pioneer in cell and gene therapy with a proven track record of expertise in the translational research, clinical development and manufacturing of cell therapy products, in order to advance our lead product candidate in clinical trials along with our preclinical product candidates.

Our History and Team

Our scientific co-founders, Aimee Payne, M.D., Ph.D., and Michael Milone, M.D., Ph.D., began partnering at Penn in 2013 to combine Dr. Payne’s expertise in B cell-mediated autoimmune diseases with Dr. Milone’s deep and experienced insights into the design and implementation of CAR T products. Dr. Payne is a worldwide leader in characterizing B cell-mediated autoantibody repertoires in PV and other autoimmune diseases. Dr. Milone is a renowned scientist in CAR T therapy and was a co-inventor of and a key driver in the preclinical discovery and development efforts that yielded Kymriah, the first FDA-approved CAR T therapy for the treatment of B cell cancers. Dr. Payne’s laboratory surmised that by incorporating an antigen instead of an antibody fragment as the extracellular domain of the CAAR, specific pathogenic B cells could be targeted. This resulted in a collaboration between the two investigators to apply the scientific foundation of CAR T technology as it has been advanced by Drs. Payne and Milone in order to address B cell-mediated autoimmune diseases.

Their first scientific publication, “Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease” (Science, July 2016), attracted the attention of a colleague, Steven Nichtberger, M.D., who is an adjunct professor at the Wharton School at the University of Pennsylvania, teaching a class on biotech company

formation, financing and leadership in the Vagelos Life Sciences & Management Program. Additionally, Dr. Nichtberger has experience creating and building companies, including a novel cellular therapy company, which required transferring the technology from an academic institution, establishing a research and development organization, hiring of manufacturing and quality teams, creating novel manufacturing processes, reaching agreement with the FDA on novel clinical development pathways and constructing a commercial-scale Good Manufacturing Practices, or GMP, facility that manufactured autologous cell therapy products for clinical trials. In 2017, based on over a year of interaction and discussions regarding the optimal strategy to advance the scientific opportunity into a commercially developed product portfolio that could offer potentially curative treatment options to patients, Drs. Payne, Milone and Nichtberger decided to launch Cabaletta Bio.

The longstanding and highly productive partnership between our co-founders has been complemented by additional management experience that brings a successful history of translating academic cellular therapy research from Penn and elsewhere into commercially sponsored clinical trials and the establishment of a GMP manufacturing facility and organization. Gwendolyn Binder, Ph.D., our Executive Vice President, Science and Technology, was an early member of the Translational Research Program Operations team at Penn for over five years and participated in the submission and acceptance of multiple INDs for novel engineered T cell therapy products. As part of the cell therapy organization at Penn, Dr. Binder partnered with Dr. Milone and others to drive the IND-enabling translational studies that facilitated the initial CAR T clinical trial in B cell cancers at Penn. Dr. Binder also built and led a clinical stage biotechnology company’s manufacturing operations and quality teams, including creation of a fully functioning commercial grade GMP facility. Dr. Binder also built the translational research program and ultimately led the company’s research organization.

Our Research and Manufacturing Collaboration with Penn

Our CABA platform has already produced multiple product candidates through our sponsored research agreements, or SRAs, with Penn for the laboratories of our scientific co-founders, Drs. Payne and Milone. Our continuing relationship with our scientific co-founders provides important guidance and insights to us. Our contractual relationship with Penn through ongoing licensing and research arrangements also provides important services around manufacturing supply.

In May 2020, we amended and restated our worldwide license agreement with Penn to develop our CAAR T technology to treat B cell-mediated autoimmune and alloimmune diseases. This license agreement provides us with access to multiple patent families covering CAAR T therapy as applied to the field of B cell-mediated autoimmune and alloimmune diseases and to the robust intellectual property portfolio created by Penn under these SRAs in this field. See “—Our Material Agreements—Amended and Restated License Agreement with Penn.”

Our ongoing collaboration with Penn is also based on a Master Translational Research Services Agreement, or the Services Agreement, that we entered into in October 2018, along with multiple additional agreements under the Services Agreement to engage and partner in individual Penn entities, including cell product manufacturing, correlative research, vector manufacturing, clinical trial operations and protocol development. In addition to the Services Agreement, we have agreements in place with various functional areas and centers that provide additional resources to Penn as well as contractual commitments from Penn with the goal of providing the capacity to manufacture our lead product candidate, DSG3-CAART. Penn has also agreed to manufacture vector product for use in our clinical trials. Penn’s obligations are subject to certain limitations and termination rights. See “—Our Material Agreements—Master Translational Research Services Agreement with Penn”.

We believe Penn is uniquely suited to be our partner in our efforts to develop product candidates leveraging our CAAR T technology based on a decade of experience, including manufacturing and clinical support for approximately a dozen active cell therapy clinical trials. The original manufacturing process for the first FDA-approved CAR T therapy was developed at Penn before being transferred to Novartis Pharmaceuticals Corporation during late-stage clinical trials. We are leveraging Penn’s experience, validated standard operating procedures, manufacturing facilities and staffing to accelerate development efforts for our lead product candidate.

Our Strategy

Our goal is to build upon our first mover advantage and expertise in cell therapies for B cell-mediated autoimmune diseases to accelerate the discovery, development and commercialization of our CAAR T cell therapies, with a focus on reliable manufacturing. We believe achieving this goal could result in potentially curative therapies for patients with unmet medical needs who suffer from certain B cell-mediated autoimmune diseases. To achieve this goal, key elements of our strategy include:

•

Achieving clinical proof-of-concept for our lead product candidate, DSG3-CAART in mPV, the first in a series of well-understood and validated B cell-mediated autoimmune diseases for which we are developing CAAR T cell product candidates. It is well-established that the presence of DSG3 autoantibodies and DSG3 autoantibody producing B cells in patients are both necessary and sufficient to cause mPV in the vast majority of cases. We believe our biologic understanding coupled with the well-understood clinical signs, symptoms and natural course of the disease, identify mPV as a model disease to evaluate our CAAR T approach. In addition, we have made significant investment in the design and development of DSG3-CAART, generating a lead candidate that has demonstrated robust target engagement and no off-target toxicities in preclinical studies. Taken together, our Phase 1 clinical trial evaluating DSG3-CAART for the treatment of mPV represents an optimal first opportunity to establish initial clinical proof-of-concept of our CABA platform.

•

Leveraging our CABA platform to identify optimal targets for the CAAR T approach and apply learnings from DSG3-CAART to advance additional product candidates. Shortly after inception, we undertook a comprehensive review of all known B cell-mediated autoimmune diseases in order to evaluate and prioritize the opportunity for selective destruction of B cells in an effort to cure B cell-mediated autoimmune diseases. Central to this analysis were (i) scientific, clinical and commercial assessment, (ii) epitope mapping to determine regions targeted by autoantibodies, (iii) evaluation of the ability to optimize the CAAR construct and design with the goal of selectively ablating reactive B cells, and (iv) evaluation of existing or required development of new preclinical models and in vitro and in vivo clinical testing. As we performed this analysis of potential product candidates, we considered possible paths for clinical trial design and regulatory approval. This analysis incorporated the extensive learnings gleaned from years of effort devoted to development of DSG3-CAART. We prioritized the targets and since then have been focused on being first to discover and develop a series of products with each providing the potential for cure of an important B cell-mediated autoimmune disease in patients. We intend to continue to apply our proprietary learnings from DSG3-CAART, including scientific and regulatory learnings, to most effectively advance these additional opportunities. Preclinical studies that are generally similar to, and informed by, DSG3-CAART preclinical studies are actively ongoing with other CAAR T cell product candidates.

•

Expanding upon our established IP position and first mover advantage in CAAR T therapy targeted towards B cell-mediated autoimmune diseases. We are focused on protecting our intellectual property as we continue to pursue the development of future product candidates. We believe the issued U.S. patent on our initial CAAR constructs is the first patent covering cells engineered to express the known pathogenic epitopes recognized by DSG3 and DSG1 autoantibodies, which we are working to supplement with additional patent filings. The design of a broadly effective CAAR requires a deep understanding of the location of immunogenic epitopes targeted by autoantibodies, a competency that we believe we are uniquely positioned to utilize in product candidate development. We believe there is a particularly high value to the first mover advantage including, but not limited to, experience in discovery, preclinical development, regulatory efforts, intellectual property and insights from clinical trials that can be translated across programs.

•

Leveraging our cellular therapy experience and knowledge in addition to knowledge gained through our Penn collaboration to rapidly build our own fully-integrated internal infrastructure. We have differentiated expertise that we believe is uniquely suited for the continued buildout of our CABA platform specializing in B cell-mediated autoimmune diseases. Our scientific co-founders who initially developed our technology continue to collaborate closely with us through SRAs. In addition, our management team has a successful history of building the capabilities of cell therapy-based companies from the discovery and preclinical stage through Phase 3 readiness. In combination with our team, which possesses significant experience in executing on manufacturing strategies for cell therapy products, our partnership with Penn allows us to utilize their existing infrastructure, which accelerated our ability to submit our first IND. In parallel, we continue to build out an experienced team to manage the relationship with Penn while also developing and continuing to implement a path to our manufacturing independence. Ultimately, we intend to prepare and build our own manufacturing facility depending on the achievement of sufficient initial clinical trial data for DSG3-CAART.

B Cell-Mediated Autoimmune Diseases: Overview and Current Treatment Paradigm

The body’s immune system, which is designed to protect the body from infection and cancer, includes B cells and T cells. B cells are responsible for producing antibodies against antigens that the body perceives as foreign whereas T cells are responsible for cell-mediated immunity. In the case of B cell-mediated autoimmune diseases, certain populations of the patient’s B cells mistakenly produce antibodies directed against normal tissues and cells, leading to disease. While these autoantibodies are the major effectors of B cell-mediated autoimmune diseases, the underlying root cause of each B cell-mediated autoimmune disease is the defective B cells that mistakenly make these pathogenic antibodies. These pathogenic B cells express autoantibodies on their surface with the same antigen specificity as the circulating pathogenic autoantibodies, which can be used to distinguish them from the healthy B cell population, as shown in the figure below.

Antibodies are B cell receptors that drive B cell maturation. CD19 serves as a B cell marker throughout the naïve B cell phase, while CD20 is a surface marker expressed later in B cell maturation. CAAR T is designed to eliminate antigen specific B cells and prevent their further development to antibody producing plasma cells. IgM: immunoglobulin M; IgD: immunoglobulin D; IgA: immunoglobulin A; sIg: surface immunoglobulin, representing the autoantibody on the B cell surface.

Current treatment options for autoimmune mediated diseases involve generalized immune suppression, achieved through corticosteroids, immunosuppressive medications and biologics. Most commonly, corticosteroids are used on both a chronic and acute basis to control disease, and act via a variety of mechanisms to control or downregulate multiple inflammatory pathways. In many cases, systemic immunosuppressive medications often used in chemotherapy such as mycophenolate, azathioprine and methotrexate, are added in an effort to minimize symptoms and manage the expected recurrences in patients. Biologic therapies have emerged as a new class of therapies and have a variety of targets including cytokines, B cells, and co-stimulation molecules. One particular biologic, rituximab, is an anti-CD20 antibody and is employed in multiple autoimmune diseases. Rituximab was approved by the FDA in 2018 for treatment of moderate to severe PV. Currently existing treatment options target parts of the immune system in addition to disease-causing B cells, and in general require chronic administration to reduce recurrence rates. We believe the ideal therapy in autoimmune diseases would completely and specifically eliminate the pathogenic B cells while sparing the immune cells that protect against infection, without requiring chronic administration.

Our Approach

Using our CABA platform, we are developing engineered T cell therapy candidates that express CAARs, which serve as “decoys” for antibodies expressed on the surface of B cells. We believe these CAARs enable the T cells to specifically engage and eliminate pathogenic B cells while sparing normal B cells. By harnessing the power of cell therapy, our technology has the potential to overcome the ability of these B cells to evade elimination and thus lead to durable responses. Our CAAR T platform is based on the foundation of established CAR T therapeutics, differing primarily in their use of the antigen rather than an antibody fragment to target pathogenic B cells. We

believe our technology has broad applicability and we are building a portfolio of product candidates for B cell-mediated autoimmune diseases.

Background: CAR T Cells

Engineered T cell therapy is a type of immunotherapy in which human T cells are genetically modified to express specific receptors, enabling the T cells to recognize and eliminate pathogenic cells.

A key application of engineered cell therapy involves the use of CARs, which are engineered molecules that enable T cells to identify specific antigens present on the surface of diseased cells. When expressed on the patient’s T cells, the CAR directs the T cells to kill cells that express a particular antigen. These CAR-expressing T cells, or CAR T cells, can proliferate, generating memory CAR T cells.

Many companies are using CAR T technology to develop therapies for the treatment of B cell cancers. Several drug candidates have demonstrated clinical success, leading to the first FDA regulatory approvals of CAR T therapies for certain B cell cancers. In these B cell cancers, CAR T therapy has resulted in complete remission of disease in many patients, even in cancer patients with severe, refractory disease. Despite success in treating certain B cell cancers, we believe that CARs have not yet been developed or evaluated as a treatment option for other types of B cell-mediated autoimmune diseases in patients.

Our Technology: CAARs

Our CAAR T platform builds upon the scientific foundation of CARs to enable targeted B cell elimination in an autoimmune setting, which may lead to complete and durable remission of disease while sparing all other B cell populations that can provide beneficial immunity from infection.

The co-stimulatory domain and the signaling domain of both a CAR T cell and CAAR T cell carry out the same activation and cytotoxic functions once the engineered cell therapy engages a B cell. Our CAAR T cells differ from CAR T cells primarily in the extracellular targeting domain. Our CAAR T cells incorporate the relevant parts of the autoantigen that is subject to attack in autoimmune disease, as shown in the figure below.

Key differences between CAR T (left) vs. CAAR T therapy (right). A CAR T cell typically contains a signaling domain and a co-stimulatory domain and incorporates antibody fragments that recognize a specific antigen, such as CD19, which is present in both B cell leukemia cells and healthy B cells. In contrast, a CAAR T cell typically contains an antigen as its targeting domain rather than an antibody fragment. The antigen is recognized by the specific, pathogenic antibody along with the limited population of B cells that produce the antibody. The model

CAAR T cell depicted here contains an identical signaling domain and a co-stimulatory domain. The primary difference between a CAR T cell and a CAAR T cell is the target domain expressed on the cell surface. The example shown demonstrates the pan-B cell ablation that happens when targeting the B cell lineage marker, CD19, and the highly selective pathogenic B cell targeting approach of CAAR T.

Potential Advantages of CAAR T Cell Therapy in B Cell-Mediated Autoimmune Diseases

In contrast to currently available therapies for B cell-mediated autoimmune diseases, based on observations of CAR T activity in refractory B cell cancers, we believe a single CAAR T treatment could potentially offer complete and durable remission of certain specific B cell-mediated autoimmune diseases while leaving the humoral, or bodily fluid, antibody-producing immune system intact. We believe our CAAR T cells can recognize the specific autoantibodies that are responsible for causing an underlying disease and kill the cells that express the autoantibodies on their surface. As a result, we believe CAAR T cell therapy used in B cell-mediated autoimmune disease has the potential for durable elimination of pathogenic B cells and an associated elimination of clinical recurrences with an improved adverse event, or tolerability, profile relative to the current standard of care.

Enhanced target specificity and preservation of humoral immune system

Preservation of the humoral immune system with CAAR T cell therapy represents a potentially meaningful benefit over existing CD19- or CD20-targeting methods for B cell ablation, as patients would be less susceptible to infection they may encounter after non-specific B cell elimination and would not require chronic in-hospital treatment with intravenous immunoglobulin, or IVIG, or other prophylactic therapies. Additionally, because self-reactive B cells make up only 0.01% to 1% of the normal B cell population, we believe the risk of on-target toxicity may be reduced compared to systemically immunosuppressive medications that non-specifically weaken the immune system. Continued use of these drugs poses significant risks, such as the potential for fatal infections due to the non-specific tempering of the immune system related to the complete depletion of CD20+ or CD19+ B cells.

Potential for complete, long-lasting elimination of pathogenic B cells

The current standard of care for B cell-mediated autoimmune disease displays limited and transient therapeutic benefit while also weakening the humoral immune system. We believe our CAAR T cells have the potential to eliminate the reactive, antibody-producing B cells that are ultimately responsible for disease, while sparing normal B cells. The curative potential of CAAR T cells would be consistent with clinical findings from use of CAR T products in B cell cancers and would be a significant improvement relative to the current standard of care for certain B cell-mediated autoimmune diseases.

While CAR T has demonstrated significant clinical success in B cell cancers, cancer cells employ a variety of mechanisms to evade detection by targeting immune cells, and antigen escape poses a significant risk of failure for CAR T cell treatment in oncology. Antigen escape in CAR T treatment occurs when the antigen that the CAR T cell targets is lost from the malignant cell. Clinically, this results in response rates that decline from an initial complete response level of about 80% to approximately 50% over a period of years.

We believe this risk of antigen escape is reduced in our setting as mechanisms to evade CAAR T therapy would involve B cell receptor down-regulation or mutation such that antigen specificity is lost. We believe that the implication of this is that the mutated B cell would no longer produce autoantibodies that recognize the antigen and therefore should no longer be pathogenic. We also believe that a single infusion of CAAR T cells has the potential for curative effects due to either complete ablation of pathogenic cells or production of memory CAAR T cells.

Our CABA Platform

Our team has developed our CABA platform to inform product candidate development from indication selection through preclinical studies. Using our CABA platform, our team has identified our highest priority target indications following a rigorous analysis of B cell-mediated autoimmune diseases. A deep understanding of the antigenic epitopes targeted in these diseases is required to design and construct a successful CAAR. Our scientific founders have studied B cell repertoires for many years in the context of PV. Their expertise is essential to provide insights and guidance regarding our portfolio of products. We leverage the experience and insight gained from the development of each product candidate to improve the efficiency of our CABA platform in evaluating additional potential product candidates.

Scientific, Clinical and Commercial Assessment

Through broad literature review and consultation with internal and external experts, we have identified and continue to monitor the universe of diseases where pathogenic B cells are implicated in disease pathophysiology. From this set of possible indications, our team then evaluates each disease based on numerous criteria, which include, but are not limited to:

Biologic Opportunity for Cure

•

the presence of the antibody is well established in patients with the clinical manifestations of the disease;

•

the identified antibody has been shown to be necessary and sufficient in causing clinical disease;

•

there is a correlation between antibody titer and disease activity;

•

B cell-depleting therapies are shown or believed to be effective in treating the disease;

•

the antibody repertoire has been or can be characterized for the disease;

Identifiable and Underserved Patient Populations

•

a routine and established antibody test exists or can be developed for diagnosis and biomarker assessment;

•

the clinical course and severity of the disease warrant a cellular therapy despite current standard of care;

•

products in development do not have the potential to materially improve outcomes versus the current standard of care;

Evaluation of Preclinical and Clinical Development Pathway

•

preclinical in vitro and in vivo models exist or can be developed; and

•

potential clinical trial designs and endpoints appear reasonable and achievable.

In addition to assessing the underlying biologic and clinical rationale for each potential target, we also assess commercial feasibility of CAAR T therapy in various B cell-mediated indications. As part of this assessment, we evaluate the direct lifetime drug and overall healthcare costs due to the burden from the disease, including the costs of managing potential adverse effects from existing standard of care compared to the potential CAAR T therapy.

We perform this rigorous and detailed conceptual analysis to enable us to be thorough and thoughtful before committing significant resources to a program. We believe this analysis allows us to prioritize and advance potential product candidates through the CABA platform with a higher degree of confidence and a higher probability of success.

Epitope Mapping

Epitope mapping involves identifying specific sites on the antigen that are responsible for binding to the antibody of interest. This step is required in order to facilitate an understanding of CAAR design and feasibility. An understanding of the locations of the key immunogenic epitopes on the antigen heavily informs the potential feasibility of a CAAR. With an understanding of these epitopes, we then leverage our cell therapy expertise to design the CAAR construct.

CAAR Construct / Design

Our scientists and collaborators design and create multiple CAAR constructs following completion of epitope mapping, which are tested against the antibody or antibodies of interest. The goal in CAAR design is to maximize the inclusion of known immunogenic epitopes on the antigen while also optimizing the size of the construct to improve the ability of the CAAR to bind to the antibody. Determining the location of antigen expression and if there are other antigens that may unintentionally cross-react with the CAAR will also inform CAAR design and feasibility. The size of the antigen will also determine whether a CAAR can be designed based on the size constraints of the delivery system. Once we have designed and developed optimal CAAR constructs, we test them in a variety of in vitro and in vivo studies.

In Vitro and In Vivo Testing

In vitro preclinical testing is focused on establishing the specificity and activity of the potential CAAR T cell product candidate against B cells expressing known pathogenic target antibodies. Specificity is evaluated against non-target membrane proteins that may be expressed on other cells, with specific focus against any proteins that are known to bind to the antigen presented on the CAAR. CAAR T function is tested in the presence and absence of soluble, or free, antibodies isolated from patients, since these antibodies may enhance or inhibit CAAR T cell function. Where relevant animal models exist, the CAAR T cell product candidate is tested in one or more models to address specific questions around safety and the ability of the potential product candidate to reduce disease activity in vivo.

Pipeline

We are developing a portfolio of CAAR T cell product candidates for the treatment of B cell-mediated autoimmune diseases. Our lead product candidate, DSG3-CAART, targets B cells that express pathogenic autoantibodies against the DSG3 protein, which cause mPV. The publication of the first in vivo evaluation of activity and toxicity of the candidate in an animal model was followed by additional preclinical studies to support our IND submission, which was cleared by the FDA in September 2019 The FDA granted our lead product candidate, DSG3-CAART, designed to treat patients with mPV, orphan drug designation for the treatment of PV in January 2020 and fast track designation for improving healing of mucosal blisters in patients with mPV in May 2020. We initiated our DesCAARTes™ trial in June 2020 and announced the dosing of the first patient in December 2020. Our next PV-directed product candidate, DSG3/1-CAART, targets B cells that give rise to pathogenic autoantibodies against either the DSG3 or DSG1 protein, which cause mcPV, and could address a broader PV population.

Our second product candidate, MuSK-CAART, targets B cells that give rise to pathogenic autoantibodies against the MuSK receptor in patients with MG. An additional product candidate, FVIII-CAART, targets B cells that produce alloantibodies against exogenous FVIII in Hemophilia A patients who consequently require repeated and increased exogenous FVIII administration. In May 2020, we expanded our Payne SRA to include CAAR design and optimization efforts in three additional B cell-mediated autoimmune diseases. We are exploring additional CAAR T cell product candidates that will focus on patients with B cell-mediated autoimmune diseases with well-defined antibody targets.

Our Product Candidates

DSG3-CAART for Mucosal PV

Our lead product candidate, DSG3-CAART, is a CAAR T cell therapy expressing DSG3 antigen epitopes as the extracellular domain of a chimeric immunoreceptor, and is designed to enable specific cytotoxicity toward B cells with DSG3 autoantibody targeting abilities. We believe this strategy has the potential to enable direct elimination of DSG3 autoantibody memory B cells and indirect elimination of DSG3-specific short-lived plasma cells that produce the pathogenic autoantibodies.

Scientific, Clinical and Commercial Assessment

PV is a potentially fatal, chronic autoimmune disease characterized by acantholysis, which is the loss of adhesion between cells of the skin or mucous membranes. Desmosomes are a collection of proteins that provide the structure for epithelial cells to connect with each other. PV results when specific pathogenic autoantibodies disrupt desmosomes by targeting DSG3 and/or DSG1, which are proteins that are part of the desmosomes. These autoantibodies cause the upper layer of the epidermis to split away from its base resulting in characteristic erosions and blisters. Widespread damage to the skin and mucous membranes increases susceptibility to life-threatening systemic infections. PV has two major subtypes:

•

mPV—Characterized by DSG3 autoantibodies only, affecting only mucosal surfaces—accounts for approximately 25% of PV

•

mcPV—Characterized by DSG3 autoantibodies and DSG1 autoantibodies, affecting both mucosal and cutaneous surfaces—accounts for approximately 75% of PV

The presence of DSG-specific antibodies is 98% to 100% sensitive and specific in identifying patients with PV, and these antibodies have been deemed both necessary and sufficient to cause the disease. Thus, in the absence of DSG autoantibodies, PV generally does not occur. In mPV, patients will typically develop painful skin blisters on their mucosal membrane surface, including mouth, nose, throat, genitals, and other orifices, often leading to an inability to eat, drink and function normally. The pathogenic DSG3 autoantibody is made by a specific small number of aberrant B cells, which express the DSG3 autoantibody on their surface. An overview of mPV and mcPV is provided in the figure below.

Visual evidence of clinical manifestations of PV. (Left panel) Inside of cheek of a patient with mPV, showing sloughing mucosa and blistering. (Right panel) Back of a patient showing cutaneous skin blistering and sloughing in a patient with mcPV. Image credit: D@nderm.

Like most autoimmune diseases, the current standard of care for PV relies on general immune suppression, which is often transiently effective but can lead to severe infection, potentially resulting in hospitalization and death. First-line therapy for PV typically consists of corticosteroids in moderate to high doses in combination with the anti-CD20 monoclonal antibody rituximab where clinically appropriate. Second-line therapy focuses on the several systemically immunosuppressive medications such as mycophenolate, azathioprine and methotrexate. Additional options used in the acute setting with severe disease presentation include plasmapheresis, or infusions of intravenous immunoglobulin.

B cell depletion with rituximab was approved by the FDA for the treatment of PV in 2018 and is playing an increasing role as part of the standard of care because it has proven to be one of the more effective therapies for PV. However, data suggest that a significant number of patients treated with rituximab will relapse with or without chronic therapy. Despite its recent approval for use as an adjuvant therapy with corticosteroids in PV, rituximab has several limitations in terms of efficacy, safety and convenience. Rituximab treatment frequently results in relapse, which is reduced but still occurs despite chronic treatment every six months in PV. It does not specifically target the pathogenic B cells, but rather it depletes all CD20-expressing B cells, which leads to an ongoing risk of severe infection and death. As such, there remains not only an unmet medical need in PV, but also a need for safer therapies that can provide a reliable, durable and complete remission off of all other medications.

There are several emerging therapies also being developed for the treatment of PV, which are being evaluated in late-stage clinical trials. These therapies provide important alternative therapeutic options for patients; however, we believe based on early published data that these therapies are unlikely to be curative and do not specifically ablate autoantibody producing B cells.

Epitope Mapping

DSG3 consists of five extracellular cadherin, or EC, domains as shown schematically in the figure below. Since T cell activation depends on the intermembrane distance of the immunologic synapse, we tested different combinations of ECs for expression in primary human T cells using DSG3 fragments as the extracellular domain as shown in the figure below.

Image showing the naturally occurring DSG3 protein and the five EC domains. (B) The CAAR constructs that were evaluated in preclinical studies, containing the whole or subsets of the DSG3 protein. The transmembrane and intracellular signaling domains are identical to those in the CART19 studies published by Penn.

CAAR Construct / Design

The DSG3 EC1-5 CAAR was minimally functional, likely due to the extracellular domain being too large to enable CAAR function or aggregation of the CAAR on the T cell surface. The CAAR designs with either DSG3 EC1-3 or DSG3 EC1-4 showed interferon-gamma production after exposure to the target cells, demonstrating specific cytotoxic activity across targets. In addition, no cytokine production was detected after exposure to cells that did not express surface immunoglobulins or other non-target cells.

The DSG3 EC1-3 was not effective against one target cell known to bind to the DSG3 EC3-4 domain. Together, this data suggests that the DSG3 EC1-4 CAAR is the optimal construct to balance activity while retaining the ability to target locations of known pathogenic antibodies, as shown in the figures below.

Cytotoxicity assay to assess killing activity of DSG3 CAART. Negative control is a CAR T with an antibody fragment attached to the extracellular domain. * indicates construct that was selected for further development. E:T ratio = effector to target ratio.

In Vitro Studies

A variety of in vitro studies were conducted to evaluate DSG3-CAART from a preclinical activity and toxicity perspective. These studies included an evaluation of DSG3-CAART against proteins that are known to bind the DSG3 antigen, a screen of DSG3-CAART against an array of other membrane proteins and a set of studies designed to evaluate the potential effects of soluble DSG3 antibodies against DSG3-CAART. The results of these studies are summarized below.

Evaluation of DSG3-CAART reactivity against known DSG3 binding proteins. The DSG3 antigen presented on the extracellular domain of DSG3-CAART may naturally bind proteins in the body. These proteins may bind to and activate DSG3-CAART, potentially causing toxicity. The native binding proteins for DSG3 are the desmocollin proteins, which are important for cell adhesion in the skin and mucosa. We performed a variety of studies to test whether DSG3-CAART recognizes and activates the desmocollin proteins. Epithelial cells isolated from various primary organ systems that express some level of desmocollin proteins were screened. Potential DSG3-CAART activity was evaluated through the detection of cytokines released against each cell type and cytotoxicity. The data demonstrated an absence of inflammatory T cell cytokines after being exposed to these cells, indicating an absence of T cell activation. No cytotoxicity was detected except at very high, non-pharmacologically feasible doses. Collectively, we believe there is sufficient evidence to suggest that the DSG3 protein in the context of a CAAR does not meaningfully interact with desmocollin proteins.

Evaluation of DSG3-CAART off-target binding against membrane proteins. A membrane protein array was utilized to screen the DSG3-CAART extracellular domain against 5,300 membrane proteins, which encompass the approximate number of membrane proteins contained in the human genome. The confirmatory screen yielded no off-target signals, except for one weak signal against a protein that is known to bind to glycoproteins, and which was detected in both the test and control conditions. Further evaluation of this protein in cell-based assays indicated that DSG3-CAART does not recognize and activate against this protein.

Evaluation of the effect of soluble antibodies on DSG3-CAART function. We expect that circulating antibodies may prompt an active immune response against treatment with CAAR T cell therapy. These antibodies can induce proliferation of DSG3 CAAR T cells but may also neutralize the cells. In our preclinical in vitro studies, we observed that while DSG3 antibodies may have a variable effect on CAAR function, there was no systematic effect to enhance or reduce CAAR function. These dynamics were evaluated in a series of in vitro studies as follows:

•

Soluble DSG3 antibodies were added to CAAR T cell cytotoxicity assays, at a range of concentrations likely to be encountered in patients, to assess the impact on CAAR function. In all cases when the CAAR T cells were tested in the presence of soluble DSG3 antibodies, they retained their killing function. In addition, the presence of antibodies did not demonstrate a systematic effect to enhance or reduce the CAAR T cells’ cytotoxic ability. Therefore, we believe that removal of circulating soluble DSG3 antibodies from patients prior to infusions may not be necessary to enable potential benefit.

•

Monoclonal DSG3 antibodies with an enhancing effect were evaluated in combination with PV patient serum to assess their impact on DSG3 CAAR T cell division and stimulation of cytokine production. Monoclonal DSG3 antibodies were capable of inducing DSG3 CAAR T cell division and stimulated production of moderate levels of cytokine production, as measured by interferon gamma. Therefore, we believe the presence of DSG3 autoantibodies in patients may contribute to the DSG3 CAAR T cell population expansion post-infusion.

•

Antibodies purified from PV patients were added to DSG3 CAAR T cells at a range of concentrations known to commonly occur in patients in order to evaluate the extent to which patient serum may activate CAAR T cells. These antibodies induced a dose dependent increase in interferon gamma.

•

Off-target toxicity may also be seen due to antibody-mediated bridging of DSG3 CAAR T cell cytotoxicity against hematopoietic cells that express receptors designed to bind to antibodies, known as Fc receptors. To evaluate this, we loaded DSG3 antibodies onto cells expressing antibody-binding receptors, and evaluated the ability of DSG3 CAAR T cells to bind and activate against these targets in vitro. No evidence of cytotoxicity was observed, suggesting the potentially low risk of off-target killing mediated by this mechanism.

In Vivo Studies

To evaluate DSG3-CAART in vivo, four murine models were used. These models were designed to directly compare the potency of DSG3-CAART in comparison with CART19 cells; evaluate the potential for on-target skin toxicity; and measure the activity of DSG3-CAART in the presence of polyclonal soluble DSG3 antibodies.

•

Evaluation of potency of DSG3-CAART in a human B cell tumor line compared to CART19 cells. This B cell model contained genetically-modified B cells to express DSG3 antibodies on the cell surface in addition to luciferase, a bioluminescence marker, and allowed evaluation of DSG3-CAART’s ability to engage and kill B cells that express the pathogenic antibody. CART19 cells were used as a positive control in this model as the B cells express CD19 on their cell surface. In this model, DSG3-CAART was found to result in a similar reduction of B cells compared to the CART19 cells.

•

Evaluation of on-target skin toxicity mediated by DSG3-CAART. A human skin-xenografted model was used to evaluate the potential skin toxicity of DSG3-CAART by evaluating if the extracellular domain would react with desmocollin proteins, which are the known target for DSG3. These results were compared directly to a positive control CAR T expressing a DSG3 specific antibody as an extracellular domain. In this model, we observed the absence of skin toxicity mediated by the DSG3-CAART cells compared to the positive control, which did demonstrate skin toxicity.

•

Evaluation of DSG3-CAART in the presence of soluble antibodies. We also tested a model where mice have circulating DSG3 antibodies to mimic the situation in PV patients. In this model, the DSG3 antibodies have well-defined and different epitopes with varying affinities, which may reflect the potential breadth of B cell targets that could be encountered in PV patients. The mice were then treated with DSG3-CAART, which was compared to non-CAAR expressing T cells, or negative control CAR T cells. In this model, we observed amelioration of disease (see figure A below), reduction of DSG3 antibody titers (see figure B below), as well as control of the pathogenic B cells (see figure C below), by DSG3-CAART. In this model, DSG3-CAART also demonstrated dose-related activity, particularly in regard to reduction of serum autoantibodies, epithelial-bound autoantibodies (not shown in Figures) and DSG3-CAART engraftment, suggesting that higher DSG3-CAART doses may promote engraftment (see Figures D and E). We believe these results show the functional activity of DSG3-CAART in the presence of soluble antibody.

Histology showing DSG3 CAAR maintaining normal epithelial cell structure in treated animals.

OD450 is a proxy measure for anti-serum DSG3antibodies in the blood. * indicates statistically significant reduction in DSG3 serum antibody level in DSG3-CAART treated mice. P value is < 0.05. *** indicates statistically significant increase in DSG3 serum antibody level in the negative control CAR treated group. P value is < 0.001.

Total flux is a quantitative measure of cell bioluminescence, which approximates cell activity in this assay.


D

OD450 is a proxy measure for the level serum anti-DSG3 antibodies in the blood. Serum anti-DSG3 ELISA was performed on day 10 for all mice with remaining serum samples available, indicating that mice treated with the 3x10⁷ and 1x10⁷ DSG3-CAART dose effectively reduced serum anti-DSG3 IgG production compared to mice treated with NTD T-cells or the 3x10⁶ DSG3-CAART dose.** indicates statistically significant reduction in DSG3 serum antibody level in DSG3-CAART treated mice. P value is < 0.01. * indicates statistically significant increase in DSG3 serum antibody level in the negative control CAR treated group. P value is < 0.05. ns indicates a non-significant difference.

Quantification by flow cytometry of CD3-positive T-cells in peripheral blood on day 10 and 17 is shown. The data support dose-related DSG3-CAART engraftment based on increased CD3+ cells with increased DSG3-CAART dose.

•

Evaluation of DSG3-CAART in an active immune model. An exploratory active immune mouse model for PV was developed to better represent the human phenotype in autoimmune disease. This model involved generating anti-DSG3 B cells in a mouse without DSG3 by repeated immunization with human DSG3. Splenocytes containing anti-DSG3 B cells from the immunized mouse were transferred into an immunodeficient mouse to generate the PV phenotype. These mice produced DSG3 antibodies against multiple extracellular domains of the DSG3 antigen, including EC5, at physiologic levels comparable to those observed in PV patients. Treatment with DSG3 EC1-4 CAAR T cells, in the absence of preconditioning, effectively lowered serum DSG3 antibody levels by ELISA, reduced antibodies against relevant DSG3 domains by epitope mapping and reduced blistering by histology. These mice retained autoantibodies targeting the DSG3 EC5 region, though the mice did not show clinical manifestations of PV.

•

See figure F below for a schematic representation of the experiment.

Schematic representation of the PV active immune model. A DSG3 knockout mouse is immunized with DSG3 EC1-5. The knockout mouse develops antibodies against DSG3 across all EC domains. The splenocytes from the knockout mouse are transferred to an immunodeficient mouse where the DSG3 antibodies cause a clinical phenotype consistent with PV. Those mice are then treated with DSG3-CAART (EC1-4 domains only).

Clinical Development Plan

The FDA cleared our IND for a Phase 1 trial of DSG3-CAART in September 2019. The FDA granted DSG3-CAART orphan drug designation for the treatment of PV in January 2020 and fast track designation for improving healing of mucosal blisters in patients with mPV in May 2020. We announced that the first patient was dosed in the DesCAARTes^TM trial in December 2020. The DesCAARTes^TM trial is an open-label trial to assess the safety and tolerability of various dosing regimens of DSG3-CAART in the treatment of subjects with active mPV. DSG3-CAART will be administered by intravenous infusion, using a fractionated-dose infusion scheme of escalating numbers of DSG3-CAART cells for the initial cohorts in the first phase. This dosing scheme is designed to reduce the potential risks associated with acute infusion-related toxicities while preserving potential benefit for subjects by

allowing a total infused dose that we believe is large enough to be potentially therapeutic based on prior CAR T trials.

We expect that the Phase 1 trial will have three parts:

•

Part A: Fractionated dose escalation

•

Part B: Fractionation reduction at the selected dose

•

Part C: Expansion phase at the selected dose and administration scheme

In Part A, the split dose uses dose fractionation to accommodate a low number of cells in the first infusion while still advancing the dose within the cohort up towards and spanning the range of cell doses that have been therapeutic in past gene-engineered T cell therapy trials. In Part B, the dose selected from Part A will be delivered in a decreasing number of dose fractionations to determine the dose fractionation strategy. In Part C, subjects will be enrolled at the dose and fractionation, as determined in Part A and B, to generate additional safety and outcome data to support the rationale for and design of future clinical trials.

Patients are eligible to be enrolled if they have a confirmed diagnosis of mPV based on biopsy for histology and positive DSG3 ELISA; active disease at screening; elevated DSG3 by ELISA at screening; and previously been inadequately managed by, or refractory to, or relapsed after, or with contraindications to or intolerance of at least one prior systemic therapy. The primary objective of the trial is to evaluate the safety of DSG3-CAART cells, and secondary objectives include evaluating the initial signs of target engagement.

We believe the risk of cytokine release syndrome, or CRS, a potentially life-threatening toxicity that has been observed after treatment with some types of immunotherapy, may be reduced with our CAAR T cells, due to its correlation with target cell burdens. In the context of treating cancer, the target cell population consists of all B cells (healthy and cancerous), whereas our CAAR T cells only target the small subset of disease-causing reactive B cell population. While the possibility of cytokine release in a clinical trial resulting from strongly activating soluble antibody cannot be ruled out, to date we have not observed any evidence of it in preclinical studies.

The primary endpoint of the study is the incidence of adverse events within three months of DSG3-CAART infusion, including dose limiting toxicity defined as occurring within 28 days of infusion. The FDA has requested, and we have agreed, that we will share data from cohort A to inform a discussion on the optimal design of cohort C. According to FDA guidance, the submission of cohort A data is not gating to planned enrollment in cohort B and the FDA plans to provide feedback, if any, in a timely manner. In addition, we plan to report on acute tolerability data on no less than a cohort basis, which is defined to include adverse events within eight days following DSG3-CAART infusion. We believe the eight-day timeframe appropriately covers the period of time when one would expect the onset of CRS in most subjects. We also currently intend to communicate serious adverse events once we have sufficient understanding of the events, if they materially change timelines or the trial design.

We also expect to provide updates from time-to-time related to target engagement in subjects receiving DSG3-CAART typically only once data is available for a full cohort. Although possible but not expected in the lower dosing cohorts, we believe target engagement could be observed if DSG3 autoantibody titer falls within six months after DSG3-CAART infusion in addition to other parameters of engraftment and target engagement that will be monitored regularly. Clinical responses, including improvement or resolution of mucosal lesions and absence of new lesions will also be evaluated.

DSG3/1-CAART for mcPV

Scientific and Commercial Assessment

Our next PV product candidate, DSG3/1-CAART, is being designed to target DSG3 and/or DSG1 autoantibodies on pathogenic B cells that cause mcPV. mcPV is the most severe and most common subtype of PV and affects approximately 75% of PV patients. While mPV is caused by DSG3 autoantibodies, mcPV involves autoantibodies to both DSG3 and DSG1, resulting in the additional involvement of skin erosion and blistering.

Similar to mPV, mcPV is typically treated with immune suppression, which has a high rate of relapse and potential for hospitalizations and fatal infections.

Epitope Mapping

DSG1 consists of five EC domains, with all known pathogenic epitopes occurring in the DSG1 EC1-4 domains. Similar to development of DSG3-CAART, we tested different combinations of DSG1 ECs for expression in primary human T cells using DSG1 fragments as the DSG1 EC domains. Given prior development of DSG3 CAAR, we leveraged those findings in the design of our DSG1 CAAR.

CAAR Construct / Design

We also tested multiple combinations of EC domains of DSG1 CAAR administered alone and in combination with the DSG3 EC1-4 CAAR to evaluate for cell-surface expression of the CAAR along with the potency and breadth of target cell killing. In this setting, the DSG1 EC1-4 CAAR showed robust and specific cytotoxicity towards all known pathogenic epitopes.

In Vitro Studies

CAAR development for mcPV, based on the targeting of DSG3- and/or DSG1-specific B cells, has shown promising preclinical results. DSG1 CAAR T cells specifically killed DSG1-specific B cells in vitro. In addition, we observed that with a 1:1 mixture of DSG3 and DSG1 CAAR T cells had killing capabilities without synergistic or antagonistic effect.

In Vivo Studies

The activity and toxicity of DSG3 and DSG1-CAAR T cells was evaluated using human skin xenografts in comparison with anti-CART19 cells, which are known from human clinical trials not to cause direct skin toxicity. A 1:1 mixture of DSG3 and DSG1 CAAR T cells did not show off-target toxicity in vivo.

Development Plan

From a regulatory and clinical trial design perspective, we anticipate that many of the elements incorporated into the planned DesCAARTes^TM trial will carry over to DSG3/1-CAART. We plan to evaluate the initial cohorts of patients from the planned DesCAARTes^TM trial to evaluate for safety and evidence of target engagement prior to proceeding with an IND submission for DSG3/1-CAART. We believe that, because mcPV is the most prevalent subset of PV and the patients are generally followed by the same subspecialists, it will allow for a wider patient pool eligible for a clinical trial. We anticipate the DSG3/1-CAART clinical trial protocol will have a significant amount of overlap with the DSG3-CAART protocol, but it will be informed by clinical data from the early cohorts in the DesCAARTes^TM trial. We further anticipate being able to use the same centers from the DesCAARTes^TM trial to enroll patients for the DSG3/1-CAART clinical trials.

We are currently evaluating advanced manufacturing technologies that would potentially allow us to administer DSG3/1-CAART as a single product rather than requiring separate administration. The size of the DSG3/1 product candidate will likely require us to incorporate additional technologies to accommodate the size of the final CAAR construct. An evaluation of potential technologies to achieve this objective is ongoing. Upon completing the evaluation of these manufacturing technologies, we expect to conduct additional in vitro and in vivo studies using the combined product. While a product that administers a DSG3 CAAR and DSG1 CAAR as two separate products may be feasible, we believe that there would be significant advantages to developing a combined product from a regulatory and commercial perspective.

MuSK-CAART for MuSK Myasthenia Gravis

Scientific, Clinical and Commercial Assessment

MG is an autoimmune disease induced by autoantibodies targeting the neuromuscular junction, or NMJ, which can lead to life-threatening muscle weakness. Generalized MG, or gMG, is characterized by profound muscle weakness throughout the body, resulting in motor impairment, disabling fatigue, shortness of breath due to respiratory muscle weakness and episodes of respiratory failure.

gMG affects approximately 50,000 to 80,000 patients in the United States. The majority of patients who develop gMG have autoantibodies against some part of the NMJ that are known to be pathogenic. 80% to 90% of patients with gMG have autoantibodies against the acetylcholine receptor, or AchR, detectable in their serum. Approximately 6% to 7.5% of patients with gMG have autoantibodies against MuSK, which is a different target on the surface of the muscle membrane.

Patients diagnosed with MuSK MG have a different recommended treatment course compared to patients with AchR MG. Importantly, many patients with MuSK MG respond poorly to cholinesterase inhibitors, which are often the first line of therapy in AchR MG. In that setting, patients with MuSK MG are typically started on corticosteroids in addition to one or more steroid-sparing immunosuppressive agents. Corticosteroids are tapered to the extent possible to prevent disease relapse, though many remain dependent on corticosteroid despite concomitant treatment with immunosuppressive medications. In the acute setting, plasmapheresis or intravenous immunoglobulin may be used to address severe disease. Rituximab is often considered as a second-line therapeutic option in patients with an inadequate response to initial immunosuppressive medications. Importantly, complement is not thought to be meaningfully implicated in the pathophysiology of MuSK MG, and complement inhibitors are not indicated for treatment of disease.

Epitope Mapping

The MuSK protein has a similar structure and size as compared to DSG3. MuSK contains four extracellular domains, as shown below.

Figure illustrating the domains of the wild-type MuSK protein.

Studies conducted in patients with MuSK MG have revealed that the autoantibodies may be against epitopes located in each of the extracellular domains for MuSK.

CAAR Construct and Design

With an understanding that pathogenic autoantibody epitopes may target any domain of MuSK, multiple MuSK CAAR candidates have been engineered that incorporate all extracellular domains. Each CAAR construct is being or will be tested in preliminary in vitro and in vivo experiments.

In Vitro Studies, In Vivo Studies and Development Plan

Data from our initial in vitro and in vivo studies of MuSK-CAART was presented at the American Academy of Neurology’s Science Highlights Virtual Platform in May 2020. The efficacy and safety of MuSK CAAR T cells were investigated using in vitro cytotoxicity assays, in vitro screens for off-target toxicity and a mouse model to evaluate the efficacy of human MuSK CAAR T cells against MuSK antibody expressing B cells in vivo. In preclinical studies, MuSK CAAR T cells containing the native MuSK extracellular domain demonstrated in vitro cytotoxicity towards a panel of B cells expressing anti-MuSK antibodies specific for different extracellular regions of the MuSK protein, but no observed cytotoxicity when anti-MuSK antibodies are not expressed (figure below). Additionally, MuSK CAAR T cells did not demonstrate cytotoxicity toward cells expressing LRP4, which is a different protein in the neuromuscular junction that can bind with naturally occurring MuSK in certain configurations.

Figure illustrating that MuSK-CAART, which contains the native MuSK extracellular domain, demonstrated selective and specific in vitro cytotoxicity towards a B cell line expressing anti-MuSK antibodies targeting different MuSK epitopes across multiple domains of the native MuSK protein. The specific lysis increases directly with increasing effector to target ratios for MuSK-CAART.

As illustrated in the figure below, in an in vivo mouse model, MuSK CAAR T cells, but not control CAAR T cells, showed biological activity by blocking the growth of B cell lines expressing an anti-MuSK antibody.

Figure illustrating MuSK CAAR T cells are able to recognize and suppress anti-MuSK target cells in a murine model. The target cells express both CD19 and anti-MuSK B cell receptors, and CART19 is used as a positive control in this experimental system.

Based in part on these results, IND-enabling studies were initiated for the MuSK-CAART product candidate. An IND submission is anticipated in the second half of 2021 for MuSK-CAART.

FVIII-CAART for Hemophilia A with Factor VIII Alloantibodies

While our CABA platform is primarily directed towards the treatment of B cell-mediated autoimmune diseases, we believe the approach may be applicable in other instances where B cell antibody production is implicated. Specifically, we have identified an opportunity to apply the CABA platform to develop potential CAAR adjunctive therapies in cases where the immune system has or produces antibodies against potential therapies, which is known as an alloimmune response. These alloantibodies can prevent a particular therapy from being delivered effectively because the therapy is degraded by the immune response due to alloantibody binding. We believe our approach has the potential to address the alloantibody response by specifically ablating the B cells responsible for producing the alloantibodies through a similar mechanism seen in autoimmune disease. With the alloantibody producing cells ablated, the treatment could then be provided.

Scientific, Clinical and Commercial Assessment

Hemophilia A is an X-linked bleeding disorder caused by mutations in the FVIII gene resulting in a deficiency of functional FVIII, a critical factor in blood coagulation. It affects about 1:5,000 male births. Severe Hemophilia A, where FVIII levels are less than 1% of normal, accounts for about 60% of all cases and is characterized by frequent spontaneous bleeds. Currently, Hemophilia A is treated with FVIII replacement via intravenous administration.

The main complication of FVIII replacement therapy is that 20% to 30% of patients with severe disease develop neutralizing alloantibodies against the FVIII protein. These alloantibodies decrease the levels of FVIII and at high titers, render attempts to replace or stimulate the production of FVIII ineffective. The risk of alloantibody development for patients with severe Hemophilia A is highest during their initial FVIII exposures. The standard treatment to reverse alloantibody formation consists of repeated high-dose infusions of FVIII, which has limited efficacy, a high cost and is difficult to titrate to an appropriate therapeutic level for the patient. We believe FVIII-

CAART could be effective in addressing patients with Hemophilia A who have developed FVIII antibodies that require repeated, high-dose administrations of FVIII.

Epitope Mapping

The following image depicts FVIII, which is a large glycoprotein consisting of six domains that interact with each other to form the full complex.

Studies conducted in patients with Hemophilia A have revealed that acquired FVIII alloantibodies following exogenous FVIII administration are typically directed against A2, C1 and C2 domains of FVIII.

CAAR Construct and Design

Preliminary FVIII CAAR and CAAR-like constructs have been engineered that target parts, but not all, of the FVIII domains. Dr. Milone, one of our scientific co-founders, has led the development of one such construct.

Development Plan

Internally, we are conducting additional studies to optimize our FVIII-CAART development. The focus of these studies will be to fully characterize any additional pathogenic epitopes and construct a FVIII-CAART that includes additional FVIII domains. Given the size of the FVIII protein, this will likely require us to incorporate additional technologies to reduce the size of the final CAAR construct. An evaluation of potential technologies to achieve this objective is ongoing.

Manufacturing

Manufacturing Strategy

We intend to implement a three-stage plan that we believe will ultimately enable us to achieve manufacturing independence. Part of our strategy relies on engaging non-profit and commercial suppliers early and in a staged manner. We believe partnering with proven and reputable manufacturing partners will allow us to efficiently deploy financial and personnel resources. Stage 1 of this plan is in place and utilizes the deep expertise in cell and vector manufacturing from our partners at Children’s Hospital of Philadelphia, or CHOP, and Penn. This included early development work, support of the DSG3-CAART IND, and cell and vector product manufacturing for our DesCAARTes^TM trial. We believe these facilities will allow us to move efficiently into clinical trials but are not sufficient to support a commercial license.

Stage 2 of our plan is designed to engage partners who are qualified for manufacturing of vector at commercial grade and scale and cell therapy products. We are aware that changes in any manufacturing process or facility introduces regulatory and scientific risk to a development program, if the changes result in a product that is not comparable. We plan to mitigate these risks primarily in two ways:

By securing contract manufacturing organizations, or CMOs, as partners during Stage 2 of our manufacturing strategy early on for both vector and cell manufacturing. We plan to prioritize potential partners who are qualified to, and have an established track record of, the commercial production of vector and cell products. We believe this allows us to make one change in our supply partners during an early period of clinical development to facilitate in vitro comparability testing and clinical validation, prior to controlled clinical studies.

By licensing the cell manufacturing process used for our planned Phase 1 DSG3-CAART first-in-human study from Penn. This is allowing us the time to understand the process used in order to reduce the chance of changes that may impact comparability.

In addition to Stage 2, and contingent on sufficient clinical evidence from our planned DesCAARTes^TM trial, we are further planning to pursue Stage 3 in manufacturing supply. During Stage 3, we plan to build, qualify and run our own manufacturing facility. We believe this additional stage will enable full control of continuous improvement, product development and commercial supply for products arising from our CABA platform. Our Chief Executive Officer and Executive Vice President, Science and Technology have both, in prior roles, built and led organizations that have constructed and commissioned cell therapy facilities.

Vector Manufacturing

The lentiviral vector that we plan to use in the initial subjects in our DesCAARTes^TM trial was manufactured at CHOP. We have also reserved multiple vector manufacturing slots at Penn and CHOP, which we may use in our DSG3-CAART or subsequent clinical trials. In parallel, we are engaging in development work with multiple CMOs with a plan to secure production slots for vector which may be used in our DSG3-CAART or subsequent clinical trials. We believe these efforts will provide us with sufficient clinical-grade vector to move forward with our anticipated clinical trials.

Cell Manufacturing

We have entered into a collaboration with the Clinical Cell and Vaccine Production Facility, or CVPF, at Penn, to provide focused scientific, technical and regulatory support for CAAR T cell manufacture. CVPF is accredited by the Foundation for the Accreditation of Cellular Therapy and is capable of and experienced at supporting manufacture for early-phase clinical trials of novel cell therapy products in first-in-man clinical trials. We expect to rely upon CVPF to provide initial Phase 1 clinical trial drug supply for DSG3-CAART. Penn’s manufacturing process for DSG3-CAART is directly related to the process developed at Penn for early clinical trials of CART19, which subsequently became known commercially as Kymriah. The process was later transferred to Novartis Pharmaceuticals Corporation and further modified for the Kymriah program.

As we scale our manufacturing of DSG3-CAART and our other product candidates to meet our expected needs for further clinical trials, we may or may not rely on Penn, but we also expect to rely on CMOs and other third parties for the manufacturing and processing of our clinical trial materials. Any CMO that we select will be subject to cGMP requirements. We believe the use of contract manufacturing for our pipeline programs will be cost-effective and allow us to rapidly prepare for clinical trials in accordance with our development plans. In preparation for this transition, we have engaged multiple third-party contractors to manufacture clinical grade viral vector used to deliver the applicable CAAR gene into the T cells. We have also initiated development work with certain contractors for cGMP and commercial vector production. We expect third-party manufacturers will be capable of providing and processing sufficient quantities of our product candidates to meet anticipated clinical trial demands and commercial need. In January 2021, we initiated a collaboration with WuXi to serve as our cell processing manufacturing partner for the anticipated MuSK-CAART Phase 1 clinical trial.

Once we have sufficient clinical data from subjects in our DSG3-CAART study, we intend to begin the process of engineering and then establishing our own commercial scale GMP-compliant manufacturing facility. We believe this will allow us to enhance supply chain control, increase supply capacity and help ensure clinical and commercial demand for our pipeline programs is met in the event that DSG3-CAART receives marketing approval. Informed by our experience in building cell therapy facilities and creating supply chains, we plan to develop a robust supply chain with alternative sources to maintain continuous supply. In parallel with these activities, we are evaluating and executing proof-of-concept studies to test advanced manufacturing and automation technologies to continuously improve the manufacturing process and meet commercial and scalability targets.

Commercialization

Our aim is to become a fully integrated cellular therapy company in order to improve the lives of patients with B cell-mediated autoimmune diseases. We have designed a strategic approach to move forward with our lead product candidate, DSG3-CAART, while at the same time having a number of product candidates in development. The product candidates from our CABA platform address clinical indications where there is a compelling opportunity to improve clinical outcomes in comparison with the current standard of care in an easily identified patient population. Our initial product candidates are focused on rare disease populations where we believe there is potential to commercialize independently. This is due to a concentration of treatment paradigms and limited but easily identified patient populations. Our plan is to focus commercialization and launch efforts initially in the United States, and eventually in the European Union and Asia-Pacific geographies.

Competition

The biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies, intense competition and a strong focus on intellectual property. We face competition from many different players, including large and specialty pharmaceutical and biotechnology companies, academic research organizations and governmental agencies. Any therapeutic candidates we successfully develop and commercialize will compete with the existing standard of care as well as any novel therapies that may gain regulatory approval in the future.

Existing treatment options for PV are limited. Rituximab, marketed by Roche Holding AG, is the first drug to have received approval for PV in the United States in over 60 years. In Europe, the approved therapies for PV are corticosteroids, azathioprine and rituximab. Other standard of care treatments include various immunosuppressants, plasmapheresis, and intravenous immunoglobulin infusions given monthly or on another periodic chronic basis. Additionally, multiple biopharmaceutical companies have therapies in clinical development.

Competition in the MuSK MG autoimmune space is currently dominated by the current standard of care, rituximab. A second approved approach to treating patients is IVIG, which is available through CSL Behring LLC, Grifols, S.A., and Mitsubishi Tanabe Pharma Corporation. Additionally, multiple biopharmaceutical companies have therapies in clinical development.

Multiple therapies are approved or in development for the treatment of Hemophilia A patients who develop alloantibodies against FVIII. Standard of care is typically immune tolerance induction, or ITI, therapy with higher doses of FVIII. Available treatments for those who do not respond to ITI include anti-inhibitor coagulation complexes, recombinant factor VIIa, and bispecific factor IXa- and factor X-directed antibodies. Companies who market products or are developing product candidates within these categories of medicine include Catalyst Pharmaceuticals, Inc., Novo Nordisk A/S, OPKO Health, Inc., Roche Holding AG and Takeda Pharmaceutical Company.

We believe we are the first and only company developing CAAR T drug candidates for the treatment of B cell-mediated autoimmune diseases. However, despite the significant differences in discovery, development and target populations between oncology and autoimmune targets, we recognize that companies with an investment and expertise in CAR T cell development for oncology indications could attempt to leverage their expertise into B cell-mediated autoimmune disease-affected populations. We are aware of biotechnology companies that are exploring other methods of engineering T cells for the treatment of autoimmune conditions. In addition, some biotechnology companies are engineering red blood cells to incorporate self-antigens with the goal of tolerizing the immune system to treat autoimmune and alloimmune conditions.

Many of the companies against which we are competing or against which we may compete in the future have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industry may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.

Intellectual Property and Barriers to Entry

We strive to protect the proprietary technologies that we believe are important to our business, including pursuing and maintaining patent protection intended to cover our product candidates and their use, as well as other inventions that are important to our business. In addition to patent protection, we also rely on know-how, confidentiality agreements, invention assignment agreements and trade secrets to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection, to develop and maintain our proprietary position. The confidentiality agreements are designed to protect our proprietary information and the invention assignment agreements are designed to grant us ownership of technologies that are developed for us by our employees, consultants or certain other third parties. We seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical security of our premises and physical and electronic security of our information technology systems. While we have confidence in our agreements and security measures, either may be breached, and we may not have adequate remedies. In addition, our trade secrets may otherwise become known or independently discovered by competitors.

Our commercial success depends in part upon our ability to obtain and maintain patent and other proprietary protection for commercially important technologies, inventions and trade secrets related to our business, defend and enforce our intellectual property rights, particularly our patent rights, preserve the confidentiality of our trade secrets and operate without infringing valid and enforceable intellectual property rights of others.

The patent positions for biotechnology companies like us are generally uncertain and can involve complex legal, scientific and factual issues. In addition, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted and even challenged after issuance. As a result, we cannot guarantee that any of our product candidates will be protectable or remain protected by enforceable patents. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. Any patents that we hold may be challenged, circumvented or invalidated by third parties.

As of February 1, 2021, our patent estate (all of which has been in-licensed) included one issued U.S. patent, seven pending U.S. patent applications, and 34 pending foreign patent applications. See “—Our Material Agreements—Amended and Restated License Agreement with the Trustees of the University of Pennsylvania and the Children’s Hospital of Philadelphia.”

With regard to our DSG3-CAART and DSG3/1-CAART product candidates, we have one issued U.S. patent with claims directed to a genetically modified cell containing a chimeric autoantibody receptor containing an extracellular domain containing DSG3, DSG1 or fragments thereof, which is scheduled to expire in 2035, without taking a potential patent term extension into account. We also have four pending U.S. patent applications and

counterpart patent applications pending in Canada, China and Europe, which if issued, would be expected to expire in 2035. This patent family is owned by Penn and exclusively licensed to us in the field of the license.

With regard to our MuSK-CAAR T cell product candidate, we have one pending U.S. patent application and counterpart patent applications pending in Australia, Canada, China, Europe, Israel, Japan, Korea, Mexico, New Zealand, and Russia, which if issued, would be expected to expire in 2039. This patent family is owned by Penn and exclusively licensed to us in the field of the license.

With regard to our FVIII-CAAR T cell product candidate, we have one pending U.S. patent application and counterpart patent applications pending in Australia, Canada, China, Europe, Japan, Hong Kong, Korea, Mexico, New Zealand, and Russia, which if issued, would be expected to expire in 2037. This patent family is co-owned by Penn and CHOP and is exclusively licensed to us in the field of the license.

The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent term is 20 years from the earliest date of filing a non-provisional patent application.

In the United States, the term of a patent covering an FDA-approved drug may be eligible for a patent term extension under the Hatch-Waxman Act as compensation for the loss of patent term during the FDA regulatory review process. The period of extension may be up to five years beyond the expiration of the patent, but cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval. Only one patent among those eligible for an extension may be extended, and a given patent may only be extended once. Similar provisions are available in Europe and in certain other jurisdictions to extend the term of a patent that covers an approved drug. It is possible that issued U.S. patents covering each of our product candidates may be entitled to patent term extensions. If our product candidates receive FDA approval, we intend to apply for patent term extensions, if available, to extend the term of patents that cover the approved product candidates. We also intend to seek patent term extensions in any jurisdictions where they are available, however, there is no guarantee that the applicable authorities, including the FDA, will agree with our assessment of whether such extensions should be granted, and even if granted, the length of such extensions.

In addition to patent protection, we also rely on know-how and trade secret protection for our proprietary information that is not amenable to, or that we do not consider appropriate for, patent protection, to develop and maintain our proprietary position. However, trade secrets can be difficult to protect. Although we take steps to protect our proprietary information, including restricting access to our premises and our confidential information, as well as entering into agreements with our employees, consultants, advisors and potential collaborators, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our know-how, trade secrets, and other proprietary information.

In addition, we plan to rely on regulatory protection based on orphan drug exclusivities, data exclusivities, and market exclusivities. See “—Government Regulation” for additional information.

Our Material Agreements

Amended and Restated License Agreement with the Trustees of the University of Pennsylvania and the Children’s Hospital of Philadelphia

In July 2019, we entered into an amended and restated license agreement, or the License Agreement, as further amended in May 2020, with Penn and CHOP, collectively the Institutions, pursuant to which we obtained (a) a non-exclusive, non-sublicensable, worldwide research license to make, have made and use products in two subfields of use, (b) effective as of October 2018, an exclusive, worldwide, royalty-bearing license, with the right to sublicense, under certain patent rights of the Institution to make, use, sell, offer for sale and import products in the same two subfields of use, and (c) effective as of October 2018, a non-exclusive, worldwide, royalty-bearing license, with limited rights to sublicense, under certain of Penn’s know-how, which know-how satisfies certain criteria and is listed on a mutually agreed-to schedule, to make, have made, use, sell, offer for sale, import and have imported products in the same two subfields of use. Our rights are subject to the rights of the U.S. government and certain

rights retained by the Institutions. The License Agreement was amended in May 2020 to add certain intellectual property relating to one of the three undisclosed disease targets.

Unless earlier terminated, the License Agreement expires on the expiration or abandonment or other termination of the last valid claim in the intellectual property we license from Penn. We may terminate the License Agreement at any time for convenience upon 60 days written notice. In the event of an uncured, material breach, Penn may terminate the License Agreement upon 60 days written notice.

Penn maintains control of all filing, prosecution and maintenance of the Institutions’ patent rights licensed by us, and we are responsible for all ongoing patent costs during the term of the agreement. We also reimbursed Penn for its out-of-pocket expenses incurred prior to the effective date of the agreement with respect to the filing, prosecution and maintenance of the patent rights licensed by us. Under the terms of the License Agreement, we were also obligated to pay $2.0 million annually for three years beginning August 2018 for funding to the laboratories of each of Drs. Milone and Payne. See “—Sponsored Research Agreements with the Trustees of the University of Pennsylvania.”

Under the License Agreement, we must use commercially reasonable efforts to develop and commercialize a product in each subfield. During the term of the License Agreement until the first commercial sale of the first product, we are obligated to pay Penn a non-refundable, non-creditable annual license maintenance fee of $10,000. We are required to pay certain milestone payments upon the achievement of specified clinical and commercial milestones. Milestone payments are reduced by a certain percentage for the second product that achieves a milestone, by an additional percentage for the third product that achieves a milestone, and so on, for each subsequent product that achieves a milestone. In the event that we are able to successfully develop and launch multiple products under the License Agreement, total milestone payments could be approximately $21.0 million. Penn is also eligible to receive tiered royalties at percentage rates in the low single-digits, subject to an annual minimum royalty, on annual worldwide net sales of any products that are commercialized by us, our affiliates or our sublicensees that contain, use, embody, result from the use of or incorporate, or are covered by, the intellectual property licensed by us. To the extent we sublicense our license rights under the License Agreement, Penn would be eligible to receive tiered sublicense income at percentage rates in the mid-single to low double-digits. We have also entered into a subscription and technology transfer agreement with Penn, pursuant to which we owed Penn an upfront subscription fee, which was paid in 2019, and a nominal non-refundable royalty on the net sales of products, a portion of which will be credited toward milestone payments and royalties under this License Agreement. Technology transfer activities would be at our cost and subject to agreement as to the technology to be transferred.

Sponsored Research Agreements

The Company has sponsored research agreements with two faculty members at Penn, who are also scientific co-founders of the Company and members of the Company’s scientific advisory board. In May 2020, one of the agreements was amended to expand the scope of sponsored research. In August 2020, this agreement was further amended to extend the term of the original research plan.

Under the amended agreements, the Company has committed to funding a defined research plan through February 2023. The total estimated cost of $11,781 under the agreements satisfies the Company’s annual obligation under the License Agreement (see Amended and Restated License Agreement with the Trustees of the University of Pennsylvania above). As of December 31, 2020, $7,090 of cost has been incurred pursuant to these agreements. For the years ended December 31, 2020 and 2019, the Company recognized research and development expense of $2,995 and $2,137, respectively, related to these agreements in the accompanying statements of operations. As of December 31, 2020 and 2019, $1,851 and $1,588 respectively, of advance payments are included in Prepaid expenses and other current assets in the accompanying balance sheets and there was $217 included in Accrued and other current liabilities in the accompanying balance sheets as of December 31, 2020.

Master Translational Research Services Agreement

In October 2018, the Company entered into a services agreement (the Services Agreement) with Penn for additional research and development services from various laboratories within Penn. The research and development activities are detailed in separately executed Penn organization-specific addenda. In May 2020, the Company amended its Addendum with the Center for Advanced Retinal and Ocular Therapeutics (CAROT) to expand access to vector manufacturing.

Research and development expense related to executed addenda under the master translational research service agreement with Penn recognized in the accompanying statements of operations for the years ended December 31, 2020 and 2019 was $2,474 and $2,355, respectively. The Company may incur additional expenses up to $1,360 through the remaining term of the CAROT Amended Addendum.

Subscription and Technology Transfer Agreement

In July 2019, the Company entered into a subscription and technology transfer agreement pursuant to which the Company owed Penn an upfront subscription fee, which was paid in 2019, and a nominal non-refundable royalty on the net sales of products, a portion of which will be credited toward milestone payments and royalties, respectively, under the Amended License Agreement. Technology transfer activities will be at the Company’s cost and subject to agreement as to the technology to be transferred. Under this agreement, the Company recognized $250 of research and development expense for the year ended December 31, 2019. No expense was recognized under this agreement for the year ended December 31, 2020.

Collaboration and License Agreement

In July 2020, the Company entered into a collaboration and license agreement with Artisan Bio, Inc. (Artisan), wherein the Company and Artisan agreed to collaborate to potentially enhance certain pipeline products of the Company at specific targets using Artisan’s gene editing and engineering technology. If the Artisan technology

F-15

is applied to any of the Company’s products, the Company will be responsible for the development, manufacturing, and commercialization of any such products. Under the terms of the agreement, the Company was required to pay Artisan a nominal upfront fee, as well as costs associated with research and development activities. Artisan is eligible to receive future research, development and regulatory milestones, and is also eligible to receive sales milestones and tiered royalties on net sales of products that incorporate the Artisan technology. The Company can terminate the agreement at will upon advance written notice with payment of a nominal cancellation fee.

7. Commitments and Contingencies

Operating Lease Agreement

In February 2019, the Company entered into an operating lease agreement for new office space in Philadelphia, Pennsylvania. The lease term commenced in May 2019 and will expire in July 2022. The initial annual base rent is $261, and such amount will increase by 2% annually on each anniversary of the commencement date. The Company records rent expense on a straight-line basis over the lease term. Rent expense related to this lease agreement recognized in the accompanying statement of operations was $266 and $178 for the years ended December 31, 2020 and 2019.

As of December 31, 2020, the future minimum payments for operating leases are as follows:


2021	$	268
2022		158
Thereafter		—
	$	426

Other Purchase Commitments

In the normal course of business, the Company enters into various purchase commitments with third-party contract manufacturers for the manufacture and processing of its product candidates and related raw materials, contracts with contract research organizations for clinical trials and agreements with vendors for other services and products for operating purposes. These agreements generally provide for termination or cancellation, other than for costs already incurred.

Indemnification

The Company enters into certain types of contracts that contingently requires the Company to indemnify various parties against claims from third parties. These contracts primarily relate to (i) the Company’s bylaws, under which the Company must indemnify directors and executive officers, and may indemnify other officers and employees, for liabilities arising out of their relationship, (ii) contracts under which the Company must indemnify directors and certain officers and consultants for liabilities arising out of their relationship, (iii) contracts under which the Company may be required to indemnify partners against certain claims, including claims from third parties asserting, among other things, infringement of their intellectual property rights, and (iv) procurement, consulting, or license agreements under which the Company may be required to indemnify vendors, consultants or licensors for certain claims, including claims that may be brought against them arising from the Company’s acts or omissions with respect to the supplied products, technology or services. From time to time, the Company may receive indemnification claims under these contracts in the normal course of business. In addition, under these contracts, the Company may have to modify the accused infringing intellectual property and/or refund amounts received.

In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.

F-16

8. Convertible Preferred Stock

Preferred Stock

The Company has 10,000,000 shares of authorized preferred stock as of December 31, 2020, none of which is issued or outstanding. The preferred stock is not redeemable and does not have a stated voting, dividend or liquidation preference.

Convertible Preferred Stock

The Company has issued Series A Preferred, Series A-1 Preferred, Series A-2 Preferred, and Series B Preferred of Convertible Preferred Stock. The Company classified Convertible Preferred Stock outside of stockholders’ equity (deficit) because the shares contained deemed liquidation rights that were a contingent redemption feature not solely within the control of the Company.

	Series A Preferred						Series A-1 Preferred						Series A-2 Preferred						Series B Preferred						Total Convertible Preferred Stock
	Shares			Amount			Shares			Amount			Shares			Amount			Shares			Amount			Shares			Amount
Balance—December 31, 2018		3,146,551			12,575			7,372,719			24,994			1,873,777			6,352			—			—			12,393,047			43,921
Issuance		—			—			—			—			—			—			6,963,788			50,000			6,963,788			50,000
Exchange, including deemed dividend		—			—			—			—			(1,405,332	)		(4,764	)		1,405,332			10,090			—			5,326
Issuance costs		—			—			—			—			—			—			—			(1,293	)		—			(1,293	)
Conversion to common stock		(3,146,551	)		(12,575	)		(7,372,719	)		(24,994	)		(468,445	)		(1,588	)		(8,369,120	)		(58,797	)		(19,356,835	)		(97,954	)
Balance—December 31, 2019		—		$	—			—		$	—			—		$	—			—		$	—			—		$	—

In January 2019, the Company’s certificate of incorporation was amended to increase the authorized shares of Convertible Preferred Stock to 20,762,168 shares, and the Company issued 6,963,788 shares of Series B Preferred, resulting in gross proceeds of $50,000. In connection, the Company issued a further 1,405,332 shares of Series B Preferred in exchange for 1,405,332 shares of Series A-2 Preferred. The Company determined the terms of the Series B Preferred to be materially, qualitatively different than the terms of the Series A-2 Preferred and, as such, applied extinguishment accounting with respect to the Series A-2 Preferred received in the exchange resulting in removal of the carrying amount of the Series A-2 Preferred received ($4,764), the addition of the Series B Preferred issued at fair value determined with reference to the contemporaneous issuance of Series B Preferred ($10,090) and the difference ($5,326) determined to be a deemed dividend recorded to additional paid-in capital (to the extent of paid-in capital) and accumulated deficit within stockholders’ deficit on the balance sheet.

The shares of Convertible Preferred Stock had various rights, including voting and dividend rights, preferences and privileges, including optional and mandatory conversion rights.

In October 2019, the Convertible Preferred Stock was converted into 12,904,534 shares of Common Stock. Certain holders of the Company’s Convertible Preferred Stock elected to have such shares convert into 6,409,519 shares of non-voting Common Stock following the closing of the Company’s IPO. The non-voting shares of Common Stock have the same rights and preferences as the Common Stock but are non-voting. No Convertible Preferred Stock was outstanding as of December 31, 2020 or 2019.

9. Common Stock

Common Stock

Pursuant to the Company’s Third Amended and Restated Certificate of Incorporation filed in October 2019, the Company is authorized to issue 143,590,481 shares of voting common stock and 6,409,519 shares of non-voting common stock. Holders of voting common stock shall have the exclusive right to vote for the election of directors of the Company and on all other matters requiring stockholder action. Each share of the Company’s non-voting common stock may be converted at any time into one share of common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. In August 2020, 1,733,904 shares of non-voting common stock were converted to voting common stock.

F-17

At-The-Market Offering Sales Agreement

On November 10, 2020, the Company filed a Shelf Registration Statement in relation to the registration of common stock, preferred stock, debt securities, warrants and/or units of any combination thereof for the purposes of selling, from time to time, the Company’s common stock, debt securities or other equity securities in one or more offerings. The Company also simultaneously entered into a Sales Agreement with Cowen and Company, LLC, to provide for the offering, issuance and sale of up to an aggregate amount of $75.0 million of the Company’s common stock from time to time in “at-the-market” offerings under the Shelf Registration Statement and subject to the limitations thereof. No shares have been sold under the Sales Agreement as of December 31, 2020.

Share-based Payment Awards

In May 2018, several of the Company’s founders agreed to modify their shares of common stock outstanding to include vesting provisions that require continued service to the Company in order to vest in those shares. As such, the 2,904,000 modified shares of common stock became compensatory upon such modification. The fair value of the awards on the modification date was determined to be $0.74 per share of common stock, based on the issuance of convertible notes in May 2018, considering the maximum conversion price and the seniority of the notes. The total compensation cost resulting from the modification was $2,126. The total compensation cost is being recognized over the three-year vesting term attendant to the founders’ common shares.

During the year ended December 31, 2020, the Company recognized $495 and $177 of this amount in research and development expense and general and administrative expense, respectively. During the year ended December 31, 2019, the Company recognized $529 and $177 of this amount in research and development expense and general and administrative expense, respectively.

2018 Stock Option and Grant Plan

In September 2018, the Company adopted the 2018 stock option and grant plan (the 2018 Plan), which provided for the Company to sell or issue common stock, or other stock-based awards, to employees, members of the board of directors and consultants of the Company. The Company generally granted stock-based awards with service conditions only (service-based awards), although there was one grant with performance conditions. As of December 31, 2020, there are no unvested options with performance conditions. Stock options granted under the 2018 Plan generally vest over three to four years. There were 1,959,411 options granted under the 2018 Plan prior to the Company’s IPO in October 2019. No further grants may be made under the 2018 Plan subsequent to the IPO.

2019 Stock Option and Incentive Plan

The 2019 Stock Option and Incentive Plan (2019 Plan) was approved by the Company’s board of directors on October 14, 2019, and became effective on October 23, 2019. The 2019 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to the Company’s officers, employees, directors and consultants. The number of shares initially reserved for issuance under the 2019 Plan was 2,342,288, which will be increased each January 1 thereafter by 4% of the number of shares of the Company’s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company’s board of directors or compensation committee of the board of directors. On January 1, 2021, the total number of shares under the 2019 Plan was increased by 962,511 shares. As of December 31, 2020, there were 2,314,303 shares remaining available for issuance.

F-18

A summary of the stock option activity is presented below:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding as of January 1, 2019		971,353		$	1.01		9.8	$	4,051
Granted		1,340,839			7.97
Exercised		(5,667	)		1.01
Cancelled		(176,893	)		4.22
Outstanding as of December 31, 2019		2,129,632			5.12		9.2	$	18,844
Granted		813,172			13.03
Exercised		(25,611	)		5.44				183
Forfeited		(16,714	)		6.30
Outstanding as of December 31, 2020		2,900,479		$	7.33		8.5	$	16,303
Options Exercisable at December 31, 2020		1,068,675		$	4.04		8.1	$	9,059

The aggregate intrinsic value of options granted is calculated as the difference between the exercise price of the options and the estimated fair value of the Company’s common stock. The weighted average grant-date fair value of stock options granted during the year ended December 31, 2020 and 2019 was $8.31 and $5.24, respectively.

The fair value of each award is estimated using Black-Scholes based on the following assumptions:

	For the Year Ended December 31,
	2020	2019
Risk-free interest rate	0.28%—1.48%	1.39%—2.59%
Expected term	5.7—6.1 years	0.3—6.1 years
Expected volatility	70%—79%	70%—76%
Expected dividend yield	0%	0%

Black-Scholes requires the use of subjective assumptions which determine the fair value of stock-based awards. These assumptions include:

Fair value of common stock—Prior to the Company’s IPO in October 2019, the fair value of the Company’s common stock underlying stock-based awards was estimated on each grant date by the Company’s board of directors. In order to determine the fair value of the Company’s common stock underlying stock-based awards, the Company’s board of directors considered, among other things, a valuation of the Company’s common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.

Expected volatility—As a privately held company prior to the Company’s IPO in October 2019, the Company has limited trading history for its common stock and, as such, the expected volatility is estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock-based awards. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available.

F-19

Expected dividend—The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.

Stock-based Compensation

The Company has recorded stock-based compensation in the accompanying statements of operations as follows:

	For the Year Ended December 31,
	2020		2019
Research and development	$	1,989	$	1,304
General and administrative		2,399		996
Total	$	4,388	$	2,300

As of December 31, 2020, there was $9,809 of unrecognized compensation cost related to unvested option awards, which is expected to be recognized over a weighted-average period of 2.8 years. As of December 31, 2020, there was $239 of unrecognized compensation cost related to unvested founder stock awards, which is expected to be recognized over a weighted-average period of 0.3 years.

2019 Employee Stock Purchase Plan

The 2019 Employee Stock Purchase Plan (2019 ESPP) was approved by the Company’s board of directors on October 14, 2019, and became effective on October 23, 2019. A total of 234,229 shares of common stock were initially reserved for issuance under the 2019 ESPP, and will be increased each January 1 thereafter through January 1, 2029 by the least of (i) 234,229 shares of common stock, (ii) 1% of the number of shares of the Company’s common stock outstanding on the immediately preceding December 31 or (iii) such lesser number of shares determined by the 2019 ESPP’s administrator. On January 1, 2021, the total number of shares under the 2019 ESPP was increased by 234,229 shares.

Employee contributions are made through payroll deductions of up to 15% of eligible compensation over the offering period. A participant may not accrue rights to purchase more than $25 worth of the Company’s common stock for each calendar year in which such right is outstanding. At the end of each offering period, shares of the Company’s common stock may be purchased at 85% of the lesser of the Company’s common stock on (i) the first trading day of the relevant offering period and (ii) the last trading day of the relevant offering period. The first offering period commenced on July 1, 2020 and ended on November 30, 2020. Thereafter, offerings will be six months in duration and will commence on each December 1 and June 1. The Company recognized stock-based compensation expense of $18 during the year ended December 31, 2020 related to the 2019 ESPP.

10. Income Taxes

The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate is as follows:

	For the Year Ended December 31,
	2020			2019
Expected income tax benefit at the federal statutory rate		21.0	%		21.0	%
State and local taxes, net of federal benefit		12.5			13.1
Research and development credit, net		2.6			2.3
Non-deductible items and other		(0.8	)		(3.3	)
Change in valuation allowance		(35.3	)		(33.1	)
Total		0.0	%		0.0	%

F-20

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The principal components of the Company’s deferred tax assets consisted of the following:

	December 31,
	2020			2019
Deferred tax assets:
Federal, state and local net operating loss carryforwards	$	15,241		$	5,688
License fee deductions		340			362
Research and development tax credits		1,317			452
Stock-based compensation deductions		1,243			264
Accrued expenses		837			457
Gross deferred tax assets		18,978			7,223
Less: valuation allowance		(18,978	)		(7,223	)
Total deferred tax assets		—			—
Deferred tax liabilities:		—			—
	$	—		$	—
Net deferred tax assets	$	—		$	—

The Company increased its valuation allowance by $11,755 for the year ended December 31, 2020 in order to maintain a full valuation allowance against its deferred tax assets. Based on the Company’s history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December 31, 2020. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to support a reversal of the allowance.

As of December 31, 2020, the Company had federal, state and local net operating loss carryforwards of $45,550, $47,735 and $38,645, respectively; $45,301 of the federal amounts do not expire, and the remaining $249 expire in 2037. The state net operating losses begin to expire in 2037. The local net operating losses begin to expire in 2039. As of December 31, 2020, the Company had federal research and development tax credit carryforwards of $1,317, which begin to expire in 2038. Under the provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the IRC), these net operating losses, credit carryforwards and other tax attributes may be subject to limitation based on previous significant changes in ownership and upon future significant changes in ownership of the Company, as defined by the IRC.

The Company files income tax returns in the U.S. federal jurisdiction as well as in Pennsylvania and Philadelphia. The tax years 2019, 2018 and 2017 remain open to examination by the jurisdictions where the Company is subject to tax.

The Company evaluates tax positions for recognition using a more-likely-than-not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of December 31, 2020, the Company had no unrecognized income tax benefits that would affect the Company’s effective tax rate if recognized.

F-21

11. Net Loss Per Share

The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. For the years ended December 31, 2020 and 2019, the Company had voting and non-voting common stock outstanding. Since the rights of the voting and non-voting common stock are identical, except with respect to voting, the undistributed losses of the Company have been allocated on a proportionate basis to the two classes. Diluted net loss per share is calculated using the if-converted method, which assumes conversion of all non-voting common stock to voting common stock.

	Year ended December 31, 2020
	Voting common stock			Non-voting common stock
Basic net loss per share:
Numerator
Allocation of undistributed losses attributable to common stockholders	$	(25,090	)	$	(8,249	)

Denominator
Weighted average number of shares used in basic per share computation		17,417,900			5,727,327
Net loss per share, basic	$	(1.44	)	$	(1.44	)

Diluted net loss per share:
Numerator
Allocation of undistributed losses for basic computation	$	(25,090	)	$	(8,249	)
Reallocation of undistributed losses as a result of conversion of non-voting to voting common shares		(8,249	)		—
Allocation of undistributed losses	$	(33,339	)	$	(8,249	)

Denominator
Weighted average number of shares used in basic per share computation		17,417,900			5,727,327
Add: Conversion of non-voting to voting common shares outstanding		5,727,327			—
Weighted average number of shares used in diluted per share computation		23,145,227			5,727,327
Net loss per share, diluted	$	(1.44	)	$	(1.44	)

F-22

	Year ended December 31, 2019
	Voting common stock			Non-voting common stock
Basic net loss per share:
Numerator
Allocation of undistributed losses attributable to common stockholders	$	(17,693	)	$	(4,576	)

Denominator
Weighted average number of shares used in basic per share computation		4,345,530			1,123,861
Net loss per share, basic	$	(4.07	)	$	(4.07	)

Diluted net loss per share:
Numerator
Allocation of undistributed losses for basic computation	$	(17,693	)	$	(4,576	)
Reallocation of undistributed losses as a result of conversion of non-voting to voting common shares		(4,576	)		—
Allocation of undistributed losses	$	(22,269	)	$	(4,576	)

Denominator
Weighted average number of shares used in basic per share computation		4,345,530			1,123,861
Add: Conversion of non-voting to voting common shares outstanding		1,123,861			—
Weighted average number of shares used in diluted per share computation		5,469,391			1,123,861
Net loss per share, diluted	$	(4.07	)	$	(4.07	)

The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive:

	For the Year Ended December 31,
	2020		2019
Stock options to purchase common stock		2,900,479		2,129,632
Non-vested founder stock		465,801		1,388,977
Total		3,366,280		3,518,609

F-23

12. 401(k) Savings Plan

The Company maintains a defined-contribution savings plan under Section 401(k) of the IRC, or the 401(k) Plan. The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis. In 2019, the Company made a safe harbor nonelective contribution of 3% of eligible compensation on behalf of all employees. Effective January 1, 2020, the Plan provided for matching contributions on a portion of participant contributions pursuant to the 401(k) Savings Plan’s matching formula, up to 4% of eligible compensation. All matching contributions and participant contributions vest immediately. Contributions totaled $203 and $74 for the years ended December 31, 2020 and 2019, respectively, and have been recorded in the statements of operations.

13. Subsequent Events

In January 2021, the Company entered into a Development and Manufacturing Services Agreement (Wuxi Agreement) with WuXi Advanced Therapies (Wuxi) to serve as the Company’s cell processing manufacturing partner for the anticipated MuSK-CAART Phase 1 clinical trial. The Company has the right to terminate the Wuxi Agreement for convenience or other reasons specified in the Wuxi Agreement upon prior written notice. If the Company terminates the Wuxi Agreement, it will be obligated to pay an early termination fee of $1,500.

In February 2021, the Company entered into a research service agreement with CHOP for vector manufacturing, with a total cost of $670, expected to be incurred during 2021.

F-24

EXHIBIT INDEX

Exhibit Number		Description

3.1		Third Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-39103) filed on October 30, 2019)

3.2		Amended and Restated Bylaws of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K (File No. 001-39103) filed on October 30, 2019)

4.1		Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form S-1 (File No. 333-234017) filed on October 16, 2019)

4.2		Amended and Restated Investors' Rights Agreement among the Registrant and certain of its stockholders, dated January 2, 2019 (incorporated by reference to Exhibit 4.2 of the Registrant’s Registration Statement on Form S-1 (File No. 333-234017) filed on September 30, 2019)

4.3		Description of Securities (incorporated by reference to Exhibit 4.3 of the Registrant’s Annual Report on Form 10-K (File No. 001-39103) filed on March 30, 2020)

10.1#		2018 Stock Option and Grant Plan, as amended, and form of award agreements thereunder (incorporated by reference to Exhibit 10.1 of the Registrant’s Registration Statement on Form S-1 (File No. 333-234017) filed on September 30, 2019)

10.2#		2019 Stock Option and Incentive Plan, and form of award agreements thereunder. (incorporated by reference to Exhibit 10.2 of the Registrant’s Registration Statement on Form S-1/A (File No. 333-234017) filed on October 16, 2019)

10.3#		2019 Employee Stock Purchase Plan. (incorporated by reference to Exhibit 10.3 of the Registrant’s Registration Statement on Form S-1/A (File No. 333-234017) filed on October 16, 2019)

10.4#		Senior Executive Cash Incentive Bonus Plan (incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q filed on December 5, 2019)

10.5#		Form of Indemnification Agreement between the Registrant and each of its directors (incorporated by reference to Exhibit 10.5 of the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.6#		Form of Indemnification Agreement between the Registrant and each of its executive officers (incorporated by reference to Exhibit 10.4 of the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.7+		Amended and Restated License Agreement, dated as of July 23, 2019, among the Registrant, the Trustees of the University of Pennsylvania and the Children’s Hospital of Philadelphia (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.8+		Sponsored Research Agreement, dated as of April 23, 2018, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.9+		Sponsored Research Agreement, dated as of April 23, 2018, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.8 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

144


10.10+		Master Translational Research Services Agreement, dated as of October 2018, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.11+		CAROT Master Services Addendum to Master Translational Research Services Agreement, dated as of February 4, 2019, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.10 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.12+		CVPF Master Services Addendum to Master Translational Research Services Agreement, dated as of October 22, 2018, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.11 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.13+		Research Agreement A19-3095, dated as of October 31, 2018, between the Registrant and The Regents of the University of California (incorporated by reference to Exhibit 10.12 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.14		Lease, dated as of February 11, 2019, between the Registrant and Brandywine Cira, L.P. (incorporated by reference to Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.15#		Employment Agreement between the Registrant and Steven Nichtberger (incorporated by reference to Exhibit 10.16 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.16#		Employment Agreement between the Registrant and Anup Marda (incorporated by reference to Exhibit 10.17 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.17#		Employment Agreement between the Registrant and Gwendolyn Binder (incorporated by reference to Exhibit 10.18 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.18#		Employment Agreement between the Registrant and David Chang (incorporated by reference to Exhibit 10.19 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.19#		Employment Agreement between the Registrant and Brian Stalter (incorporated by reference to Exhibit 10.20 to the Registrant’s Registration Statement on Form S-1, filed with the SEC on September 30, 2019)

10.20#		Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.1 to the Registrant’s Annual Report on Form 10-K (File No. 001-39103) filed on March 30, 2020)

10.21+		Amendment No. 1, dated May 27, 2020, to the Sponsored Research Agreement, dated April 23, 2018, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-39103) filed on May 28, 2020)

10.22+		First Amendment, dated May 27, 2020, to the Amended and Restated License Agreement, dated July 23, 2019, among the Registrant, the Trustees of the University of Pennsylvania and the Children’s Hospital of Philadelphia (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No. 001-39103) filed on May 28, 2020)

145


10.23+		Amendment to CAROT Master Services Addendum to Master Translational Research Services Agreement, dated as of May 18, 2020 between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-39103) filed on August 6, 2020)

10.24+		Amendment No. 2, dated August 17, 2020, to the Sponsored Research Agreement, dated April 23, 2018, as amended by Amendment No. 1 dated May 27, 2020, between the Registrant and the Trustees of the University of Pennsylvania (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-39103) filed on November 10, 2020)

21.1*		List of Subsidiaries of the Registrant

23.1*		Consent of Ernst & Young, independent registered public accounting firm

31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended

31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended

32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

#	Management Contract or compensatory plan or arrangement.

+	Confidential treatment has been granted by the Securities and Exchange Commission as to certain portions.

*	Filed herewith.

The certifications furnished in Exhibit 32.1 and 32.2 hereto are deemed to accompany this Annual Report on Form 10-K and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.

146

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cabaletta Bio, Inc.

Date: March 16, 2021	By:	/s/ Steven Nichtberger
		Steven Nichtberger
		Chief Executive Officer and President

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

Name	Title	Date

/s/ Steven Nichtberger	Director, Chief Executive Officer and President	March 16, 2021
Steven Nichtberger	(Principal Executive Officer)

/s/ Anup Marda	Chief Financial Officer	March 16, 2021
Anup Marda	(Principal Financial and Accounting Officer)

/s/ Catherine Bollard	Director	March 16, 2021
Catherine Bollard

/s/ Brian Daniels	Director	March 16, 2021
Brian Daniels

/s/ Richard Henriques	Director	March 16, 2021
Richard Henriques

/s/ Mark Simon	Director	March 16, 2021
Mark Simon

147

EX-21.1 2 caba-ex211_8.htm EX-21.1 caba-ex211_8.htm

Exhibit 21.1

List of Subsidiaries

None.

EX-23.1 3 caba-ex231_13.htm EX-23.1 caba-ex231_13.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1) Registration Statement (Form S-8 No. 333-234367) pertaining to the Cabaletta Bio, Inc. 2018 Stock Option and Incentive Plan, the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan, and the Cabaletta Bio, Inc. 2019 Employee Stock Purchase Plan,

(2) Registration Statement (Form S-8 No. 333-237484) pertaining to the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan and the Cabaletta Bio, Inc. 2019 Employee Stock Purchase Plan, and

(3) Registration Statement (Form S-3 No. 333-250006) of Cabaletta Bio, Inc.

of our report dated March 16, 2021, with respect to the financial statements of Cabaletta Bio, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.

/s/ Ernst & Young LLP

Philadelphia, Pennsylvania

March 16, 2021

EX-31.1 4 caba-ex311_10.htm EX-31.1 caba-ex311_10.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven Nichtberger, certify that:

1.	I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2020 of Cabaletta Bio, Inc. (the “registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: March 16, 2021

By:

/s/ Steven Nichtberger

Steven Nichtberger

Chief Executive Officer and President

(Principal Executive Officer)

EX-31.2 5 caba-ex312_12.htm EX-31.2 caba-ex312_12.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Anup Marda, certify that:

1.	I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2020 of Cabaletta Bio, Inc. (the "registrant");

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: March 16, 2021

By:

/s/ Anup Marda

Anup Marda

Chief Financial Officer

(Principal Financial and Accounting Officer)

EX-32.1 6 caba-ex321_11.htm EX-32.1 caba-ex321_11.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Cabaletta Bio, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 16, 2021

By:

/s/ Steven Nichtberger

Steven Nichtberger

Chief Executive Officer

(Principal Executive Officer)

EX-32.2 7 caba-ex322_7.htm EX-32.2 caba-ex322_7.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 16, 2021

By:

/s/ Anup Marda

Anup Marda

Chief Financial Officer

(Principal Accounting and Financial Officer)

GRAPHIC 8 gaz3apgusshz000012.jpg GRAPHIC begin 644 gaz3apgusshz000012.jpg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end GRAPHIC 9 gaz3apgusshz000010.jpg GRAPHIC begin 644 gaz3apgusshz000010.jpg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end GRAPHIC 10 gaz3apgusshz000006.jpg GRAPHIC begin 644 gaz3apgusshz000006.jpg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end GRAPHIC 11 gaz3apgusshz000011.jpg GRAPHIC begin 644 gaz3apgusshz000011.jpg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gaz3apgusshz000015.jpg GRAPHIC begin 644 gaz3apgusshz000015.jpg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end GRAPHIC 13 gaz3apgusshz000016.jpg GRAPHIC begin 644 gaz3apgusshz000016.jpg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end GRAPHIC 14 gaz3apgusshz000013.jpg GRAPHIC begin 644 gaz3apgusshz000013.jpg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end GRAPHIC 15 gaz3apgusshz000003.jpg GRAPHIC begin 644 gaz3apgusshz000003.jpg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Ȫ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gaz3apgusshz000001.jpg GRAPHIC begin 644 gaz3apgusshz000001.jpg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�NHQN\:A),R*6'R'M6I@>E&!Z4 90U.)D1@DF&Z?(:&U.)4=BDN%8*?D/ M>M3 ]*7 ]* ,MM0C1Y%*29C(!^0T#4(RP79)DJ6^X>U:F!Z48'I0!E+J43+$ M0DG[U2P^0]O6C^TXMF[9+UQ]PUJX'I1@>E &6VHQ*)3LD_=,%/R'OZ4'4(P[ M+LDX_P!@UJ8'I1@>E &6NHQL\:A),R*6'R'M2#4XBJ,$DPW3Y#6K@>E&!Z4 M9+:G$J,Q27"L%/R'O3GU"-'D4I)F,@'Y#6I@>E&!Z4 98U",L%V29*D_M:N!Z48'I0!E?VG%MW;).N/N&AM2C42Y23]TP4_(>_I M6K@>E&!Z4 9?]H1AV79)Q_L&A=1C9XU"2?O%+#Y#VK4P/2C ]* ,G^TXBBL$ MDPPX^0TS1KA9KN]VAQM<9W+CM6Q@>E(J*K,RJ 6Z^] #J*** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+10! M&5J)H\U8Q28H IF*F>35W;2;* *?DBCR15S91LH I^2*/)%7-E&R@"GY(H\D M5 GRAPHIC 17 gaz3apgusshz000002.jpg GRAPHIC begin 644 gaz3apgusshz000002.jpg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end GRAPHIC 18 gaz3apgusshz000017.jpg GRAPHIC begin 644 gaz3apgusshz000017.jpg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end GRAPHIC 19 gaz3apgusshz000007.jpg GRAPHIC begin 644 gaz3apgusshz000007.jpg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gaz3apgusshz000009.jpg GRAPHIC begin 644 gaz3apgusshz000009.jpg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end GRAPHIC 21 gaz3apgusshz000019.jpg GRAPHIC begin 644 gaz3apgusshz000019.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHKYT^/G_(]6/_ &#(_P#T;+0!]%T5\HV7PL\::A86][:Z M-YEO<1++$_VJ$;D89!P7R.#WJ?\ X5!X[_Z 7_DW!_\ %T#L?4]%?+'_ J# MQW_T O\ R;@_^+KV'X7^#[_2/ NI:)XCL?*^V7,N^'SE;?$\2(?F1CC.&'7- M CT:BOEOP'J3>!?BDMM?W")"D\FG7DB8V$;MN=S8PH=58G@X!^E?4E !113) MIHK:"2>>5(H8E+R22,%5% R22> .] #Z*^5--,OQ(^+$$EZB;=0O/,EB=R M($&3'N4 Y$:;0< DX)QUKZKH **^//!G_(]>'O\ L)VW_HU:^PZ "BOG3X^? M\CU8_P#8,C_]&RU[?X,_Y$7P]_V#+;_T4M &Y17B'[0__,M_]O/_ +2KM_A! M_P DMT;_ +;_ /H^2@#N**** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "OG3X^?\CU8_P#8,C_]&RU]%U\Z?'S_ )'JQ_[!D?\ Z-EH M&CV_P9_R(OA[_L&6W_HI:W*\"T7X[?V1H6GZ9_PCGF_8[:.W\S[=MW[%"YQY M9QG'3-7O^&A_^I6_\J'_ -KH"Q[?17CVB_';^U]=T_3/^$<\K[9P7./+&<9Z9KV&@1\[_ !YT1;'Q59ZO&J*NHP;9,,2S21X!)!X VM&!C^Z> M.Y]E\">(D\4>#=.U+SO-N#$(KHG:&$RC#Y"\+D_,!QPP.!FLKXM:!_;WP_OM MLFR73_\ 3DRV%;RU;<#P?X"^.G..<9KSWX">(VAU*^\.3.@AN%-U;[F"GS%P M&4#&6)7!Z\",\J\]^,GB-M"\#2VL#H+G4V^R@%AN$9!,C!2#D8^4], M;P3(Z8.8\'D_*>G?VRL?PIHB^&_"NF:0%0-;0*L MOEL65I#RY!/."Q8]NO0=*V* /CSP9_R/7A[_ +"=M_Z-6OL.OCSP9_R/7A[_ M +"=M_Z-6OL.@;/G3X^?\CU8_P#8,C_]&RU[?X,_Y$7P]_V#+;_T4M>(?'S_ M )'JQ_[!D?\ Z-EKV_P9_P B+X>_[!EM_P"BEH \L_:'_P"9;_[>?_:5=O\ M"#_DENC?]M__ $?)7$?M#_\ ,M_]O/\ [2KM_A!_R2W1O^V__H^2@.AW%%%% M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYT^/G_(]6 M/_8,C_\ 1LM?1=?.GQ\_Y'JQ_P"P9'_Z-EH&CU?PEX2\-W/@S0IY_#VDRS2Z M?;O)))91LSL8U)))&22>];'_ AGA7_H6M&_\ (O_B:/!G_(B^'O^P9;?^BE MK'M)BFB8/')'91JR,#D$$#((/>MBBB@ KY1O%G^&7Q1? M[*WG?V; M="HQ_P!=,Y/]W ZT#1ZUK.O6ND^&+O71)#-;PVQN(R)@J3<90!^1\QP 1G.1 MC-?._P +;"7Q7\4H[^_9)F@:34K@L2A=PW! 48SYCJV.!@'Z&WJ7C634O@;9 MZ2]W"MY#?)92P[T,DMLB%T;;C*J"(UR.I3D\D5Z%\"]$6P\%2:JRIYVISE@R ML2?+C)100> 0WF'CLPY[ ]0HHHH$?'G@S_D>O#W_83MO_1JU]AU\>>#/^1Z M\/?]A.V_]&K7V'0-GSI\?/\ D>K'_L&1_P#HV6O;_!G_ "(OA[_L&6W_ **6 MO$/CY_R/5C_V#(__ $;+7M_@S_D1?#W_ &#+;_T4M 'EG[0__,M_]O/_ +2K MM_A!_P DMT;_ +;_ /H^2N(_:'_YEO\ [>?_ &E7;_"#_DENC?\ ;?\ ]'R4 M!T.XHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>4 M?$[X8ZUXT\26^HZ==6$4,5FL#+<2.K;@[MGY4(QAAWKU>B@#.\/V$ND^&]+T MZ=D::TLXH)&C)*ED0*2,@'&1Z5HT44 %%%% !6/XKT1?$GA74](*H6N8&6+S M&*JL@Y0DCG 8*>_3H>E;%% 'SI_PH/Q5_P!!#1O^_P!+_P#&Z^A+*S@T^PM[ M*UC\NWMXEBB3).U%& ,GD\#O4]% !1110!X+X?\ @EXDTGQ)I>HSWVDM#:7D M4\BQRR%BJ.&(&8P,X'K7O5%% 'E'Q.^&.M>-/$EOJ.G75A%#%9K RW$CJVX. M[9^5",88=Z]&\/V$ND^&]+TZ=D::TLXH)&C)*ED0*2,@'&1Z5HT4 ><_%3P# MJOCC^R?[,N+.+['YWF?:79<[]F,;5/\ =/Z5T?@30+KPOX+T_1KV2&2XM_,W MM"Q*'=(S#!(!Z,.U='10 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !117">(?B/_8.NW.F?V5Y_D[?WGVC;G*ANFT^ MOK51@Y.R [NBO,?^%O?]0/\ \F__ +"C_A;W_4#_ /)O_P"PK3V%3L.QZ=17 MF/\ PM[_ *@?_DW_ /84?\+>_P"H'_Y-_P#V%'L*G8+'IU%>8_\ "WO^H'_Y M-_\ V%'_ M[_J!_^3?_ -A1["IV"QZ=17F/_"WO^H'_ .3?_P!A1_PM[_J! M_P#DW_\ 84>PJ=@L>G45YC_PM[_J!_\ DW_]A1_PM[_J!_\ DW_]A1["IV"Q MZ=17F/\ PM[_ *@?_DW_ /84?\+>_P"H'_Y-_P#V%'L*G8+'IU%5=-O/[0TN MSO?+\O[1 DNS.=NY0<9[]:M5B(**** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ KPKXA_\CUJ7_;+_ -%)7NM>%?$/_D>M2_[9 M?^BDKHPWQC1E_P!G0_WG_,?X4?V=#_>?\Q_A5NBOJ?J]+^4_//[5QO\ S\94 M_LZ'^\_YC_"C^SH?[S_F/\*MT4?5Z7\H?VKC?^?C*G]G0_WG_,?X4?V=#_>? M\Q_A5NBCZO2_E#^U<;_S\94_LZ'^\_YC_"C^SH?[S_F/\*MT4?5Z7\H?VKC? M^?C*G]G0_P!Y_P Q_A1_9T/]Y_S'^%6Z*/J]+^4/[5QO_/QE3^SH?[S_ )C_ M JG=0K!*%4D@KGFM>LS4?\ CX7_ '/ZFN?%481IWBCULFQV)K8I0J3;5F>_ M>&_^16TC_KRA_P#0!6G69X;_ .16TC_KRA_] %:=?+RW9]8%%%%( HKF-;^( M?A7P[J3:=JFKI#=JH9XEBDD*@],[%(!QS@\X(/0BM+0/$FD^*+&2]T:[^TV\ MH!R!@G!K5H **** "BB MB@ HHHH **** "BBB@ HHHH *\*^(?\ R/6I?]LO_125[K7A7Q#_ .1ZU+_M ME_Z*2NC#?&-%:BBBOKS\L"BBB@ HHHH **** "BBB@ K,U'_ (^%_P!S^IK3 MK,U'_CX7_<_J:Y<9_"/;R#_?5Z,]^\-_\BMI'_7E#_Z *TZS/#?_ "*VD?\ M7E#_ .@"M.ODY;L^W"H+Z]M].L+F^NY/+MK:)II7VD[44$DX')X!Z5/7D7QY M\1):^'K3P_#/BXOI1-/&-I_97=O=^#/&3P@>9=:1?!HC/$4$IC<,C%#WH'Y'V-14%C>V^HZ? M;7UI)YEMVFG6KW5]=0VMLF-\T\@1%R0!DG M@9) _&OG+XF_%&3Q:9=&TQ/+T5)582GI16T<9QUK&\>?#2T\$> ]/O9 M+A[G5Y[V.*=PW[I!Y6Y.W("Y(H&;W[/,$+7/B&X:)#,B6Z)(5& MY58R%@#U )5'?L\??\2_2U_P#:U>XT PHHHH$%%%% !1110 44 M44 %%%% !1110 5X5\0_^1ZU+_ME_P"BDKW6O"OB'_R/6I?]LO\ T4E=&&^, M:*U%%%?7GY8%%%% !1110 4444 %%%% !69J/_'PO^Y_4UIUF:C_ ,?"_P"Y M_4URXS^$>WD'^^KT9[]X;_Y%;2/^O*'_ - %:=9GAO\ Y%;2/^O*'_T 5IU\ MG+=GVX5\E^//$!;F:U+K=WCBS@D3(\IG#$OD$$$*K8(Z-MXQFOGCP?X+U3QKJ$]GIAAC M^SQ>;)-<;A&O( 7A>'KZ]DO+":TMU^TSP07#Y8(#\V&55) M56<]_LCQ]%:2R;;;4HFMFW3;$$GWD)'1FR"@'7]X<>A^FZ 85Y5\?O\ MD1M/_P"PHG_HJ6O5:\<_:#U+RM%T72_*S]HN9+GS=WW?+7;C&.<^=G.>-O?/ M (H?L\?ZWQ+]+7_VM7N5>0?L_:?#'X=U?4U9_.N+M;=U)&T+&@92.,YS*V>> MP_'U^@;"BBB@04444 %%%% !1110 4444 %%%% !7A7Q#_Y'K4O^V7_HI*]U MKPKXA_\ (]:E_P!LO_125T8;XQHK4445]>?E@4444 %%%% !1110 4444 %9 MFH_\?"_[G]36G69J/_'PO^Y_4URXS^$>WD'^^KT9[]X;_P"16TC_ *\H?_0! M6G69X;_Y%;2/^O*'_P! %:=?)RW9]N?,_P :O$;:SXW;3HW1K325\E"CJP,C M -(<@9!!VH5).#&>A)%>J?!GPXVA^!H[N=$%SJC_ &HD(NX1$ 1J6!.X8RXZ M8\PC .:G@^#O@U8C]ML[K4;EF9Y;N[O)#+*S$DEBI4$\])(H8D"1QQJ%5% P . .U(9)4<\$-U;R6]Q$DT,J%)(Y%#*ZD8((/!!': MI**!'QEJ^G7?AGQ)>:?YT\=SI]RR1SA3$YVM\DBC.5R-K @]P0>]?7?A[6(O M$'AW3]7A"*MW LI1)!((V(^9-PZE6RIX'(/ KD?%OPCT+Q9JMUJTES>VFH3Q M!2T3JT9=5VJS*1D\!00"N0O8DFMWP/X8G\'^'%T>;4_[0CBE=X7^SB+RT;DK M@$Y^8L9Y/EXRB+C&X_W,YSWKJZ 84444 %%%% !1110 4444 %%%% !1 M110 5X5\0_\ D>M2_P"V7_HI*]UKPKXA_P#(]:E_VR_]%)71AOC&BM14'VVW M_P">G_CIH^VV_P#ST_\ '37U?MJ?\R^\_-_J&*_Y]2^Y_P"1/14'VVW_ .>G M_CIH^VV__/3_ ,=-'MJ?\R^\/J&*_P"?4ON?^1/14'VVW_YZ?^.FC[;;_P#/ M3_QTT>VI_P R^\/J&*_Y]2^Y_P"1/14'VVW_ .>G_CIH^VV__/3_ ,=-'MJ? M\R^\/J&*_P"?4ON?^1/14'VVW_YZ?^.FC[;;_P#/3_QTT>VI_P R^\/J&*_Y M]2^Y_P"1/69J/_'PO^Y_4U<^VV__ #T_\=-4;R5)9@R'("XZ5S8NI"5.R9Z^ M286O3Q:E4@TK/=-'T!X;_P"16TC_ *\H?_0!6G69X;_Y%;2/^O*'_P! %:=? M+2W9]@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH *\*^(?_ "/6I?\ ;+_T4E>ZUX5\0_\ D>M2_P"V7_HI*Z,-\8T4/_H K3J);L^<"BBBD 45P?B?XM^'?"NNRZ/=PZA/=0JIE^SQ*50L- MP7+,N3@@\9'(YSD#9\'^-M*\;6-Q=:8)H_L\OER0W&T2#(!#85C\IY /&_^16TC_KRA_\ 0!6G69X; M_P"16TC_ *\H?_0!6G6TMV?'!4%]>V^FZ?$,-;\=>* MI&AB^U:OJ,KR"(2!1P"Q52[<*JJ0 3P% KI_@WXD30O'4-O.[BUU1/LA =MH MD)!C8J =QW?(.F/,)R!G/0? /0?M.N:CKLT>8[.(6\!>'(,C\L5<]&55P0.< M2]L\\5\2?#;>&?'&HV>Q%M;AC=6HC14412$D*%!. I#)V^[G !% SZTJO?7M MOINGW-]=R>7;6T333/M)VHH)8X')X!Z5E>#?$!\4^$--UEH_+DN(OWJA< 2* M2C[1D_+N4XRE CY+O[[6 M/B-XW5OG>[U"<16\3DNMO&2=J_*OW$!))"]F8\DU]%:%\+O".@VK0KI,-_(W MWY]019W;!)'!&U>N/E S@9SC-3Z1\-_"6@ZK!J>F:3Y%Y!N\N3[1*VWD7F@WMQYDNG[7M?,E!8HX %)\>?$26GAZT\/ MPSXN+Z433QKM/[A.1NSRN7VD$#G8PSP0<3]GW2=^I:SK+I./)A2TB;'[M]YW MN,XY8;(^AX#****!!1110 4444 %%%% !1110 4444 %>%?$/_D> MM2_[9?\ HI*]UKPKXA_\CUJ7_;+_ -%)71AOC&CA:***\8_10HHHH **** " MBBB@ HHHH *N6G^J/^]5.KEI_JC_ +U=F!_C'E9S_NK]4?2'AO\ Y%;2/^O* M'_T 5IUF>&_^16TC_KRA_P#0!6G6TMV?'!7RY\7_ !$^N^/KR!)]]GIO^B0J M-P 8?ZTD'^+?E20!D(O7&:^C?$VO0>&/#5_K-RNY+6+&]%NO&'BRTTLWFVYOI6:2YG)<\ N['NS8#'D\GJ1UI#1[]\-M6\ M*^'? 6EVC^(=&2YEB^TW :XBB?S)/FVN-V=R@A,GGY!TZ#D?C<^A:Y8:?J^E M:SI-U=6C-#-%!<1-*\38*GAMQ"L/N@'_ %A/ !J;_AGC_J:?_*?_ /;*/^&> M/^II_P#*?_\ ;* *WP"\1)!>ZCX=N)]OVG%U:H=H!=1B0 _>+%0A YX1CQSG MWBOC;3;R]\)>++>YDC=+S2[S]]"DVTDHV'CWKD8.&4D9!!/45]A6-[;ZEI]M M?6DGF6US$LT3[2-R, 0<'D<$=: 9/7,>,O'6D>#-.DENYDEOB@,%@D@$LI.0 M#CJJ94Y8C'!QDX!H_$/XAV?@C3@B!+C6+A9)CD(#VZL1@="5\ \ M/>']>^)?BN9FG>661A+?7\PRL2G@$XP,X&%08Z8&%!(!#+6#6?B9X]RZ[KR_ ME5[B2&(;+>(84MC(^5% RKN M>[' _( 8 "^'?#NF^%M&ATO2X?+@CY9FY>5SU=SW8X_0 8 &K0,****!!1 M110 4444 %%%% !1110 4444 %>%?$/_ )'K4O\ ME_Z*2O=:\*^(?\ R/6I M?]LO_125T8;XQHX6BBBO&/T4**** "BBB@ HHHH **** "KEI_JC_O53JY:? MZH_[U=F!_C'E9S_NK]4?2'AO_D5M(_Z\H?\ T 5IUF>&_P#D5M(_Z\H?_0!6 MG6TMV?''C'Q\\1K%86'AJ%W$T["[N-KLH\L95%(QA@S9/7@QCCD&H?V?M$7R MM7U]U0L6%E"0S;EP \F1TP19P[O+CWLV-S%CRQ)ZD]Z0%ZBBB M@#YK^-OAU-'\:)J%O!Y=MJL7G$C:%,RG$F .1P48D]6=CGKCL_AAXZ6U^%FJ MR7\R2S: K%(Y)&0O&5S"A=LC)<-&H'0!1CIGTS7_ WI/BBQCLM9M/M-O'*) ME3S'3#@$ Y4@]&/YUA0_"KP5;PW,46B[4NHA%,/M4QW('5P/O\?,BGCT^M ' MS%J6IS:]K]QJ>J3.)+N?S)WC4N4!/1%9N0HX52PX &17LWASXL^ _"NBQ:7I M>DZS' GS,[0Q%Y7/5W/F!/^@%_Y-S__ !='_"H/ G_0 M"_\ )N?_ .+H&U7_^%0>!/^@%_P"3<_\ \76K MH'@/PUX7U![[1M-^S7+Q&%G\^1\H2"1AF(ZJ/RH#0Z.BBB@04444 %%%% !1 M110 4444 %%%% !7A7Q#_P"1ZU+_ +9?^BDKW6O"OB'_ ,CUJ7_;+_T4E=&& M^,:.%HHHKQC]%"BBB@ HHHH **** "BBB@ JY:?ZH_[U4ZN6G^J/^]79@?XQ MY6<_[J_5'TAX;_Y%;2/^O*'_ - %:=9GAO\ Y%;2/^O*'_T 5IUM+=GQP444 M4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPKX MA_\ (]:E_P!LO_125[K7A7Q#_P"1ZU+_ +9?^BDKHPWQC1S.UO0_E1M;T/Y5 M/167U^78^9_M^I_(B#:WH?RHVMZ'\JGHH^OR[!_;]3^1$&UO0_E1M;T/Y5/1 M1]?EV#^WZG\B(-K>A_*C:WH?RJ>BCZ_+L']OU/Y$0;6]#^5&UO0_E4]%'U^7 M8/[?J?R(@VMZ'\J3!'458J*3[WX5M0Q4JL^5H[P%%%%( HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\*^(?_(]:E_VR_P#125[K M7A7Q#_Y'K4O^V7_HI*Z,-\8T8%%%%>6?G04444 %%%% !1110 4444 %12?> M_"I:BD^]^%=6"_BGK9+_ +TO1GT-X;_Y%;2/^O*'_P! %:=9GAO_ )%;2/\ MKRA_] %:=7+=GUP4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ KPKXA_\CUJ7_;+_P!%)7NM>%?$/_D>M2_[9?\ HI*Z,-\8 MT8%%%%>6?G04444 %%%% !1110 4444 %12?>_"I:BD^]^%=6"_BGK9+_O2] M&?0WAO\ Y%;2/^O*'_T 5IUF>&_^16TC_KRA_P#0!6G5RW9]<%%%%( HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\*^(?\ R/6I M?]LO_125[K7A7Q#_ .1ZU+_ME_Z*2NC#?&-&!1117EGYT%%%% !1110 4444 M %%%% !44GWOPJ6HI/O?A75@OXIZV2_[TO1GT-X;_P"16TC_ *\H?_0!6G69 MX;_Y%;2/^O*'_P! %:=7+=GUP45Y1^T!_P B-IW_ &%8_P#T5+7BOA'PE?\ MC36)-,TZ:VBFCMVN"UPS*NT,JD?*"M2_[9?^BDKW6O"OB'_R M/6I?]LO_ $4E=&&^,:,"BBBO+/SH**** "BBB@ HHHH **** "HI/O?A4M12 M?>_"NK!?Q3ULE_WI>C/H;PW_ ,BMI'_7E#_Z *TZS/#?_(K:1_UY0_\ H K3 MJY;L^N/*/V@/^1&T[_L*Q_\ HJ6N)^ ?_(_WG_8+E_\ 1L->J?&'_DEFL_6# M_P!'QU\\>$?%U_X+U>34].AMI9I(&MRMPK,NTLK$_*0Y [U]2UY'\#XO"D>ER-I]QYWB)XMUZ)DVR1IN MQLC[%,@$D$Y)4MCY5'KE ,****!!1110 4444 %%%% !1110 4444 %%%% ! M1110 5X5\0_^1ZU+_ME_Z*2O=:\*^(?_ "/6I?\ ;+_T4E=&&^,:,"BBBO+/ MSH**** "BBB@ HHHH **** "HI/O?A4M12?>_"NK!?Q3ULE_WI>C/H;PW_R* MVD?]>4/_ * *TZS/#?\ R*VD?]>4/_H K3JY;L^N.&^,/_)+-9^L'_H^.O*_ M@'_R/UY_V"Y/_1L5>J?&'_DE>L_6#_T?'7E?P#_Y'V\_[!-\,UW&CKD C()R."#^-96K?$CPCH]@UU)KEG Y =&*G&1RIP1@CD'!'.*^QK&]M]2 MT^VOK23S+:YB6:%]I&Y& *G!Y'!'6OCV*#4/&/BPQPQ1_P!H:K>,Y5%;8C2, M68\9(1 .M V3T444" M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPKXA_\CUJ7_;+_P!%)7NM M>%?$/_D>M2_[9?\ HI*Z,-\8T8%%%%>6?G04444 %%%% !1110 4444 %12? M>_"I:BD^]^%=6"_BGK9+_O2]&?0WAO\ Y%;2/^O*'_T 5IUF>&_^16TC_KRA M_P#0!6G5RW9]<N6 M=MC'E_9HFGW=:1X'@D:U+W-_,H6:[F W$ # M*H!]U"1G')Z9)P,==110(**** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ KPKXA_\ (]:E_P!LO_125[K7A7Q#_P"1ZU+_ +9?^BDKHPWQC1@4445Y M9^=!1110 4444 %%%% !1110 5%)][\*EJ*3[WX5U8+^*>MDO^]+T9]#>&_^ M16TC_KRA_P#0!6G69X;_ .16TC_KRA_] %:=7+=GUP4444@"BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPKXA_\CUJ7_;+_ -%) M7NM>%?$/_D>M2_[9?^BDKHPWQC1@4445Y9^=!1110 4444 %%%% !1110 5% M)][\*EJ*3[WX5U8+^*>MDO\ O2]&?0WAO_D5M(_Z\H?_ $ 5IUF>&_\ D5M( M_P"O*'_T 5IUZUX5\0_^1ZU+_ME_P"BDKHP MWQC1@4445Y9^=!1110 4444 %%%% !1110 5%)][\*EJ*3[WX5U8+^*>MDO^ M]+T9]#>&_P#D5M(_Z\H?_0!6G69X;_Y%;2/^O*'_ - %:=7+=GUP4444@"BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPKXA_P#( M]:E_VR_]%)7NM>%?$/\ Y'K4O^V7_HI*Z,-\8T@H\QO05A_VM/_ '(_ MR/\ C1_:T_\ 8WH*P_P"UI_[D?Y'_ M !H_M:?^Y'^1_P :/[/C_*@^I8/^1&YYC>@H\QO05A_VM/\ W(_R/^-']K3_ M -R/\C_C1_9\?Y4'U+!_R(W/,;T%'F-Z"L/^UI_[D?Y'_&C^UI_[D?Y'_&C^ MSX_RH/J6#_D1N>8WH*/,;T%8?]K3_P!R/\C_ (T?VM/_ '(_R/\ C1_9\?Y4 M'U+!_P B-SS&]!368L2L M:T<-AZ4/_ * *TZS/#?\ R*VD?]>4/_H K3KRI;LZ M0HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M7A7Q#_Y'K4O^V7_HI*]UKPKXA_\ (]:E_P!LO_125T8;XQH\PHHHKZ0Y@HHH MH **** "BBB@ HHHH *V=)_X]6_WS_(5C5LZ3_QZM_OG^0K#$? 73^(^F/#? M_(K:1_UY0_\ H K3K,\-_P#(K:1_UY0_^@"M.OFY;LU"BBBD 445S&M_$/PI MX=U)M.U35TANT4,\2Q22%0>F=BD XYP><$'H10!T]%96@>)-)\46,E[HUW]I MMXY3"S^6Z8< $C# 'HP_.M6@ HHJAJ^M:;H-@U]JM[#:6ZY&^5L;B 3M4=6; M .%&2<<"@"_17#_\+?\ G_0=_\ )2?_ .(K\4>8-&U2&YDCSNBP4 MD &,ML8!MOS ;L8R<9H W**** "BBB@ HHHH **** "BBB@ HHHH *\*^(?_ M "/6I?\ ;+_T4E>ZUX5\0_\ D>M2_P"V7_HI*Z,-\8T>84445](K?[Y_D*QJV=)_X]6_WS_(5AB/@+I_$?3'AO_D5M M(_Z\H?\ T 5IUF>&_P#D5M(_Z\H?_0!6G7S2XN)4BAB M0O))(P544#)))X [U\>ZSJ.I^-/%5YJ$=G/<7M]*7CM8$\QPH'RH H&[:B@ M9QSMR>]?07QG\2-H?@:2TMW076J/]D +KN$1!,C!2#N&/D/3'F YSBO.?@/H MBW_BZ\U:149-,M\)EF#+++E0P X(V+*#G^\..X!HJ_!'Q$FC^,WT^XG\NVU2 M+R@#M"F93F/+'D<%U '5G QTQ]*5\B>,]"N/!_C>^LH%>T6&?S[%XF<;8B=T M95SR2O SD_,IY.,U]2^&=>@\3^&[#6;9=B746YDR3Y;@X=0;O+D^TRMMRI M4\,Q!X)ZB@1RFA? S0+;16BUIYKS4IHL/-%*42!^>8AQG&1RX(.T' R17DGC MSP?=> /%$<,%Q,UN^+BQNU!1QANFX8'F(0,E?53QG ^L*^FV M6EW$-W#80NSW,$N]&>3;\H(&#@(IR"?O8X*F@9[%\.O%/_"7>#;2_E;=>Q?Z M/>O4$( M&!XR&'U/HE F%%%% !1110 4444 %%%% !1110 5X5\0_P#D>M2_[9?^BDKW M6O"OB'_R/6I?]LO_ $4E=&&^,:/,****^D.8**** "BBB@ HHHH **** "MG M2?\ CU;_ 'S_ "%8U;.D_P#'JW^^?Y"L,1\!=/XCZ8\-_P#(K:1_UY0_^@"M M.LSPW_R*VD?]>4/_ * *TZ^;ENS4***H:UJ]IH&BWFJWS[;:UB,CX(!;'15R M0"Q. !GDD"D!\[?&KQ(VL^-WTZ-T:STE?)38ZL#(P#2'(&00=J%23@QGH217 ML7PGT1=$^'6F\)YU\OVV5D9B&\S!3KT(CV @<9!Z]3\VZ;I^J>,O%*6L3)-J M>I3O([N0BECEW& M2QNA]HB\L>8$SME3:W1BI9><8)[=: /L6BH/MUI_9_V_[5!]B\KSOM'F#R_+ MQG?NZ;<GJ*!' MG'C7X>>,_&OB/4KB.^2UT@7"_9;.^NV*_)&JF143>J@G?C.&Y.0,UY?J6@ZI M\/M=C&N:'9W>17UO7G_QIM(+GX97\TT> MZ2UF@EA.XC:YD6,GCK\KL.?7UQ0%S9\$>-]/\<:5)=VD3V\T#+'<6\C*61BH M.1@Y*$Y 8@9VG@8KIZ^=O@%-*OC74(!*XA?3F=XPQVLRR1A21T) 9L'MN/K7 MT30-A1110(**** "BBB@ HHHH **** "O"OB'_R/6I?]LO\ T4E>ZUX5\0_^ M1ZU+_ME_Z*2NC#?&-'F%%%%?2',%%%% !1110 4444 %%%% !6SI/_'JW^^? MY"L:MG2?^/5O]\_R%88CX"Z?Q'TQX;_Y%;2/^O*'_P! %:=9GAO_ )%;2/\ MKRA_] %:=?-RW9J%>1?'GQ$EIX>M/#\,^+B^E$T\8VG]RAR-V>5R^T@@<[&& M>"#Z[7#>*OA;H_C'6O[4U._U,3")842%XE1$&3@9C)ZECR3U], (#@/@%X=2 M>]U'Q%<0;OL^+6U<[2 [#,A ^\&"E!GCAV'/./>*QO"_AG3_ CH<>DZ:',* M.SM)+M\R1F." M0.I5?2@#D_A=J2>,_A=WB?39#$ZB3R&3"-C'RX4E 2#DQD\G->(7- MGKOP[\7P^>GD:C8RK-&P9O+F7/4$8+1L,@]."RG!R!]&^#_AOI7@G4+B[TR^ MU.3SXO*DAN)E,9Y!#;54?,.0#V#-ZUJ^)_".C>+[%;75[7S/+W&&9&*R0L1@ ME3^1P<@D#(.!0,HZ3\2/".L6"W4>N6=MG :&\F6"1&P"00Q&<9QD9&0<$XKQ M_P"*_P 3K;Q1#'HFAN[:8K++/[D M:R\1S0VQQLCFM!*Z\#.6#*#SG^$>GO6_H?P1\+:5/!<7C7.IS1HNY+A@(2X( M.[8HSC(/RLS#!(.>M :&-\"_"-WIUO>>([^U\HWD2Q619B',6=SMMZ;6(CP3 MR=I(P""WL=%% @HHHH **** "BBB@ HHHH **** "O"OB'_R/6I?]LO_ $4E M>ZUX5\0_^1ZU+_ME_P"BDKHPWQC1YA1117TAS!1110 4444 %%%% !1110 5 MLZ3_ ,>K?[Y_D*QJV=)_X]6_WS_(5AB/@+I_$?3'AO\ Y%;2/^O*'_T 5IUF M>&_^16TC_KRA_P#0!6G7SZUX5\0_^1ZU+_ME M_P"BDKHPWQC1YA1117TAS!1110 4444 %%%% !1110 5LZ3_ ,>K?[Y_D*QJ MV=)_X]6_WS_(5AB/@+I_$?3'AO\ Y%;2/^O*'_T 5IUF>&_^16TC_KRA_P#0 M!6G7SZUX5\0_^1ZU+_ME_P"BDKHPWQC1R?V: M#_GA'_WP*/LT'_/"/_O@5H45T?66?4?ZMK_GY_Y+_P $S_LT'_/"/_O@4?9H M/^>$?_? K0HH^LL/]6U_S\_\E_X)G_9H/^>$?_? H^S0?\\(_P#O@5H44?66 M'^K:_P"?G_DO_!,_[-!_SPC_ .^!1]F@_P">$?\ WP*T**/K+#_5M?\ /S_R M7_@F?]F@_P">$?\ WP*/LT'_ #PC_P"^!6A11]98?ZMK_GY_Y+_P3/\ LT'_ M #PC_P"^!3T1(QA$51UPHQ5VH)OOCZ54:SF[''CLF^J4?:\]_E;]3Z%\-_\ M(K:1_P!>4/\ Z *TZS/#?_(K:1_UY0_^@"M.O.ENSP@HHHI %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A7Q#_ .1ZU+_ME_Z* M2O=:\*^(?_(]:E_VR_\ 125T8;XQHPZ***D_4 HHHH **** "BBB@ HHHH * M@F^^/I4]03??'TK6C\1XV>_[F_5'T+X;_P"16TC_ *\H?_0!6G69X;_Y%;2/ M^O*'_P! %:=ZUX5\0_^1ZU+_ME_P"BDKHP MWQC1AT445)^H!1110 4444 %%%% !1110 5!-]\?2IZ@F^^/I6M'XCQL]_W- M^J/H7PW_ ,BMI'_7E#_Z *TZS/#?_(K:1_UY0_\ H J_//#:V\EQ<2I##$A> M221@JHH&223P !WKEENSX)M2DM-'9[5;A7CBL["#S)2OS'(;!?>%ZLNW[N0!7-^)M:O?'O MCB6Z@1W>]G6WL8';:53.V-.6(4G.3SCV>Y))0SPV;1?B]!IHOWE\1F$JK;4U!WEPV,?N@Y?//(VY'.<8 M-/T+XR^*_#UR;36$_M.*#]R\%T/*FC* KC>!G=G&[>&/R]B2:^DZ\P^,_@U- M<\.-KML,7^E1,[ *H\V#(+AB<'Y!N8Y:V98AM4O')O*X M(/S*!D ^9GG KZ#H$PKP?XA?&.\76DL_"&H>7;VVY9[I8XY$N'./N;E/RK@_ M,/O9/8 G#\9?%G6?&3_V3HL,UEIUR# 8(\/-=[F^4$@9&1@;%Z[F!+ C'$:W MX?U+P[+9PZI!]GGNK5;I86^^B,S* X_A;Y,X[9&<'( ,^H/AKK-_X@\ :;J> MJ3^?>3&;S)-BKG;,ZCA0!T '2NKKA?@Y_P DKT?_ 'KC_P!'R5W5 F%%%% ! M1110 4444 %%%% !1110 4444 %>%?$/_D>M2_[9?^BDKW6O"OB'_P CUJ7_ M &R_]%)71AOC&C#HHHJ3]0"BBB@ HHHH **** "BBB@ J";[X^E3U!-]\?2M M:/Q'C9[_ +F_5'T+X;_Y%;2/^O*'_P! %8WQ-U'^R_AMKUQY/F^9;&VV[MN/ M-(BST/3?G'?&..M;/AO_ )%;2/\ KRA_] %8WQ-T[^U/AMKUOYWE>7;&YW;= MV?*(EQU'79C/;.>>E:*#XH:')-*D2;Y4#.P +-"ZJ.>Y8@ =R0*^K*D;"BBB@0454 MT_5-/U:!I]-O[6]A5MC26TRR*&P#@E21G!!Q[BK= &%X?\&^'O"P?^QM+AM7 M?(:7)>0@XRN]B6V_*#C.,C.*\/\ CY_R/MG_ -@N/_T;+7T;7SE\?/\ D?K/ M_L%Q_P#HV6@#U/X.?\DKT?\ WKC_ -'R5W5<+\'/^25Z/_O7'_H^2NZH!A11 M10 4444 %%%% !1110 4444 %%%% !7A7Q#_ .1ZU+_ME_Z*2O=:\*^(?_(] M:E_VR_\ 125T8;XQHPZ***D_4 HHHH **** "BBB@ HHHH *@F^^/I4]03?? M'TK6C\1XV>_[F_5'T+X;_P"16TC_ *\H?_0!5^>"&ZMY+>XB2:&5"DD4/_ * *TZY9;L^'/CG5M.O_ 7XOGLA-MO=+N5: M&?:ISM(>.3;EAR-K;3G&<'O7U;X6\26?BOP]:ZM9NG[Q0)HE?<8)<#=&> <@ MGK@9&"."*P_B'\/+/QOIWF1E+?6+=,6UT1PPZ^7)CDH3WZJ3D9R0WAG_ B' MC_P9KV_3]/U-;F/[MSIR-+'(@?C)4$%24!V,.F,K2&?5%>=_%WQE9:!X4N]( M61)-4U.!H8X,;ML3?*[M@C:,;@I[MV(#8\BB^+GCZZ\BUM]4\RX>4A/+LXF> M4MM"IC9@\CC R2QSGC$>C_#KQGXNUS=J-KJ%N&9!F^"=&%E9#S;B3#75VRX>=Q_)1DX7MD]223TE ,*^-GO^YOU1]"^&_P#D5M(_Z\H?_0!6G69X;_Y%;2/^O*'_ M - %:=ZUX5\0_^1ZU+_ME_Z*2NC#?&-&/_ M &'JW_0+O?\ P'?_ H_L/5O^@7>_P#@._\ A7M-%?(_ZWU_^?:^]G7[!=SQ M;^P]6_Z!=[_X#O\ X4?V'JW_ $"[W_P'?_"O::*/];Z__/M?>P]@NYXM_8>K M?] N]_\ =_\*/[#U;_H%WO_ (#O_A7M-%'^M]?_ )]K[V'L%W/%O[#U;_H% MWO\ X#O_ (4?V'JW_0+O?_ =_P#"O::*/];Z_P#S[7WL/8+N>+?V'JW_ $"[ MW_P'?_"C^P]6_P"@7>_^ [_X5[311_K?7_Y]K[V'L%W/%O[#U;_H%WO_ (#O M_A5:XM;BSD$=S;RP.1N"RH5)'K@U[E7FGQ#_ .0_!_UZK_Z$]>GE/$%7'8E4 M9025FR)TE%7/7/#?_(K:1_UY0_\ H K3K,\-_P#(K:1_UY0_^@"M.O4ENSF" MBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %> M%?$/_D>M2_[9?^BDKW6O"OB'_P CUJ7_ &R_]%)71AOC&CU&BBBOR(](**** M "BBB@ HHHH **** "O-/B'_ ,A^#_KU7_T)Z]+KS3XA_P#(?@_Z]5_]">OH M>%_^1@O1F5;X3USPW_R*VD?]>4/_ * *TZS/#?\ R*VD?]>4/_H K3K[66[. M$****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M5X5\0_\ D>M2_P"V7_HI*]UKPKXA_P#(]:E_VR_]%)71AOC&CU&BBBOR(](* M*** "BBB@ HHHH **** "O-/B'_R'X/^O5?_ $)Z]+KS3XA_\A^#_KU7_P!" M>OH>%_\ D8+T9E6^$]<\-_\ (K:1_P!>4/\ Z *TZS/#?_(K:1_UY0_^@"M. MOM9;LX0HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !7A7Q#_ .1ZU+_ME_Z*2O=:\*^(?_(]:E_VR_\ 125T8;XQH]1HHHK\ MB/2"BBB@ HHHH **** "BBB@ KS3XA_\A^#_ *]5_P#0GKTNO-/B'_R'X/\ MKU7_ -">OH>%_P#D8+T9E6^$]<\-_P#(K:1_UY0_^@"M.LSPW_R*VD?]>4/_ M * *TZ^UENSA"N4\4_$7PWX1W17]YYUXN/\ 0[4"24?=ZC("\,&^8C(SC-9O MQ4\#/#\*V&S^U+YFC@+J2(E ^>3&,$C*@ ]V!P0"*\3\!^ ]2\?ZS)>..>P MT?X9>#]&@\N+1+:Y=D57EO5\]G*C[WS9"DY).T 'TX&.<\8_!G0=0TV[NM"M M9++5%226**&3]U.YY"%6.%!P0-I4+NZ$ "@>AZ'I.LZ;KU@M[I5[#=V[8&^) ML[3@':PZJV",J<$9Y%7J^2/!OBO4O GB99_W\#P2#]8?;K3^S_ .T/M4'V+RO.^T>8/+\O&=^[IMQSGIB@#-\0^*]#\*P0 M2ZUJ"6JSL4B!1G9R!DX503@<9.,#(]17"?\ "_?"W_0/UG_OS%_\,D[5^5>$0$DD+V9B,DU]#>&_A;X7T#34@FTVVU* MZ*@3W-Y")"[#/*JV0@YZ#L!DDC- %'2/C3X/U2?R9;BZTYBRHAO8<*Y8X^\A M8*!QDL0!GZX]#KYU^*_PQMO#$,>MZ&CKICLL4]L=SFW8CAPQS\A(P=QX8C!. MX!>G^!?BZ[U&WO/#FH77FFSB66Q#*2XBSM==W3:I,> >1N(&0 >QT444"" MBBB@ HHHH **** "BBB@ HHHH *\*^(?_(]:E_VR_P#125[K7A7Q#_Y'K4O^ MV7_HI*Z,-\8T>HT445^1'I!1110 4444 %%%% !1110 5YI\0_\ D/P?]>J_ M^A/7I=>:?$/_ )#\'_7JO_H3U]#PO_R,%Z,RK?">N>&_^16TC_KRA_\ 0!6G M69X;_P"16TC_ *\H?_0!6G7VLMV<)\L_%_4FU'XEZD/M*3PVBQVT)3:0@5 6 M7(ZD2-)G/(.1VQ7NGPJTG^R/AOI".D EN8S=N\0^_P"82REC@98(44_[N.@% M?-_C6"6W\>>(4FB>)SJ5PX5U*DJTC,IY[%2"#W!!KZD\$?\ (@^'/^P7;?\ MHI:0^AO4444".)O?A1X2U/7-0U6_L))Y;UE=HQ*8HXV PQ41[3ECRQ8G)YXR M:Z?^QM/_ + _L+[/_P 2W[+]C\G>W^JV[-N[.[[O&@ MZK!J>F:3Y%Y!N\N3[3*VW*E3PS$'@GM7545SGC/QGIO@K1C>WI\RXDRMK:JV M'G(H++PFFA1SP->7\J-)"O2Z\T^(?_ "'X/^O5?_0GKZ'A?_D8+T9E6^$]<\-_ M\BMI'_7E#_Z *TZS/#?_ "*VD?\ 7E#_ .@"M.OM9;LX3YG^-VD2Z?\ $*6^ M8NT.I01S(QC(5611&R!NC$!%8^F\<=SZQ\'/$2:YX#MK62??>:9_HLJG:"$' M^J( _AV87) R4;KC-:/Q$\#Q>./#XM4E2#4+9S+:3LH(#8P48XR$;C..X4X. M,'YWT7Q!XC^&OB.[CB3[/=I^ZNK.Y4M&_'R[@",XSE6!Z'@D,0"X(M0PC"O\R8 MW$G.TKGGKG'%?.7P[^'.H>+=5MI[BU>+0HF$D\\JLJSJ&(,<9&"Q)4J2#\O) MSG /TGXAUB+P_P"'=0U>8(5M(&E"/((Q(P'RIN/0LV%'!Y(X- SG?B'\0[/P M1IP1 EQK%PF;:U)X4=/,DQR$![=6(P.A*^ >'O#^O?$OQ7,S3O++(PEOK^89 M6)3P"<8&<#"H,=,#"@D8FHZG-KVOW&IZI,XDNY_,G>-2Y0$]$5FY"CA5+#@ M9%>S>'/BSX#\*Z+%I>EZ3K,<"?,SM#$7E<]7<^9RQQ^& #TSPQX0T7P MA8O;:1:^69=IFF=BTDQ48!8G\3@8 ). ,FMVO*_^%^>%?^@?K/\ WYB_^.5O M^$?B?HOC35Y-,TZUU"*:.!K@M<1HJ[0RJ1\KDYRX[>M CM:*** "BBB@ HHH MH **** "BBB@ HHHH *\*^(?_(]:E_VR_P#125[K7A7Q#_Y'K4O^V7_HI*Z, M-\8T>HT445^1'I!1110 4444 %%%% !1110 5YI\0_\ D/P?]>J_^A/7I=>: M?$/_ )#\'_7JO_H3U]#PO_R,%Z,RK?">N>&_^16TC_KRA_\ 0!6G69X;_P"1 M6TC_ *\H?_0!6G7VLMV<(5E:[X:T7Q-:K;:SIT-VB_<9@0Z<@G:XPRYVC.", MXP>*U:*0'FU_\#?!]Y<+) -0L4"A3%;W *DY/S?O QSSCKC@<=:NZ;\'?!6G MI!OTU[R:%]_G74[L7(;(W*I"$=L;<$#G/-=Y10!'!!#;6\=O;Q)%#$@2..-0 MJHH& !P !VJIK.C6'B#2IM,U2W\^SFV^9'O9<[6##E2#U /6K]% '#_ /"H M/ G_ $ O_)N?_P"+H_X5!X$_Z 7_ )-S_P#Q==Q10!P__"H/ G_0"_\ )N?_ M .+K5T#P'X:\+Z@]]HVF_9KEXC"S^?(^4)!(PS$=5'Y5T=% !1110 455U._ MBTK2KS49U=H;2!YW5 "Q55+'&<%_\ GPUC_OS%_P#'*/\ A?'A?_GPUC_OS%_\%_^?#6/^_,7_P %_P#GPUC_ +\Q?_'*.278#U&O"OB'_P CUJ7_ &R_]%)72?\ "^/" M_P#SX:Q_WYB_^.5YMXJ\;Z;KGB2[U&V@NTAFV;5E10PPBJ>?\+D\/?\ /GJG_?J/_P"+H_X7)X>_Y\]4_P"_4?\ \77YG_8^/_Y] M,[O:0[GH=%>>?\+D\/?\^>J?]^H__BZ/^%R>'O\ GSU3_OU'_P#%T?V/C_\ MGTP]I#N>AT5YY_PN3P]_SYZI_P!^H_\ XNC_ (7)X>_Y\]4_[]1__%T?V/C_ M /GTP]I#N>AT5YY_PN3P]_SYZI_WZC_^+H_X7)X>_P"?/5/^_4?_ ,71_8^/ M_P"?3#VD.YZ'17GG_"Y/#W_/GJG_ 'ZC_P#BZ/\ A'O^?/5/\ OU'_ /%UR'BK MQUIFN:I%YP_E^*P^-52K!I69G5G%QLF?0?AO\ MY%;2/^O*'_T 5IUY%I/QM\-V&C6-G+8ZL9+>WCB7?\+X\+_P#/AK'_ 'YB_P#CE'_"^/"_ M_/AK'_?F+_XY2Y)=@/4:*\N_X7QX7_Y\-8_[\Q?_ !RC_A?'A?\ Y\-8_P"_ M,7_QRCDEV ]1HKR[_A?'A?\ Y\-8_P"_,7_QRC_A?'A?_GPUC_OS%_\ '*.2 M78#U&BO+O^%\>%_^?#6/^_,7_P H:;YOE?;+:2#S-N[9O4KG&1G&>F:\ MA_X9]_ZF?_R0_P#ME%%-2<=@#_AGW_J9_P#R0_\ ME'_ S[_P!3/_Y(?_;* M**?M)=P#_AGW_J9__)#_ .V4?\,^_P#4S_\ DA_]LHHH]I+N ?\ #/O_ %,_ M_DA_]LH_X9]_ZF?_ ,D/_ME%%'M)=P#_ (9]_P"IG_\ )#_[91_PS[_U,_\ MY(?_ &RBBCVDNX!_PS[_ -3/_P"2'_VRC_AGW_J9_P#R0_\ ME%%'M)=P#_A MGW_J9_\ R0_^V4?\,^_]3/\ ^2'_ -LHHH]I+N ?\,^_]3/_ .2'_P!LH_X9 M]_ZF?_R0_P#ME%%'M)=P#_AGW_J9_P#R0_\ ME'_ S[_P!3/_Y(?_;***/: M2[@'_#/O_4S_ /DA_P#;*/\ AGW_ *F?_P D/_ME%%'M)=P#_AGW_J9__)#_ M .V4?\,^_P#4S_\ DA_]LHHH]I+N ?\ #/O_ %,__DA_]LH_X9]_ZF?_ ,D/ M_ME%%'M)=P#_ (9]_P"IG_\ )#_[91_PS[_U,_\ Y(?_ &RBBCVDNX!_PS[_ M -3/_P"2'_VRC_AGW_J9_P#R0_\ ME%%'M)=P#_AGW_J9_\ R0_^V4?\,^_] M3/\ ^2'_ -LHHH]I+N ?\,^_]3/_ .2'_P!LH_X9]_ZF?_R0_P#ME%%'M)=P M#_AGW_J9_P#R0_\ ME'_ S[_P!3/_Y(?_;***/:2[@'_#/O_4S_ /DA_P#; K*/\ AGW_ *F?_P D/_ME%%'M)=P#_AGW_J9__)#_ .V5[7112E)RW __V0$! end GRAPHIC 22 gaz3apgusshz000014.jpg GRAPHIC begin 644 gaz3apgusshz000014.jpg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end GRAPHIC 23 gaz3apgusshz000004.jpg GRAPHIC begin 644 gaz3apgusshz000004.jpg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ù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end GRAPHIC 24 gaz3apgusshz000005.jpg GRAPHIC begin 644 gaz3apgusshz000005.jpg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end GRAPHIC 25 gaz3apgusshz000018.jpg GRAPHIC begin 644 gaz3apgusshz000018.jpg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end GRAPHIC 26 gaz3apgusshz000008.jpg GRAPHIC begin 644 gaz3apgusshz000008.jpg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ĸ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�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end EX-101.INS 27 caba-20201231.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure caba:Segment caba:Faculty 0001759138 2020-01-01 2020-12-31 0001759138 2021-03-10 0001759138 2020-06-30 0001759138 2020-12-31 0001759138 2019-12-31 0001759138 caba:VotingCommonStockMember 2020-12-31 0001759138 caba:VotingCommonStockMember 2019-12-31 0001759138 us-gaap:NonvotingCommonStockMember 2020-12-31 0001759138 us-gaap:NonvotingCommonStockMember 2019-12-31 0001759138 2019-01-01 2019-12-31 0001759138 us-gaap:ConvertiblePreferredStockMember 2018-12-31 0001759138 us-gaap:CommonStockMember 2018-12-31 0001759138 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001759138 us-gaap:RetainedEarningsMember 2018-12-31 0001759138 2018-12-31 0001759138 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-12-31 0001759138 us-gaap:CommonStockMember us-gaap:IPOMember 2019-01-01 2019-12-31 0001759138 us-gaap:AdditionalPaidInCapitalMember us-gaap:IPOMember 2019-01-01 2019-12-31 0001759138 us-gaap:IPOMember 2019-01-01 2019-12-31 0001759138 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001759138 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001759138 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001759138 us-gaap:CommonStockMember 2019-12-31 0001759138 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001759138 us-gaap:RetainedEarningsMember 2019-12-31 0001759138 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001759138 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001759138 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-01 2020-12-31 0001759138 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001759138 us-gaap:CommonStockMember 2020-12-31 0001759138 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001759138 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-12-31 0001759138 us-gaap:RetainedEarningsMember 2020-12-31 0001759138 2019-10-15 2019-10-16 0001759138 2019-10-16 0001759138 us-gaap:IPOMember 2019-10-28 2019-10-29 0001759138 us-gaap:IPOMember 2019-10-29 0001759138 us-gaap:IPOMember 2019-11-01 2019-11-30 0001759138 caba:LaboratoryEquipmentMember 2020-01-01 2020-12-31 0001759138 us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-12-31 0001759138 us-gaap:ComputerEquipmentMember 2020-01-01 2020-12-31 0001759138 us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-12-31 0001759138 caba:ProfessionalServicesMember 2020-01-01 2020-12-31 0001759138 caba:ProfessionalServicesMember 2019-01-01 2019-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2020-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateNoteSecuritiesMember 2020-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateNoteSecuritiesMember 2020-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001759138 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001759138 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001759138 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001759138 us-gaap:CashAndCashEquivalentsMember 2020-12-31 0001759138 us-gaap:CorporateNoteSecuritiesMember 2020-12-31 0001759138 us-gaap:EquipmentMember 2020-12-31 0001759138 us-gaap:EquipmentMember 2019-12-31 0001759138 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001759138 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001759138 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001759138 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001759138 us-gaap:ComputerEquipmentMember 2020-12-31 0001759138 us-gaap:ComputerEquipmentMember 2019-12-31 0001759138 caba:LicenseAgreementMember 2020-12-31 0001759138 caba:LicenseAgreementMember 2020-01-01 2020-12-31 0001759138 caba:LicenseAgreementMember 2020-05-01 2020-05-31 0001759138 caba:SponsoredResearchAgreementsMember caba:RegentsOfUniversityOfCaliforniaMember 2020-12-31 0001759138 caba:SponsoredResearchAgreementsMember caba:RegentsOfUniversityOfCaliforniaMember 2020-01-01 2020-12-31 0001759138 caba:SponsoredResearchAgreementsMember caba:RegentsOfUniversityOfCaliforniaMember 2019-01-01 2019-12-31 0001759138 caba:SponsoredResearchAgreementsMember caba:RegentsOfUniversityOfCaliforniaMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-12-31 0001759138 caba:SponsoredResearchAgreementsMember caba:RegentsOfUniversityOfCaliforniaMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-12-31 0001759138 caba:SponsoredResearchAgreementsMember caba:RegentsOfUniversityOfCaliforniaMember caba:AccruedAndOtherCurrentLiabilitiesMember 2020-12-31 0001759138 caba:MasterTranslationalResearchServicesAgreementMember 2020-01-01 2020-12-31 0001759138 caba:MasterTranslationalResearchServicesAgreementMember 2019-01-01 2019-12-31 0001759138 caba:SubscriptionAndTechnologyTransferAgreementMember 2019-01-01 2019-12-31 0001759138 caba:SubscriptionAndTechnologyTransferAgreementMember 2020-01-01 2020-12-31 0001759138 caba:OperatingLeaseAgreementMember 2020-01-01 2020-12-31 0001759138 caba:OperatingLeaseAgreementMember 2019-01-01 2019-12-31 0001759138 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001759138 caba:SeriesA1PreferredStockMember 2018-12-31 0001759138 caba:SeriesA2PreferredStockMember 2018-12-31 0001759138 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-12-31 0001759138 caba:SeriesA2PreferredStockMember 2019-01-01 2019-12-31 0001759138 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-12-31 0001759138 caba:SeriesA1PreferredStockMember 2019-01-01 2019-12-31 0001759138 2019-01-31 0001759138 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-01-31 0001759138 caba:SeriesA2PreferredStockMember 2019-01-01 2019-01-31 0001759138 2019-01-01 2019-01-31 0001759138 2019-10-01 2019-10-31 0001759138 us-gaap:ConvertiblePreferredStockMember 2020-12-31 0001759138 us-gaap:ConvertiblePreferredStockMember 2019-12-31 0001759138 caba:VotingCommonStockMember 2019-10-31 0001759138 us-gaap:NonvotingCommonStockMember 2019-10-31 0001759138 2020-08-31 0001759138 caba:AtTheMarketOfferingSalesAgreementMember 2020-01-01 2020-12-31 0001759138 2018-05-01 2018-05-31 0001759138 us-gaap:ResearchAndDevelopmentExpenseMember caba:FoundersMember 2020-01-01 2020-12-31 0001759138 us-gaap:ResearchAndDevelopmentExpenseMember caba:FoundersMember 2019-01-01 2019-12-31 0001759138 us-gaap:GeneralAndAdministrativeExpenseMember caba:FoundersMember 2020-01-01 2020-12-31 0001759138 us-gaap:GeneralAndAdministrativeExpenseMember caba:FoundersMember 2019-01-01 2019-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandEighteenStockOptionAndGrantPlanMember 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember srt:MinimumMember caba:TwoThousandEighteenStockOptionAndGrantPlanMember 2020-01-01 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember srt:MaximumMember caba:TwoThousandEighteenStockOptionAndGrantPlanMember 2020-01-01 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandEighteenStockOptionAndGrantPlanMember 2020-01-01 2020-12-31 0001759138 caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2019-10-23 0001759138 caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2020-01-01 0001759138 caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2019-10-21 2019-10-23 0001759138 caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2018-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2019-01-01 2019-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2019-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2020-01-01 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember caba:TwoThousandNineteenStockOptionAndIncentivePlanMember 2018-01-01 2018-12-31 0001759138 srt:MinimumMember 2020-01-01 2020-12-31 0001759138 srt:MinimumMember 2019-01-01 2019-12-31 0001759138 srt:MaximumMember 2020-01-01 2020-12-31 0001759138 srt:MaximumMember 2019-01-01 2019-12-31 0001759138 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001759138 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001759138 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001759138 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001759138 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001759138 caba:FoundersMember 2020-12-31 0001759138 caba:FoundersMember 2020-01-01 2020-12-31 0001759138 caba:TwoThousandNineteenEmployeeStockPurchasePlanMember 2019-10-23 0001759138 caba:TwoThousandNineteenEmployeeStockPurchasePlanMember 2020-01-01 0001759138 caba:TwoThousandNineteenEmployeeStockPurchasePlanMember srt:MinimumMember 2019-10-23 0001759138 caba:TwoThousandNineteenEmployeeStockPurchasePlanMember srt:MinimumMember 2019-10-21 2019-10-23 0001759138 caba:TwoThousandNineteenEmployeeStockPurchasePlanMember srt:MaximumMember 2020-01-01 2020-12-31 0001759138 caba:TwoThousandNineteenEmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0001759138 caba:FederalMember 2020-12-31 0001759138 caba:FederalMember 2020-01-01 2020-12-31 0001759138 caba:VotingCommonStockMember 2020-01-01 2020-12-31 0001759138 us-gaap:NonvotingCommonStockMember 2020-01-01 2020-12-31 0001759138 caba:VotingCommonStockMember 2019-01-01 2019-12-31 0001759138 us-gaap:NonvotingCommonStockMember 2019-01-01 2019-12-31 0001759138 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001759138 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001759138 caba:NonVestedCommonStockMember 2020-01-01 2020-12-31 0001759138 caba:NonVestedCommonStockMember 2019-01-01 2019-12-31 0001759138 caba:DevelopmentAndManufacturingServicesAgreementMember caba:WuXiAdvancedTherapiesMember us-gaap:SubsequentEventMember 2021-01-31 0001759138 caba:ResearchServiceAgreementMember caba:ChildrenSHospitalOfPhiladelphiaMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-28 10-K false 2020-12-31 2020 FY CABA CABALETTA BIO, INC. Yes 0001759138 No --12-31 Non-accelerated Filer No false true true false false 24062775 214000000 001-39103 82-1685768 2929 Arch Street Suite 600 Philadelphia PA 19104 267 759-3100 Yes Common Stock, par value $0.00001 per share NASDAQ DE true false 101429000 136204000 7233000 4873000 4348000 113535000 140552000 890000 815000 299000 101000 114724000 141468000 1243000 920000 3937000 2227000 5180000 3147000 0 0 175836000 171280000 6000 -66298000 -32959000 109544000 138321000 114724000 141468000 0.00001 0.00001 10000000 10000000 0 0 0 0 0.00001 0.00001 0.00001 0.00001 150000000 150000000 143590481 143590481 6409519 6409519 24062775 24034022 19387160 17624503 4675615 6409519 24062775 24034022 19387160 17624503 4675615 6409519 21376000 11671000 12457000 7012000 33833000 18683000 -33833000 -18683000 494000 1740000 -33339000 -16943000 5326000 -33339000 -22269000 6000 -33333000 -22269000 -1.44 -4.07 12393047 43921000 3848320 1762000 -12452000 -10690000 6963788 48707000 7275501 71020000 71020000 5667 6000 6000 5326000 -1762000 -3564000 -5326000 -19356835 -97954000 12904534 97954000 97954000 2300000 2300000 -16943000 24034022 171280000 -32959000 25611 139000 139000 3142 29000 29000 6000 6000 4388000 4388000 -33339000 24062775 175836000 6000 -66298000 1293000 3408000 1.5 for 1 basis -33339000 -16943000 4388000 2300000 -119000 354000 104000 524000 3372000 198000 101000 555000 246000 1875000 1721000 -26770000 -16045000 635000 693000 11097000 3751000 -7981000 -693000 -192000 71212000 50000000 1293000 139000 6000 29000 -24000 119925000 -34775000 103187000 136204000 33017000 101429000 97954000 10090000 192000 20000 226000 DOCUMENTS INCORPORATED BY REFERENCE Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant’s definitive Proxy Statement for its 2021 annual meeting of shareholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year end of December 31, 2020. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K. 1. Basis of Presentation Cabaletta Bio, Inc. (the Company or Cabaletta) was incorporated in April 2017 in the State of Delaware as Tycho Therapeutics, Inc. and, in August 2018, changed its name to Cabaletta Bio, Inc. The Company is headquartered in Philadelphia, Pennsylvania. Cabaletta is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Principal operations commenced in April 2018, when the Company executed two sponsored research agreements with the Trustees of the University of Pennsylvania (Penn). On October 16, 2019, the Company effected a 1-for-1.5 reverse split of the Company’s issued and outstanding shares of common stock, par value $0.00001 per share (Common Stock). Upon the effectiveness of the reverse stock split: (i) all shares of outstanding Common Stock were adjusted; (ii) the conversion price of the Series A convertible preferred stock (Series A Preferred), Series A-1 convertible preferred stock (Series A-1 Preferred), Series A-2 convertible preferred stock (Series A-2 Preferred) and Series B convertible preferred stock (Series B Preferred; collectively, the Preferred Shares) was adjusted; (iii) the number of shares of Common Stock for which each outstanding option to purchase Common Stock is exercisable was adjusted; and (iv) the exercise price of each outstanding option to purchase Common Stock was adjusted. All of the outstanding Common Stock share numbers (including shares of Common Stock subject to the Company’s options and as converted for the outstanding convertible preferred stock shares), share prices, exercise prices and per share amounts contained in the financial statements have been retroactively adjusted in the financial statements to reflect this reverse stock split for all periods presented. The par value per share and the authorized number of shares of Common Stock and convertible preferred stock were not adjusted as a result of the reverse stock split. On October 29, 2019, the Company completed its initial public offering (IPO) of 6,800,000 shares of Common Stock at an offering price of $11.00 per share. The Company received net proceeds of $66,156 after deducting underwriting discounts, commissions and estimated offering expenses. In connection with the IPO, the Company’s outstanding shares of convertible preferred stock were automatically converted into 12,904,534 shares of Common Stock. In November 2019, the underwriters partially exercised their option and purchased an additional 475,501 shares of Common Stock resulting in net proceeds to the Company of $4,864, after deducting underwriting discounts and commissions. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Risks and Uncertainties The Company does not expect to generate revenue from sales of engineered T cell therapies for B cell-mediated autoimmune diseases or any other revenue unless and until the Company completes preclinical and clinical development and obtains regulatory approval for one or more product candidates. If the Company seeks to obtain regulatory approval for any of its product candidates, the Company expects to incur significant commercialization expenses. The Company is subject to risks common to companies in the biotechnology industry including, but not limited to, new technological innovations, protection of proprietary technology, dependence on key personnel, compliance with government regulations and the need to obtain additional financing. As a result, the Company is unable to predict the timing or amount of increased expenses or when or if the Company will be able to achieve or maintain profitability. Further, the Company is currently dependent on University of Pennsylvania (Penn) for much of its preclinical research, clinical research and development activities and initial manufacturing activities (Note 6). Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical and clinical testing and regulatory approval, prior to commercialization. Even if the Company is able to generate revenues from the sale of its product candidates, if approved, it may not become profitable. If the Company fails to become profitable or is unable to sustain profitability on a continuing basis, then it may be unable to continue its operations at planned levels and be forced to reduce its operations. In December 2019, a novel strain of coronavirus surfaced in Wuhan, China and has since reached multiple other regions and countries. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures, which have delayed the commencement of non-COVID-19-related clinical trials, among other restrictions. The Company’s financial results for the year ended December 31, 2020 were not significantly impacted by COVID-19, however, the Company cannot at this time predict the specific extent, duration, or full impact that the COVID-19 pandemic, including new information that may emerge concerning the severity of COVID-19, the impact of new strains of the virus, the effectiveness and availability of vaccines and the actions to contain COVID-19 or treat its impact will have on its financial condition, operations, and business plans, including its ability to raise additional capital, the timing and enrollment of patients in its ongoing and planned clinical trials, future financings and other expected milestones of its product candidates. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Liquidity The Company has sustained annual operating losses since inception and expects to continue to generate operating losses for the foreseeable future. The Company’s ultimate success depends on the outcome of its research and development activities. The Company had cash and cash equivalents and investments of $108,662 as of December 31, 2020. Through December 31, 2020, the Company has incurred an accumulated deficit of $66,298. Management expects to incur additional losses in the future as it continues its research and development and will need to raise additional capital to fully implement its business plan and to fund its operations. The Company intends to raise such additional capital through a combination of equity offerings, debt financings, government funding arrangements, strategic alliances or other sources. However, if such financing is not available at adequate levels and on a timely basis, or such agreements are not available on favorable terms, or at all, as and when needed, the Company will need to reevaluate its operating plan and may be required to delay or discontinue the development of one or more of its product candidates or operational initiatives. The Company expects that its cash, cash equivalents and investments as of December 31, 2020 will be sufficient to fund its projected operations for at least 12 months from the date the Company’s Annual Report on Form 10-K is filed with the Securities and Exchange Commission (SEC). 2. Summary of Significant Accounting Policies <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include but are not limited to the fair value of common stock, stock-based compensation and the valuation allowance on the Company’s deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Off-Balance Sheet Risk and Concentrations of Credit Risk <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, which are primarily invested in U.S. treasury-based money market funds, and available-for-sale debt securities, which are invested in investment grade corporate bonds with high credit quality issuers. These investments have maturities in 2021. A portion of the Company’s cash is maintained at a federally insured financial institution. The deposits held at this institution are in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held.  The cash in this account is swept daily into U.S. treasury-based and U.S. government-based money market funds. The Company has no off‑balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market accounts.   <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:5.94%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments are available-for-sale and carried at estimated fair value. The Company’s valuations of available-for-sale debt securities are generally derived from independent pricing services based upon quoted prices in active markets for similar securities, with prices adjusted for yield and number of days to maturity, or based on industry models using data inputs, such as interest rates and prices that can be directly observed or corroborated in active markets. Management determines the appropriate classification of its investments in debt securities at the time of purchase and at the end of each reporting period. Investments with original maturities beyond three months at the date of purchase and which mature at, or less than, twelve months from the balance sheet date are classified as current. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive income. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors including the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or if more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other-than-temporary, if any, on available-for-sale securities are included in interest and other income, net. The cost of investments sold is based on the specific-identification method. Interest income on investments as well as amortization of discount or premium is included in interest income. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Property, Plant and Equipment <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment are recorded at cost less accumulated depreciation. Cost includes the acquisition costs and all costs necessary to bring the asset to the location and working condition necessary for its intended use. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the accompanying statements of operations. Expenditures for normal, recurring or periodic repairs and maintenance related to property and equipment are charged to expense as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if it will result in future economic benefits. <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimated useful lives for property and equipment are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%; border-bottom:solid 0.75pt #000000;"> Property and equipment</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.02%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated useful life</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%; border-top:solid 0.75pt #000000;"> Laboratory equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%; border-top:solid 0.75pt #000000;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Furniture and fixtures</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Computer equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Leasehold improvements</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Lesser of estimated useful life or remaining lease term</td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurement Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows: <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2—Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses Research and development costs include costs incurred for internal and external research and development activities and are expensed as incurred in the accompanying statements of operations. Research and development costs consist of salaries and benefits, including associated stock-based compensation, and laboratory supplies and facility costs, as well as fees paid to entities that conduct certain research and development activities on the Company’s behalf. The Company records accrued liabilities for estimated costs of research and development activities conducted by service providers, which include activities under agreements with Penn (Note 6), the conduct of sponsored research, preclinical studies and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes these costs in accrued and other current liabilities and prepaid expenses and other current assets in the accompanying balance sheets and within research and development expense in the accompanying statements of operations. Non-refundable advance payments made for goods or services that will be used or rendered for future research and development activities are deferred and capitalized and recognized as expense as the goods are received or the related services are rendered. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with service providers. The Company makes significant judgments and estimates in determining the accrued liabilities and prepaid expenses in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities and prepaid expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred since its inception. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-based Compensation The Company measures its stock-based awards granted to employees and non-employees based on the estimated fair values of the awards on the respective grant dates. The Company uses the Black-Scholes option-pricing model (Black-Scholes) to estimate the fair value of its stock-based awards. The Company recognizes compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company accounts for forfeitures of stock option awards as they occur. Prior to the Company’s IPO, the assumptions used in the Company's Black-Scholes option-pricing model represented management's best estimates and involve a number of variables, uncertainties and assumptions and the application of management's judgment, as they are inherently subjective. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company’s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more-likely-than-not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets. Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more-likely-than-not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Net Loss Per Share The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. The Company has voting and non-voting common stock. The rights, including the liquidation and dividend rights, of the holders of the voting and non-voting common stock are identical, except with respect to voting. Each share of non-voting common stock may be converted at any time into one share of voting common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. The Company also considers its unvested shares of common stock held by the Company’s founders and, prior to its conversion to common stock, its convertible preferred stock to be participating securities as, in the event a dividend is paid on common stock, the holders of convertible preferred stock and unvested shares of common stock would be entitled to receive dividends on a basis consistent with the common stockholders. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock, which excludes unvested shares of common stock. The undistributed loss for each year is allocated to common stockholders based on the contractual participation rights of the voting and non-voting common stock as if the losses for the year had been distributed. As the liquidation and dividend rights are identical, the undistributed losses are allocated on a proportionate basis. Net loss attributable to common stockholders for the year ended December 31, 2019 is calculated by adjusting the net loss of the Company for the deemed dividend associated with the exchange of Series A-2 Preferred for Series B Preferred. Diluted net loss per share attributable to common stockholders is computed under the if-converted method and assumes that all non-voting common stock has been converted to common stock. Since the Company was in a loss position for all periods presented, the effects of the other potentially dilutive securities are antidilutive. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one reportable segment. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Related Party Transactions The Company engaged a firm controlled by a former executive (until February 2019) of the Company for professional services related to accounting, finance and other administrative functions. For the years ended December 31, 2020 and 2019, the costs incurred under this arrangement totaled $311 and $601, respectively. These amounts were recorded as general and administrative expense in the accompanying statements of operations. As of December 31, 2020 and 2019, amounts owed under this arrangement totaled $13 and $36, respectively, and are included in accounts payable in the accompanying balance sheets. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements Not Yet Adopted In February 2016, the Financial Accounting Standards Board (FASB) issued ASU 2016-02, Leases (Topic 842), with guidance regarding the accounting for and disclosure of leases. The update requires lessees to recognize the liabilities related all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will be effective for public companies for annual and interim periods beginning after December 15, 2018. For all other entities, including Emerging Growth Companies, this standard is effective for annual reporting periods beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. As an Emerging Growth Company, the Company expects to adopt Topic 842 for its annual period ending December 31, 2021 and has not yet finalized the assessment of the impact that ASU 2016-02 will have on its financial statements or financial statement disclosures. 3. Fair Value Measurements   As of December 31, 2020 and 2019, the Company’s financial instruments included cash and cash equivalents, available-for-sale debt securities, accounts payable and accrued expenses. The carrying amounts for cash and cash equivalents, accounts payable and accrued expenses reported in the Company’s financial statements for these instruments approximate their respective fair values because of the short-term nature of these instruments. The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.12%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Prices in <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Active Markets <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Identical <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets (Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,662</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.08%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted Prices in Active Markets for Identical Assets (Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant Other Observable Inputs (Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant Unobservable Inputs (Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.08%;"> Financial assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.08%;"> Cash equivalents:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.08%; border-bottom:solid 0.75pt transparent;"> Money market funds</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.08%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div></div>   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds are measured at fair value on a recurring basis using quoted prices and are classified as Level 1. Investments are measured at fair value based on inputs other than quoted prices that are derived from observable market data and are classified as Level 2 inputs. There were no transfers of assets between the fair value measurement levels during the years ended December 31, 2020 or 2019. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For debt securities classified as available-for-sale investments, the Company records unrealized gains or losses resulting from changes in fair value between measurement dates as a component of other comprehensive income. The Company did not hold any available-for-sale securities as of December 31, 2019.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized Gains</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized Losses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Included in cash and cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds - due in one year or less</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Included in short-term investments</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,227</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,656</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,662</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table>    </div> 4. Property, Plant and Equipment Property plant and equipment consists of the following: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Laboratory equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">961</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">544</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Furniture and fixtures</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Leasehold improvements</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> Computer equipment</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Total property, plant and equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,348</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">919</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> Less: accumulated depreciation</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(458</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(104</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;"> Property, plant and equipment, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">890</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> Depreciation expense was $354 and $104 for the years ended December 31, 2020 and 2019, respectively. 5. Accrued and Other Current Liabilities Accrued and other current liabilities consist of the following:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Research and development services</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,294</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> General and administrative services</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Compensation expense</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,445</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,522</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Other</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,937</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,227</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   6. Collaborations, Licensing Agreements and other Agreements <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Amended and Restated License Agreement with the Trustees of the University of Pennsylvania and Children’s Hospital of Philadelphia <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the Company entered into a license agreement with Penn, as amended and restated in July 2019 to include CHOP as a party, and as amended in May 2020 (the License Agreement) pursuant to which the Company obtained (a) a non-exclusive, non-sublicensable worldwide license to certain of Penn’s intellectual property to conduct research, product development, clinical trials, cell manufacturing and other activities, and (b) an exclusive, worldwide, royalty-bearing right and license, with a right to sublicense, on a target-by-target basis, under certain of Penn’s intellectual property to make, use, sell, offer for sale, import, and otherwise commercialize products for the treatment of autoimmune and alloimmune diseases. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless earlier terminated, the License Agreement expires on the expiration or abandonment or other termination of the last valid claim in Penn’s intellectual property licensed by the Company. The Company may terminate the License Agreement at any time for convenience upon 60 days written notice. In the event of an uncured, material breach, Penn may terminate the License Agreement upon 60 days written notice. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the License Agreement, the Company was obligated to pay $2,000 annually for three years beginning August 2018 for funding to the laboratories of each of Drs. Milone and Payne (see Sponsored Research Agreements). During the term of the License Agreement until the first commercial sale of the first product, the Company is obligated to pay Penn a non-refundable, non-creditable annual license maintenance fee of $10. In May 2020, the Company paid Penn an additional, non-refundable, non-creditable license fee of $33 under the amended License Agreement. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is required to pay certain milestone payments upon the achievement of specified clinical and commercial milestones. Milestone payments are reduced by a certain percentage for the second product that achieves a milestone, by an additional percentage for the third product that achieves a milestone, and so on, for each subsequent product that achieves a milestone. In the event that the Company is able to successfully develop and launch multiple products under the License Agreement, total milestone payments could be approximately $21,000. Penn is also eligible to receive tiered royalties at percentage rates in the low single-digits, subject to an annual minimum royalty, on annual worldwide net sales of any products that are commercialized by the Company or its sublicensees that contain or incorporate, or are covered by, the intellectual property licensed by the Company. To the extent the Company sublicenses its license rights under the License Agreement, Penn would be eligible to receive tiered sublicense income at percentage rates in the mid-single to low double-digits. There were no amounts due under the License Agreement as of December 31, 2020.      Sponsored Research Agreements The Company has sponsored research agreements with two faculty members at Penn, who are also scientific co-founders of the Company and members of the Company’s scientific advisory board. In May 2020, one of the agreements was amended to expand the scope of sponsored research. In August 2020, this agreement was further amended to extend the term of the original research plan. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the amended agreements, the Company has committed to funding a defined research plan through February 2023. The total estimated cost of $11,781 under the agreements satisfies the Company’s annual obligation under the License Agreement (see Amended and Restated License Agreement with the Trustees of the University of Pennsylvania above). As of December 31, 2020, $7,090 of cost has been incurred pursuant to these agreements. For the years ended December 31, 2020 and 2019, the Company recognized research and development expense of $2,995 and $2,137, respectively, related to these agreements in the accompanying statements of operations. As of December 31, 2020 and 2019, $1,851 and $1,588 respectively, of advance payments are included in Prepaid expenses and other current assets in the accompanying balance sheets and there was $217 included in Accrued and other current liabilities in the accompanying balance sheets as of December 31, 2020. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Master Translational Research Services Agreement In October 2018, the Company entered into a services agreement (the Services Agreement) with Penn for additional research and development services from various laboratories within Penn. The research and development activities are detailed in separately executed Penn organization-specific addenda. In May 2020, the Company amended its Addendum with the Center for Advanced Retinal and Ocular Therapeutics (CAROT) to expand access to vector manufacturing. Research and development expense related to executed addenda under the master translational research service agreement with Penn recognized in the accompanying statements of operations for the years ended December 31, 2020 and 2019 was $2,474 and $2,355, respectively. The Company may incur additional expenses up to $1,360 through the remaining term of the CAROT Amended Addendum. Subscription and Technology Transfer Agreement In July 2019, the Company entered into a subscription and technology transfer agreement pursuant to which the Company owed Penn an upfront subscription fee, which was paid in 2019, and a nominal non-refundable royalty on the net sales of products, a portion of which will be credited toward milestone payments and royalties, respectively, under the Amended License Agreement. Technology transfer activities will be at the Company’s cost and subject to agreement as to the technology to be transferred. Under this agreement, the Company recognized $250 of research and development expense for the year ended December 31, 2019. No expense was recognized under this agreement for the year ended December 31, 2020.   <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.73%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Collaboration and License Agreement <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2020, the Company entered into a collaboration and license agreement with Artisan Bio, Inc. (Artisan), wherein the Company and Artisan agreed to collaborate to potentially enhance certain pipeline products of the Company at specific targets using Artisan’s gene editing and engineering technology. If the Artisan technology is applied to any of the Company’s products, the Company will be responsible for the development, manufacturing, and commercialization of any such products. Under the terms of the agreement, the Company was required to pay Artisan a nominal upfront fee, as well as costs associated with research and development activities. Artisan is eligible to receive future research, development and regulatory milestones, and is also eligible to receive sales milestones and tiered royalties on net sales of products that incorporate the Artisan technology. The Company can terminate the agreement at will upon advance written notice with payment of a nominal cancellation fee. 7. Commitments and Contingencies <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Operating Lease Agreement In February 2019, the Company entered into an operating lease agreement for new office space in Philadelphia, Pennsylvania. The lease term commenced in May 2019 and will expire in July 2022. The initial annual base rent is $261, and such amount will increase by 2% annually on each anniversary of the commencement date. The Company records rent expense on a straight-line basis over the lease term. Rent expense related to this lease agreement recognized in the accompanying statement of operations was $266 and $178 for the years ended December 31, 2020 and 2019. As of December 31, 2020, the future minimum payments for operating leases are as follows: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">426</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> Other Purchase Commitments In the normal course of business, the Company enters into various purchase commitments with third-party contract manufacturers for the manufacture and processing of its product candidates and related raw materials, contracts with contract research organizations for clinical trials and agreements with vendors for other services and products for operating purposes. These agreements generally provide for termination or cancellation, other than for costs already incurred.   <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Indemnification The Company enters into certain types of contracts that contingently requires the Company to indemnify various parties against claims from third parties. These contracts primarily relate to (i) the Company’s bylaws, under which the Company must indemnify directors and executive officers, and may indemnify other officers and employees, for liabilities arising out of their relationship, (ii) contracts under which the Company must indemnify directors and certain officers and consultants for liabilities arising out of their relationship, (iii) contracts under which the Company may be required to indemnify partners against certain claims, including claims from third parties asserting, among other things, infringement of their intellectual property rights, and (iv) procurement, consulting, or license agreements under which the Company may be required to indemnify vendors, consultants or licensors for certain claims, including claims that may be brought against them arising from the Company’s acts or omissions with respect to the supplied products, technology or services. From time to time, the Company may receive indemnification claims under these contracts in the normal course of business. In addition, under these contracts, the Company may have to modify the accused infringing intellectual property and/or refund amounts received. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. 8. Convertible Preferred Stock Preferred Stock Preferred Stock The Company has 10,000,000 shares of authorized preferred stock as of December 31, 2020, none of which is issued or outstanding. The preferred stock is not redeemable and does not have a stated voting, dividend or liquidation preference. Convertible Preferred Stock The Company has issued Series A Preferred, Series A-1 Preferred, Series A-2 Preferred, and Series B Preferred of Convertible Preferred Stock. The Company classified Convertible Preferred Stock outside of stockholders’ equity (deficit) because the shares contained deemed liquidation rights that were a contingent redemption feature not solely within the control of the Company.   <div align="right"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A-1 Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A-2 Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series B Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Convertible <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance—December 31, 2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,146,551</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,575</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,372,719</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,994</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,873,777</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,352</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,393,047</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,921</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,963,788</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,963,788</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exchange, including <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   deemed dividend</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,405,332</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,764</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,405,332</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,090</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,326</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,293</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,293</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion to common <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,146,551</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,575</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,372,719</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,994</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(468,445</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,588</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,369,120</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,797</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,356,835</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,954</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance—December 31, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> In January 2019, the Company’s certificate of incorporation was amended to increase the authorized shares of Convertible Preferred Stock to 20,762,168 shares, and the Company issued 6,963,788 shares of Series B Preferred, resulting in gross proceeds of $50,000. In connection, the Company issued a further 1,405,332 shares of Series B Preferred in exchange for 1,405,332 shares of Series A-2 Preferred. The Company determined the terms of the Series B Preferred to be materially, qualitatively different than the terms of the Series A-2 Preferred and, as such, applied extinguishment accounting with respect to the Series A-2 Preferred received in the exchange resulting in removal of the carrying amount of the Series A-2 Preferred received ($4,764), the addition of the Series B Preferred issued at fair value determined with reference to the contemporaneous issuance of Series B Preferred ($10,090) and the difference ($5,326) determined to be a deemed dividend recorded to additional paid-in capital (to the extent of paid-in capital) and accumulated deficit within stockholders’ deficit on the balance sheet. The shares of Convertible Preferred Stock had various rights, including voting and dividend rights, preferences and privileges, including optional and mandatory conversion rights. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2019, the Convertible Preferred Stock was converted into 12,904,534 shares of Common Stock. Certain holders of the Company’s Convertible Preferred Stock elected to have such shares convert into 6,409,519 shares of non-voting Common Stock following the closing of the Company’s IPO. The non-voting shares of Common Stock have the same rights and preferences as the Common Stock but are non-voting. No Convertible Preferred Stock was outstanding as of December 31, 2020 or 2019. 9. Common Stock <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Common Stock Pursuant to the Company’s Third Amended and Restated Certificate of Incorporation filed in October 2019, the Company is authorized to issue 143,590,481 shares of voting common stock and 6,409,519 shares of non-voting common stock. Holders of voting common stock shall have the exclusive right to vote for the election of directors of the Company and on all other matters requiring stockholder action. Each share of the Company’s non-voting common stock may be converted at any time into one share of common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. In August 2020, 1,733,904 shares of non-voting common stock were converted to voting common stock. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">At-The-Market Offering Sales Agreement <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 10, 2020, the Company filed a Shelf Registration Statement in relation to the registration of common stock, preferred stock, debt securities, warrants and/or units of any combination thereof for the purposes of selling, from time to time, the Company’s common stock, debt securities or other equity securities in one or more offerings. The Company also simultaneously entered into a Sales Agreement with Cowen and Company, LLC, to provide for the offering, issuance and sale of up to an aggregate amount of $75.0 million of the Company’s common stock from time to time in “at-the-market” offerings under the Shelf Registration Statement and subject to the limitations thereof. No shares have been sold under the Sales Agreement as of December 31, 2020. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Share-based Payment Awards In May 2018, several of the Company’s founders agreed to modify their shares of common stock outstanding to include vesting provisions that require continued service to the Company in order to vest in those shares. As such, the 2,904,000 modified shares of common stock became compensatory upon such modification. The fair value of the awards on the modification date was determined to be $0.74 per share of common stock, based on the issuance of convertible notes in May 2018, considering the maximum conversion price and the seniority of the notes. The total compensation cost resulting from the modification was $2,126. The total compensation cost is being recognized over the three-year vesting term attendant to the founders’ common shares. <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, the Company recognized $495 and $177 of this amount in research and development expense and general and administrative expense, respectively. During the year ended December 31, 2019, the Company recognized $529 and $177 of this amount in research and development expense and general and administrative expense, respectively.  2018 Stock Option and Grant Plan In September 2018, the Company adopted the 2018 stock option and grant plan (the 2018 Plan), which provided for the Company to sell or issue common stock, or other stock-based awards, to employees, members of the board of directors and consultants of the Company. The Company generally granted stock-based awards with service conditions only (service-based awards), although there was one grant with performance conditions. As of December 31, 2020, there are no unvested options with performance conditions. Stock options granted under the 2018 Plan generally vest over three to four years. There were 1,959,411 options granted under the 2018 Plan prior to the Company’s IPO in October 2019. No further grants may be made under the 2018 Plan subsequent to the IPO. 2019 Stock Option and Incentive Plan The 2019 Stock Option and Incentive Plan (2019 Plan) was approved by the Company’s board of directors on October 14, 2019, and became effective on October 23, 2019. The 2019 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to the Company’s officers, employees, directors and consultants. The number of shares initially reserved for issuance under the 2019 Plan was 2,342,288, which will be increased each January 1 thereafter by 4% of the number of shares of the Company’s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company’s board of directors or compensation committee of the board of directors. On January 1, 2021, the total number of shares under the 2019 Plan was increased by 962,511 shares. As of December 31, 2020, there were 2,314,303 shares remaining available for issuance. A summary of the stock option activity is presented below:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of January 1, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">971,353</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.01</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,051</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,340,839</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.97</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,667</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.01</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(176,893</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.22</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,129,632</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.12</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,844</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">813,172</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.03</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,611</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.44</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,714</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.30</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,900,479</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.33</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.5</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,303</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable at December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,068,675</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.04</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,059</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table>  </div> The aggregate intrinsic value of options granted is calculated as the difference between the exercise price of the options and the estimated fair value of the Company’s common stock. The weighted average grant-date fair value of stock options granted during the year ended December 31, 2020 and 2019 was $8.31 and $5.24, respectively. The fair value of each award is estimated using Black-Scholes based on the following assumptions:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="3" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Risk-free interest rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.28%—1.48%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39%—2.59%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Expected term</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.7—6.1 years</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3—6.1 years</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Expected volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70%—79%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70%—76%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Expected dividend yield</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> </tr> </table>  </div> Black-Scholes requires the use of subjective assumptions which determine the fair value of stock-based awards. These assumptions include: <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Fair value of common stock—Prior to the Company’s IPO in October 2019, the fair value of the Company’s common stock underlying stock-based awards was estimated on each grant date by the Company’s board of directors. In order to determine the fair value of the Company’s common stock underlying stock-based awards, the Company’s board of directors considered, among other things, a valuation of the Company’s common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Expected term—The expected term represents the period that stock-based awards are expected to be outstanding. The expected term for option grants is determined using the simplified method, which is the midpoint between the vesting period and the contractual term of the option. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Expected volatility—As a privately held company prior to the Company’s IPO in October 2019, the Company has limited trading history for its common stock and, as such, the expected volatility is estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock-based awards. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of a stock-based award. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Expected dividend—The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-based Compensation The Company has recorded stock-based compensation in the accompanying statements of operations as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.76%;"> Research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,989</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:solid 0.75pt transparent;"> General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,399</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">996</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,388</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,300</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table>  </div> As of December 31, 2020, there was $9,809 of unrecognized compensation cost related to unvested option awards, which is expected to be recognized over a weighted-average period of 2.8 years. As of December 31, 2020, there was $239 of unrecognized compensation cost related to unvested founder stock awards, which is expected to be recognized over a weighted-average period of 0.3 years. 2019 Employee Stock Purchase Plan The 2019 Employee Stock Purchase Plan (2019 ESPP) was approved by the Company’s board of directors on October 14, 2019, and became effective on October 23, 2019. A total of 234,229 shares of common stock were initially reserved for issuance under the 2019 ESPP, and will be increased each January 1 thereafter through January 1, 2029 by the least of (i) 234,229 shares of common stock, (ii) 1% of the number of shares of the Company’s common stock outstanding on the immediately preceding December 31 or (iii) such lesser number of shares determined by the 2019 ESPP’s administrator. On January 1, 2021, the total number of shares under the 2019 ESPP was increased by 234,229 shares. Employee contributions are made through payroll deductions of up to 15% of eligible compensation over the offering period. A participant may not accrue rights to purchase more than $25 worth of the Company’s common stock for each calendar year in which such right is outstanding. At the end of each offering period, shares of the Company’s common stock may be purchased at 85% of the lesser of the Company’s common stock on (i) the first trading day of the relevant offering period and (ii) the last trading day of the relevant offering period. The first offering period commenced on July 1, 2020 and ended on November 30, 2020. Thereafter, offerings will be six months in duration and will commence on each December 1 and June 1. The Company recognized stock-based compensation expense of $18 during the year ended December 31, 2020 related to the 2019 ESPP. 10. Income Taxes The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate is as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Expected income tax benefit at the federal statutory rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> State and local taxes, net of federal benefit</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Research and development credit, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-deductible items and other</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.8</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.3</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> Change in valuation allowance</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35.3</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33.1</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> </tr> </table>  </div> Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The principal components of the Company’s deferred tax assets consisted of the following:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Deferred tax assets:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Federal, state and local net operating loss carryforwards</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,241</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,688</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> License fee deductions</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">340</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Research and development tax credits</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,317</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">452</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Stock-based compensation deductions</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,243</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">264</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Accrued expenses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">837</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">457</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Gross deferred tax assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,978</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,223</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Less: valuation allowance</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,978</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,223</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Total deferred tax assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Deferred tax liabilities:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Net deferred tax assets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table>  </div> The Company increased its valuation allowance by $11,755 for the year ended December 31, 2020 in order to maintain a full valuation allowance against its deferred tax assets. Based on the Company’s history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December 31, 2020. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to support a reversal of the allowance. As of December 31, 2020, the Company had federal, state and local net operating loss carryforwards of $45,550, $47,735 and $38,645, respectively; $45,301 of the federal amounts do not expire, and the remaining $249 expire in 2037. The state net operating losses begin to expire in 2037. The local net operating losses begin to expire in 2039. As of December 31, 2020, the Company had federal research and development tax credit carryforwards of $1,317, which begin to expire in 2038. Under the provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the IRC), these net operating losses, credit carryforwards and other tax attributes may be subject to limitation based on previous significant changes in ownership and upon future significant changes in ownership of the Company, as defined by the IRC. The Company files income tax returns in the U.S. federal jurisdiction as well as in Pennsylvania and Philadelphia. The tax years 2019, 2018 and 2017 remain open to examination by the jurisdictions where the Company is subject to tax. The Company evaluates tax positions for recognition using a more-likely-than-not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of December 31, 2020, the Company had no unrecognized income tax benefits that would affect the Company’s effective tax rate if recognized. 11. Net Loss Per Share <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:7.69%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. For the years ended December 31, 2020 and 2019, the Company had voting and non-voting common stock outstanding. Since the rights of the voting and non-voting common stock are identical, except with respect to voting, the undistributed losses of the Company have been allocated on a proportionate basis to the two classes. Diluted net loss per share is calculated using the if-converted method, which assumes conversion of all non-voting common stock to voting common stock.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2020</td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Non-voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses attributable to common stockholders</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,090</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,417,900</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses for basic computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,090</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reallocation of undistributed losses as a result of conversion of <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">     non-voting to voting common shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33,339</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,417,900</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Conversion of non-voting to voting common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in diluted per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,145,227</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table>  </div> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2019</td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.74%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Non-voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses attributable to common stockholders</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,693</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,345,530</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses for basic computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,693</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reallocation of undistributed losses as a result of conversion of <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">     non-voting to voting common shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,269</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,345,530</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Conversion of non-voting to voting common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in diluted per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,469,391</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table>  </div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,900,479</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,129,632</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested founder stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">465,801</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,388,977</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,366,280</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,609</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   12. 401(k) Savings Plan The Company maintains a defined-contribution savings plan under Section 401(k) of the IRC, or the 401(k) Plan. The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis. In 2019, the Company made a safe harbor nonelective contribution of 3% of eligible compensation on behalf of all employees. Effective January 1, 2020, the Plan provided for matching contributions on a portion of participant contributions pursuant to the 401(k) Savings Plan’s matching formula, up to 4% of eligible compensation. All matching contributions and participant contributions vest immediately. Contributions totaled $203 and $74 for the years ended December 31, 2020 and 2019, respectively, and have been recorded in the statements of operations.   13. Subsequent Events In January 2021, the Company entered into a Development and Manufacturing Services Agreement (Wuxi Agreement) with WuXi Advanced Therapies (Wuxi) to serve as the Company’s cell processing manufacturing partner for the anticipated MuSK-CAART Phase 1 clinical trial. The Company has the right to terminate the Wuxi Agreement for convenience or other reasons specified in the Wuxi Agreement upon prior written notice. If the Company terminates the Wuxi Agreement, it will be obligated to pay an early termination fee of $1,500. In February 2021, the Company entered into a research service agreement with CHOP for vector manufacturing, with a total cost of $670, expected to be incurred during 2021. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include but are not limited to the fair value of common stock, stock-based compensation and the valuation allowance on the Company’s deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Off-Balance Sheet Risk and Concentrations of Credit Risk <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, which are primarily invested in U.S. treasury-based money market funds, and available-for-sale debt securities, which are invested in investment grade corporate bonds with high credit quality issuers. These investments have maturities in 2021. A portion of the Company’s cash is maintained at a federally insured financial institution. The deposits held at this institution are in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held.  The cash in this account is swept daily into U.S. treasury-based and U.S. government-based money market funds. The Company has no off‑balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash and Cash Equivalents The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market accounts.   <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:5.94%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Investments <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.94%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments are available-for-sale and carried at estimated fair value. The Company’s valuations of available-for-sale debt securities are generally derived from independent pricing services based upon quoted prices in active markets for similar securities, with prices adjusted for yield and number of days to maturity, or based on industry models using data inputs, such as interest rates and prices that can be directly observed or corroborated in active markets. Management determines the appropriate classification of its investments in debt securities at the time of purchase and at the end of each reporting period. Investments with original maturities beyond three months at the date of purchase and which mature at, or less than, twelve months from the balance sheet date are classified as current. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive income. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors including the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or if more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other-than-temporary, if any, on available-for-sale securities are included in interest and other income, net. The cost of investments sold is based on the specific-identification method. Interest income on investments as well as amortization of discount or premium is included in interest income. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Property, Plant and Equipment <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment are recorded at cost less accumulated depreciation. Cost includes the acquisition costs and all costs necessary to bring the asset to the location and working condition necessary for its intended use. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the accompanying statements of operations. Expenditures for normal, recurring or periodic repairs and maintenance related to property and equipment are charged to expense as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if it will result in future economic benefits. <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimated useful lives for property and equipment are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%; border-bottom:solid 0.75pt #000000;"> Property and equipment</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.02%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated useful life</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%; border-top:solid 0.75pt #000000;"> Laboratory equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%; border-top:solid 0.75pt #000000;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Furniture and fixtures</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Computer equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Leasehold improvements</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Lesser of estimated useful life or remaining lease term</td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Fair Value Measurement Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows: <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2—Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5.24%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Research and Development Expenses Research and development costs include costs incurred for internal and external research and development activities and are expensed as incurred in the accompanying statements of operations. Research and development costs consist of salaries and benefits, including associated stock-based compensation, and laboratory supplies and facility costs, as well as fees paid to entities that conduct certain research and development activities on the Company’s behalf. The Company records accrued liabilities for estimated costs of research and development activities conducted by service providers, which include activities under agreements with Penn (Note 6), the conduct of sponsored research, preclinical studies and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes these costs in accrued and other current liabilities and prepaid expenses and other current assets in the accompanying balance sheets and within research and development expense in the accompanying statements of operations. Non-refundable advance payments made for goods or services that will be used or rendered for future research and development activities are deferred and capitalized and recognized as expense as the goods are received or the related services are rendered. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with service providers. The Company makes significant judgments and estimates in determining the accrued liabilities and prepaid expenses in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities and prepaid expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred since its inception. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-based Compensation The Company measures its stock-based awards granted to employees and non-employees based on the estimated fair values of the awards on the respective grant dates. The Company uses the Black-Scholes option-pricing model (Black-Scholes) to estimate the fair value of its stock-based awards. The Company recognizes compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company accounts for forfeitures of stock option awards as they occur. Prior to the Company’s IPO, the assumptions used in the Company's Black-Scholes option-pricing model represented management's best estimates and involve a number of variables, uncertainties and assumptions and the application of management's judgment, as they are inherently subjective. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Taxes The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company’s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more-likely-than-not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets. Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more-likely-than-not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Net Loss Per Share The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. The Company has voting and non-voting common stock. The rights, including the liquidation and dividend rights, of the holders of the voting and non-voting common stock are identical, except with respect to voting. Each share of non-voting common stock may be converted at any time into one share of voting common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. The Company also considers its unvested shares of common stock held by the Company’s founders and, prior to its conversion to common stock, its convertible preferred stock to be participating securities as, in the event a dividend is paid on common stock, the holders of convertible preferred stock and unvested shares of common stock would be entitled to receive dividends on a basis consistent with the common stockholders. Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock, which excludes unvested shares of common stock. The undistributed loss for each year is allocated to common stockholders based on the contractual participation rights of the voting and non-voting common stock as if the losses for the year had been distributed. As the liquidation and dividend rights are identical, the undistributed losses are allocated on a proportionate basis. Net loss attributable to common stockholders for the year ended December 31, 2019 is calculated by adjusting the net loss of the Company for the deemed dividend associated with the exchange of Series A-2 Preferred for Series B Preferred. Diluted net loss per share attributable to common stockholders is computed under the if-converted method and assumes that all non-voting common stock has been converted to common stock. Since the Company was in a loss position for all periods presented, the effects of the other potentially dilutive securities are antidilutive. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one reportable segment. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Related Party Transactions The Company engaged a firm controlled by a former executive (until February 2019) of the Company for professional services related to accounting, finance and other administrative functions. For the years ended December 31, 2020 and 2019, the costs incurred under this arrangement totaled $311 and $601, respectively. These amounts were recorded as general and administrative expense in the accompanying statements of operations. As of December 31, 2020 and 2019, amounts owed under this arrangement totaled $13 and $36, respectively, and are included in accounts payable in the accompanying balance sheets. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements Not Yet Adopted In February 2016, the Financial Accounting Standards Board (FASB) issued ASU 2016-02, Leases (Topic 842), with guidance regarding the accounting for and disclosure of leases. The update requires lessees to recognize the liabilities related all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will be effective for public companies for annual and interim periods beginning after December 15, 2018. For all other entities, including Emerging Growth Companies, this standard is effective for annual reporting periods beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. As an Emerging Growth Company, the Company expects to adopt Topic 842 for its annual period ending December 31, 2021 and has not yet finalized the assessment of the impact that ASU 2016-02 will have on its financial statements or financial statement disclosures. <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimated useful lives for property and equipment are as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%; border-bottom:solid 0.75pt #000000;"> Property and equipment</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.02%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated useful life</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%; border-top:solid 0.75pt #000000;"> Laboratory equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%; border-top:solid 0.75pt #000000;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Furniture and fixtures</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Computer equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Three years</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.82%;"> Leasehold improvements</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.12%;"> Lesser of estimated useful life or remaining lease term</td> </tr> </table></div> The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.12%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Prices in <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Active Markets <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Identical <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets (Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,662</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.08%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted Prices in Active Markets for Identical Assets (Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant Other Observable Inputs (Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant Unobservable Inputs (Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.08%;"> Financial assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.08%;"> Cash equivalents:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.08%; border-bottom:solid 0.75pt transparent;"> Money market funds</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.08%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,204</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized Gains</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized Losses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Financial assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Included in cash and cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,429</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate bonds - due in one year or less</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Included in short-term investments</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,227</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,233</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,656</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,662</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>     Property plant and equipment consists of the following: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Laboratory equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">961</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">544</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Furniture and fixtures</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">277</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Leasehold improvements</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> Computer equipment</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Total property, plant and equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,348</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">919</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> Less: accumulated depreciation</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(458</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(104</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;"> Property, plant and equipment, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">890</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> Accrued and other current liabilities consist of the following:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Research and development services</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,294</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> General and administrative services</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Compensation expense</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,445</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,522</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Other</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,937</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,227</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> As of December 31, 2020, the future minimum payments for operating leases are as follows: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">426</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   <div align="right"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A-1 Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A-2 Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series B Preferred</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Convertible <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:6pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance—December 31, 2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,146,551</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,575</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,372,719</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,994</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,873,777</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,352</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,393,047</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,921</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,963,788</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,963,788</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exchange, including <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   deemed dividend</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,405,332</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,764</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,405,332</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,090</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,326</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,293</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,293</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conversion to common <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,146,551</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,575</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,372,719</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,994</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(468,445</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,588</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,369,120</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,797</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,356,835</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,954</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.68%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance—December 31, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> A summary of the stock option activity is presented below:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of January 1, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">971,353</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.01</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.8</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,051</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,340,839</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.97</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,667</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.01</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(176,893</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.22</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,129,632</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.12</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,844</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">813,172</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.03</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,611</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.44</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,714</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.30</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of December 31, 2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,900,479</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.33</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.5</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,303</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable at December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,068,675</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.04</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,059</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   The fair value of each award is estimated using Black-Scholes based on the following assumptions:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="3" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Risk-free interest rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.28%—1.48%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39%—2.59%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Expected term</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.7—6.1 years</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3—6.1 years</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Expected volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70%—79%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70%—76%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.06%;"> Expected dividend yield</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.66%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> </tr> </table></div>   The Company has recorded stock-based compensation in the accompanying statements of operations as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.76%;"> Research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,989</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:solid 0.75pt transparent;"> General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,399</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">996</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.76%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,388</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,300</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate is as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Expected income tax benefit at the federal statutory rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> State and local taxes, net of federal benefit</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Research and development credit, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-deductible items and other</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.8</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.3</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> Change in valuation allowance</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35.3</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33.1</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> </tr> </table></div>   The principal components of the Company’s deferred tax assets consisted of the following:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Deferred tax assets:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Federal, state and local net operating loss carryforwards</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,241</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,688</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> License fee deductions</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">340</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">362</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Research and development tax credits</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,317</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">452</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Stock-based compensation deductions</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,243</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">264</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Accrued expenses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">837</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">457</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Gross deferred tax assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,978</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,223</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Less: valuation allowance</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,978</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,223</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Total deferred tax assets</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Deferred tax liabilities:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Net deferred tax assets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>     <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2020</td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Non-voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses attributable to common stockholders</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,090</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,417,900</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses for basic computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,090</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reallocation of undistributed losses as a result of conversion of <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">     non-voting to voting common shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33,339</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,249</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,417,900</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Conversion of non-voting to voting common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in diluted per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,145,227</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,727,327</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2019</td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.74%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Non-voting common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses attributable to common stockholders</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,693</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,345,530</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net loss per share:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses for basic computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,693</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reallocation of undistributed losses as a result of conversion of <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">     non-voting to voting common shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of undistributed losses</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,269</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,576</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in basic per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,345,530</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Conversion of non-voting to voting common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average number of shares used in diluted per share computation</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,469,391</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,123,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.07</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>   <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Year Ended December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,900,479</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,129,632</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested founder stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">465,801</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,388,977</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,366,280</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,518,609</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> 1-for-1.5 reverse split 0.67 0.00001 6800000 11.00 66156000 12904534 475501 4864000 108662000 2021 P3Y P3Y P3Y Lesser of estimated useful life or remaining lease term 0 1 1 311000 601000 13000 36000 101429000 101429000 7233000 7233000 108662000 101429000 7233000 136204000 136204000 136204000 136204000 0 0 0 0 0 0 0 101429000 7227000 108656000 6000 6000 101429000 7233000 108662000 961000 544000 277000 277000 57000 57000 53000 41000 1348000 919000 458000 104000 1294000 231000 160000 297000 2445000 1522000 38000 177000 2000000 P3Y 2018-08 10000 33000 21000000 0 2 2023-02 11781000 7090000 2995000 2137000 1851000 1588000 217000 2474000 2355000 1360000 250000 0 The lease term commenced in May 2019 and will expire in July 2022. 2019-05 2022-07 261000 0.02 266000 178000 268000 158000 426000 3146551 12575000 7372719 24994000 1873777 6352000 6963788 50000000 6963788 50000000 -1405332 -4764000 1405332 10090000 5326000 1293000 1293000 -3146551 -12575000 -7372719 -24994000 -468445 -1588000 -8369120 -58797000 -19356835 -97954000 20762168 6963788 50000000 1405332 -1405332 4764000 10090000 5326000 12904534 6409519 0 0 143590481 6409519 1733904 75000000 0 2904000 0.74 2126000 P3Y 495000 529000 177000 177000 0 P3Y P4Y 1959411 2342288 962511 0.04 2314303 971353 1340839 5667 176893 2129632 813172 25611 16714 2900479 1068675 1.01 7.97 1.01 4.22 5.12 13.03 5.44 6.30 7.33 4.04 P9Y9M18D P9Y2M12D P8Y6M P8Y1M6D 4051000 18844000 183000 16303000 9059000 8.31 5.24 0.0028 0.0139 0.0148 0.0259 P5Y8M12D P3M18D P6Y1M6D P6Y1M6D 0.70 0.70 0.79 0.76 0.00 0.00 1989000 1304000 2399000 996000 4388000 2300000 9809000 P2Y9M18D 239000 P3M18D 234229 234229 234229 0.01 0.15 25000 0.85 18000 0.210 0.210 0.125 0.131 0.026 0.023 0.008 0.033 0.353 0.331 0.000 0.000 15241000 5688000 340000 362000 1317000 452000 1243000 264000 837000 457000 18978000 7223000 18978000 7223000 0 0 11755000 45550000 47735000 38645000 45301000 249000 2037 2037 2039 1317000 2038 2017 2018 2019 0.50 0 -25090000 -8249000 17417900 5727327 -1.44 -1.44 -25090000 -8249000 -8249000 -33339000 -8249000 5727327 23145227 5727327 -1.44 -1.44 -17693000 -4576000 4345530 1123861 -4.07 -4.07 -17693000 -4576000 -4576000 -22269000 -4576000 1123861 5469391 1123861 -4.07 -4.07 2900479 2129632 465801 1388977 3366280 3518609 203000 74000 0.03 0.04 1500000 670000 EX-101.SCH 28 caba-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Property, Plant and Equipment link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Accrued and Other Current Liabilities link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Collaborations, Licensing Agreements and other Agreements link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Convertible Preferred Stock link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Common Stock link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - 401(k) Savings Plan link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Property, Plant and Equipment (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Accrued and Other Current Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Convertible Preferred Stock (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Common Stock (Tables) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Basis of Presentation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives for Property and Equipment (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Fair Value Measurements - Financial Assets Measured at Fair Value on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Fair Value Measurements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Fair Value Measurements - Schedule of Debt Securities Classified as Available-for-Sale Investments (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Property, Plant and Equipment - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Collaborations, Licensing Agreements and other Agreements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments for Operating Leases (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Convertible Preferred Stock - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Common Stock - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Common Stock - Summary of Stock Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Common Stock - Schedule of Assumptions Used to Estimate Fair Value of Stock Options (Details) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Common Stock - Summary of Stock-Based Compensation (Details) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Income Taxes - Summary of Principal Components of Company's Deferred Tax Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Income Taxes - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share (Details) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - 401 (k) Savings Plan - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Subsequent Events - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 29 caba-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 30 caba-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 31 caba-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Current Reporting Status Entity Current Reporting Status Entity Central Index Key Entity Voluntary Filers Entity Voluntary Filers Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Well-known Seasoned Issuer Entity Well Known Seasoned Issuer Entity Shell Company Entity Shell Company Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period ICFR Auditor Attestation Flag Icfr Auditor Attestation Flag Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Public Float Entity Public Float Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Document Annual Report Document Annual Report Document Transition Report Document Transition Report Accrued liabilities and other liabilities current. Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Short-term investments Short Term Investments Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property, plant and equipment, net Property Plant And Equipment Net Other assets Other Assets Noncurrent Total Assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued and other current liabilities Accrued Liabilities And Other Liabilities Current Total current liabilities Liabilities Current Commitments and contingencies (see Note 7) Commitments And Contingencies Stockholders’ equity: Stockholders Equity [Abstract] Preferred stock, $0.00001 par value: 10,000,000 shares authorized as of December 31, 2020 and 2019, respectively; no shares issued or outstanding at December 31, 2020 and 2019, respectively Preferred Stock Value Voting and non-voting common stock, $0.00001 par value: 150,000,000 (143,590,481 voting and 6,409,519 non-voting) shares authorized as of December 31, 2020 and 2019, respectively; 24,062,775 (19,387,160 voting and 4,675,615 non-voting) shares issued and outstanding as of December 31, 2020 and 24,034,022 (17,624,503 voting and 6,409,519 non-voting) issued and outstanding as of December 31, 2019, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated other comprehensive income Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Statement [Table] Statement [Table] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Voting common stock. Voting Common Stock Voting Common Stock [Member] Non-voting Common Stock Nonvoting Common Stock [Member] Statement [Line Items] Statement [Line Items] Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, authorized shares Preferred Stock Shares Authorized Preferred stock, issued shares Preferred Stock Shares Issued Preferred stock, outstanding shares Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, authorized shares Common Stock Shares Authorized Common stock, issued shares Common Stock Shares Issued Common stock, outstanding shares Common Stock Shares Outstanding Income Statement [Abstract] Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other income: Nonoperating Income Expense [Abstract] Interest income Investment Income Interest Net loss Net Income Loss Deemed dividend Dividends Net loss attributable to common stockholders Net Income Loss Available To Common Stockholders Basic Other comprehensive income: Comprehensive Income Net Of Tax [Abstract] Net unrealized gain on available-for-sale investments, net of tax Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax Net comprehensive loss Comprehensive Income Net Of Tax Net loss per voting and non-voting share, basic and diluted Earnings Per Share Basic And Diluted Temporary equity stock issued during period share new issues. Temporary equity stock issued during period value new issues net of issuance costs. Stock issued during period share stock options exercised. Temporary equity stock converted into common stock. Temporary equity converted into common stock value. Statement Of Stockholders Equity [Abstract] Accumulated Other Comprehensive Income Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Other Comprehensive Income Aoci Including Portion Attributable To Noncontrolling Interest [Member] Accumulated Deficit Retained Earnings [Member] Convertible Preferred Stock Convertible Preferred Stock [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Initial Public Offering I P O [Member] Beginning balance Beginning balance, Shares Temporary Equity Shares Outstanding Beginning balance Temporary Equity Carrying Amount Attributable To Parent Beginning balance, Shares Issuance of convertible preferred stock, net of issuance costs Temporary Equity Stock Issued During Period Value New Issues Net Of Issuance Costs Issuance of convertible preferred stock, net of issuance cost, Shares Temporary Equity Stock Issued During Period Share New Issues Issuance of common stock Stock Issued During Period Value New Issues Issuance of common stock, Shares Stock Issued During Period Shares New Issues Issuance of common stock in conjunction with exercise of stock options Stock Issued During Period Value Stock Options Exercised Issuance of common stock in conjunction with exercise of stock options, Shares Stock Issued During Period Share Stock Options Exercised Issuance of common stock under employee stock purchase plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock under employee stock purchase plan, Shares Stock Issued During Period Shares Employee Stock Purchase Plans Net unrealized gains on available-for-sale securities Debt Securities Available For Sale Unrealized Gain Loss Exchange of convertible preferred stock, including deemed dividend Reclassifications Of Temporary To Permanent Equity Conversion of convertible preferred stock into common stock Stock Issued During Period Value Conversion Of Units Conversion of convertible preferred stock into common stock, Shares Temporary Equity Stock Converted Into Common Stock Conversion of convertible preferred stock into common stock Temporary Equity Converted Into Common Stock Value Conversion of convertible preferred stock into common stock, Shares Stock Issued During Period Shares Conversion Of Units Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Net loss Ending balance Ending balance, Shares Ending balance Ending balance, Shares Issuance costs Payments Of Stock Issuance Costs Convertible preferred stock conversion basis Preferred Stock Conversion Basis Exchange of convertible preferred stock, including deemed dividend. Deferred offering costs in accounts payable and accrued and other current liabilities. Statement Of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Stock-based compensation Share Based Compensation Amortization of premium on investments Accretion Amortization Of Discounts And Premiums Investments Depreciation Depreciation Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Other assets Increase Decrease In Other Operating Assets Accounts payable Increase Decrease In Accounts Payable Accrued and other current liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Purchases of property and equipment Payments To Acquire Property Plant And Equipment Purchases of investments Payments To Acquire Available For Sale Securities Debt Proceeds from maturities of investments Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from issuance of common stock, net of issuance costs Proceeds From Issuance Of Common Stock Proceeds from issuance of convertible preferred stock Proceeds From Issuance Of Convertible Preferred Stock Issuance costs of convertible preferred stock Proceeds from issuance of common stock in connection with the exercise of stock options Proceeds From Stock Options Exercised Proceeds from the issuance of common stock under employee stock purchase plan Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Net cash (used in) provided by financing activities Net Cash Provided By Used In Financing Activities Net (decrease) increase in cash and cash equivalents Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect Cash and cash equivalents—beginning of year Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Cash and cash equivalents—end of year Supplemental disclosures of non-cash investing and financing activities: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Conversion of convertible preferred stock into common stock Conversion Of Stock Amount Converted1 Exchange of convertible preferred stock, including deemed dividend Exchange Of Convertible Preferred Stock Including Deemed Dividend Deferred offering costs in accounts payable and accrued and other current liabilities Deferred Offering Costs In Accounts Payable And Accrued And Other Current Liabilities Property and equipment purchases included in accounts payable Capital Expenditures Incurred But Not Yet Paid Documents Incorporated by Reference Documents Incorporated By Reference [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Basis of Presentation Business Description And Basis Of Presentation [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Property Plant And Equipment [Abstract] Property, Plant and Equipment Property Plant And Equipment Disclosure [Text Block] Payables And Accruals [Abstract] Accrued and Other Current Liabilities Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block] Collaborations licensing agreements and other agreement. Collaborations licensing agreements and other agreements. Collaborations Licensing Agreements And Other Agreements [Abstract] Collaborations, Licensing Agreements and other Agreements Collaborations Licensing Agreements And Other Agreements Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Temporary Equity Disclosure [Abstract] Convertible Preferred Stock Preferred Stock [Text Block] Equity [Abstract] Common Stock Shareholders Equity And Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Compensation And Retirement Disclosure [Abstract] 401(k) Savings Plan Compensation And Employee Benefit Plans [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Use of Estimates Use Of Estimates Off-Balance Sheet Risk and Concentrations of Credit Risk Off Balance Sheet Credit Exposure Policy Policy [Text Block] Cash and Cash Equivalents Cash And Cash Equivalents Policy [Text Block] Investments Investment Policy [Text Block] Property, Plant and Equipment Property Plant And Equipment Policy [Text Block] Fair Value Measurement Fair Value Measurement Policy Policy [Text Block] Research and Development Expenses Research And Development Expense Policy Stock-based Compensation Share Based Compensation Option And Incentive Plans Policy Income Taxes Income Tax Policy [Text Block] Net Loss Per Share Earnings Per Share Policy [Text Block] Segments Segment Reporting Policy Policy [Text Block] Related party transactions. Related Party Transactions Related Party Transactions Policy [Text Block] Emerging growth company status. Emerging Growth Company Status Emerging Growth Company Status Policy [Text Block] Recently issued accounting pronouncements not yet adopted. Recently Issued Accounting Pronouncements Not Yet Adopted Recently Issued Accounting Pronouncements Not Yet Adopted Policy Policy [Text Block] Schedule of estimated useful lives of property and equipment. Schedule of Estimated Useful Lives for Property and Equipment Schedule Of Estimated Useful Lives Of Property And Equipment Table [Text Block] Financial Assets Measured at Fair Value on Recurring Basis Fair Value Assets Measured On Recurring Basis [Text Block] Schedule of Debt Securities Classified as Available-for-Sale Investments Debt Securities Available For Sale Table [Text Block] Schedule of Property Plant and Equipment Property Plant And Equipment [Text Block] Accrued expenses and other current liabilities. Schedule of Accrued and Other Current Liabilities Accrued Expenses And Other Current Liabilities Table [Text Block] Schedule of Future Minimum Payments for Operating Leases Lessee Operating Lease Liability Maturity Table [Text Block] Partners Capital [Abstract] Summary of Convertible Preferred Stock Temporary Equity Table [Text Block] Summary of Stock Option Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of Assumptions Used to Estimate Fair Value of Stock Options Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Stock-Based Compensation Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block] Summary of Principal Components of Company's Deferred Tax Assets Schedule Of Deferred Tax Assets And Liabilities Table [Text Block] Schedule of Basic and Diluted Earnings Per Share Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Basis of presentation. Basis of presentation. Basis Of Presentation [Table] Basis Of Presentation [Table] Basis Of Presentation [Line Items] Basis Of Presentation [Line Items] Reverse stock split description Stockholders Equity Reverse Stock Split Reverse stock split ratio Stockholders Equity Note Stock Split Conversion Ratio1 Number of additional common stock purchased by underwriters upon partial exercise of option. Issuance of common stock, shares Common stock issued, per share Sale Of Stock Price Per Share Net proceeds from initial public offering Proceeds From Issuance Initial Public Offering Conversion of convertible preferred stock to common stock Convertible Preferred Stock Shares Issued Upon Conversion Number of additional common stock purchased by underwriters upon partial exercise of option Number Of Additional Common Stock Purchased By Underwriters Upon Partial Exercise Of Option Cash and cash equivalents and investments Cash Cash Equivalents And Short Term Investments Investments maturity year. Summary of significant accounting policies. Summary of significant accounting policies. Summary of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Table] Related Party Transaction Related Party Transaction [Axis] Related Party Transaction Related Party Transaction [Domain] Professional services. Professional Services Professional Services [Member] Summary of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Investments maturity year Investments Maturity Year Schedule Of Property Plant And Equipment [Table] Schedule Of Property Plant And Equipment [Table] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Laboratory equipment. Laboratory Equipment Laboratory Equipment [Member] Furniture and Fixtures Furniture And Fixtures [Member] Computer Equipment Computer Equipment [Member] Leasehold Improvements Leasehold Improvements [Member] Property Plant And Equipment [Line Items] Property Plant And Equipment [Line Items] Estimated useful life Property Plant And Equipment Useful Life Estimated useful life Property Plant And Equipment Estimated Useful Lives Interest or penalties related to uncertain income tax benefits Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Number of operating segment Number Of Operating Segments Number of reportable segment Number Of Reporting Units Costs incurred under the arrangement recorded as general and administrative expense Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party Amounts due to related party Due To Related Parties Current And Noncurrent Fair Value By Balance Sheet Grouping [Table] Fair Value By Balance Sheet Grouping [Table] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value Measurements Recurring [Member] Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Short-term Investments - Corporate Bonds Corporate Note Securities [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value Inputs Level1 [Member] Significant Other Observable Inputs (Level 2) Fair Value Inputs Level2 [Member] Significant Unobservable Inputs (Level 3) Fair Value Inputs Level3 [Member] Cash and Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Money Market Funds Money Market Funds [Member] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Cash and cash equivalents: Cash And Cash Equivalents [Abstract] Money market funds Cash And Cash Equivalents Fair Value Disclosure Short-term investments: Short Term Investments [Abstract] Financial assets Financial Instruments Financial Assets Balance Sheet Groupings [Abstract] Total Assets Fair Value Disclosure Fair value, assets, level 1 to level 2 transfers, amount Fair Value Assets Level1 To Level2 Transfers Amount Fair value, assets, level 2 to level 1 transfers, amount Fair Value Assets Level2 To Level1 Transfers Amount Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net Available-for-sale securities Available For Sale Securities Debt Securities Debt Securities Available For Sale [Table] Debt Securities Available For Sale [Table] Money Market Funds Included in Cash and Cash Equivalents Cash And Cash Equivalents [Member] Corporate Bonds - due in One Year or Less Schedule Of Available For Sale Securities [Line Items] Schedule Of Available For Sale Securities [Line Items] Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Gross Unrealized Gains Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Gross Unrealized Losses Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Fair value Laboratory Equipment Equipment [Member] Total property, plant and equipment Property Plant And Equipment Gross Less: accumulated depreciation Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Property, plant and equipment, net Depreciation expense Accrued research and development services current. Accrued general and administrative services current. Research and development services Accrued Research And Development Services Current General and administrative services Accrued General And Administrative Services Current Compensation expense Employee Related Liabilities Current Other Other Liabilities Current Accrued and other current liabilities Payment of obligation, term. Obligation to be paid, commencement date. License maintenance fee. Milestone payments. Collaborative agreement payments due. Collaborations licensing agreements and other agreements. Collaborations licensing agreements and other agreements. Collaborations Licensing Agreements And Other Agreements [Table] Collaborations Licensing Agreements And Other Agreements [Table] Supply Commitment Supply Commitment [Axis] Supply Commitment Arrangement Supply Commitment Arrangement [Member] License agreement. License Agreement License Agreement [Member] Sponsored Research Agreements. Sponsored Research Agreements Sponsored Research Agreements [Member] Legal Entity of Counterparty, Type Accounts Notes Loans And Financing Receivables By Legal Entity Of Counterparty Type [Axis] Legal Entity Type of Counterparty Legal Entity Type Of Counterparty [Domain] Regents of the university of California. Penn Regents Of University Of California [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Prepaid Expenses and Other Current Assets Prepaid Expenses And Other Current Assets [Member] Accrued and other current liabilities. Accrued and Other Current Liabilities Accrued And Other Current Liabilities [Member] Master translational research services agreement. Master Translational Research Services Agreement Master Translational Research Services Agreement [Member] Subscription and technology transfer agreement. Subscription and Technology Transfer Agreement Subscription And Technology Transfer Agreement [Member] Collaborations, Licensing Agreements And Other Agreements [Line Items] Collaborations Licensing Agreements And Other Agreements [Line Items] Obligation to be paid Contractual Obligation Payment term Payment Of Obligation Term Payment commencement date Obligation To Be Paid Commencement Date License maintenance fee License Maintenance Fee Total milestone payments Milestone Payments Amounts due to agreement Collaborative Agreement Payments Due Number of faculty. Funding term ending date. Advance payments. Contractual cost incurred. Number of faculty member Number Of Faculty Funding term end date Funding Term Ending Date Cost incurred Contractual Cost Incurred Research and development expense Advance payments Advance Payments Maximum research and development additional expense due in remaining term. Maximum research and development additional expense incurred Maximum Research And Development Additional Expense Due In Remaining Term Contractual expenses. Expense related to agreement Contractual Expenses Lease commencement month and year. Lease expiration month and year. Annual increase percentage of base rent. Rent expense. Commitments and contingencies disclosure. Commitments and contingencies disclosure. Commitments And Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Operating Lease Agreement. Operating Lease Agreement Operating Lease Agreement [Member] Commitments and Contingencies [Line Items] Commitments And Contingencies Disclosure [Line Items] Operating lease, description Lessee Operating Lease Description Lease commencement period Lease Commencement Month And Year Lease expiration period Lease Expiration Month And Year Initial annual base rent Operating Leases Rent Expense Minimum Rentals Percentage of annual increase of base rent Annual Increase Percentage Of Base Rent Rent expense Rent Expense Lessee operating lease liability payments due after rolling year three. 2021 Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months 2022 Lessee Operating Lease Liability Payments Due In Rolling Year Two Thereafter Lessee Operating Lease Liability Payments Due After Rolling Year Three Total Lessee Operating Lease Liability Payments Due Temporary Equity By Class Of Stock [Table] Temporary Equity By Class Of Stock [Table] Series B Preferred Stock Series B Preferred Stock [Member] Series A-2 preferred stock. Series A-2 Preferred Series A2 Preferred Stock [Member] Temporary Equity [Line Items] Temporary Equity [Line Items] Preferred stock, authorized shares Preferred stock, issued shares Preferred stock, outstanding shares Temporary equity stock issued during period, shares, new issues. Temporary equity shares exchange including deemed dividend. Temporary equity value exchange including deemed dividend. Temporary equity issuance costs. Temporary equity conversion of stock shares for common stock. Temporary equity conversion of stock value for common stock. Series A Preferred Series A Preferred Stock [Member] Series A-1 preferred stock. Series A-1 Preferred Series A1 Preferred Stock [Member] Issuance Temporary Equity Stock Issued During Period Value New Issues Issuance, shares Temporary Equity Stock Issued During Period Shares New Issues Exchange, including deemed dividend Temporary Equity Value Exchange Including Deemed Dividend Exchange, including deemed dividend, Shares Temporary Equity Shares Exchange Including Deemed Dividend Issuance costs Temporary Equity Issuance Costs Conversion to common stock Temporary Equity Conversion Of Stock Value For Common Stock Conversion to common stock, shares Temporary Equity Conversion Of Stock Shares For Common Stock Convertible preferred stock, authorized shares Temporary Equity Shares Authorized Gross proceeds from convertible preferred stock Number of preferred shares in exchange Preferred stock exchange including deemed dividend Convertible preferred stock convert into voting common stock. Convertible preferred stock convert into non-voting common stock. Convertible preferred stock convert into common stock Convertible Preferred Stock Convert Into Voting Common Stock Convertible preferred stock convert into non-voting common stock Convertible Preferred Stock Convert Into Non Voting Common Stock Convertible preferred stock, outstanding shares Conversion of non voting common stock to voting common stock shares converted. Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] At-the-market offering sales agreement. At-The-Market Offering Sales Agreement At The Market Offering Sales Agreement [Member] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development Research And Development Expense [Member] General and Administrative Expense General And Administrative Expense [Member] Title of Individual Title Of Individual [Axis] Title of Individual Title Of Individual With Relationship To Entity [Domain] Founders. Founders Founders [Member] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Stock Options Employee Stock Option [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum Minimum [Member] Maximum Maximum [Member] Two thousand eighteen stock option and grant plan. Two Thousand Eighteen Stock Option And Grant Plan Two Thousand Eighteen Stock Option And Grant Plan [Member] Two thousand nineteen stock option and incentive plan. 2019 Plan Two Thousand Nineteen Stock Option And Incentive Plan [Member] Two thousand nineteen employee stock purchase plan. 2019 ESPP Two Thousand Nineteen Employee Stock Purchase Plan [Member] Class Of Stock [Line Items] Class Of Stock [Line Items] Conversion of non-voting common stock to voting common stock Conversion Of Non Voting Common Stock To Voting Common Stock Shares Converted Share based compensation arrangement by share based payment award common stock shares modified Share based compensation arrangement by share based payment award common stock shares modified fair value. Share based compensation arrangement by share based payment award modified common stock shares compensation cost. Common stock shares modified Share Based Compensation Arrangement By Share Based Payment Award Common Stock Shares Modified Fair value of common stock shares modified Share Based Compensation Arrangement By Share Based Payment Award Common Stock Shares Modified Fair Value Total compensation cost of common stock shares modified Share Based Compensation Arrangement By Share Based Payment Award Modified Common Stock Shares Compensation Cost Unrecognized compensation cost, period for recognition Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Compensation cost recognized Allocated Share Based Compensation Expense Share-based compensation unvested number of shares Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Share-based compensation, vesting period Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Number of options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Increase in share reserved percentage. Shares reserved for issuance Common Stock Capital Shares Reserved For Future Issuance Increase in share reserved percentage Increase In Share Reserved Percentage Share-based compensation, number of shares available for grant Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Share Based Arrangements To Obtain Goods And Services [Abstract] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Number of Shares Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward Number of Shares, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Shares, Granted Number of Shares, Exercised Stock Issued During Period Shares Stock Options Exercised Number of shares, Forfeited/Cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Shares, Ending Balance Number of Shares, Options Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Weighted Average Exercise Price, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, Forfeited/Cancelled Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted Average Exercise Price, Ending Balance Weighted Average Exercise Price, Options Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term. Weighted Average Remaining Contractual Term (years) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term [Abstract] Term (years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted Average Remaining Contractual Term (years), Options Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value. Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value, Exercised Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Aggregate Intrinsic Value, Ending Balance Aggregate Intrinsic Value, Options Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Weighted average grant-date fair value of stock options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract] Risk-free interest rate, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk-free interest rate, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Expected term Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Expected volatility, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected volatility, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Expected dividend yield Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Research and Development Stock-based compensation Unrecognized compensation cost related to unvested stock-based awards Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Percentage of payroll deduction on eligible compensation. Employee stock purchase plan maximum annual rights to purchase common stock. Percentage of shares purchased at fair market value of common stock. Payroll deduction percentage of eligible compensation Percentage Of Payroll Deduction On Eligible Compensation Employee stock purchase plan maximum annual rights to purchase common stock Employee Stock Purchase Plan Maximum Annual Rights To Purchase Common Stock Percentage of shares to be purchased Percentage Of Shares Purchased At Fair Market Value Of Common Stock Effective income tax rate reconciliation nondeductible items and other. Expected income tax benefit at the federal statutory rate Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate State and local taxes, net of federal benefit Effective Income Tax Rate Reconciliation State And Local Income Taxes Research and development credit, net Effective Income Tax Rate Reconciliation Tax Credits Research Non-deductible items and other Effective Income Tax Rate Reconciliation Nondeductible Items And Other Change in valuation allowance Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Total Effective Income Tax Rate Continuing Operations Deferred tax assets license fees deductions. Deferred tax assets: Deferred Tax Assets Net [Abstract] Federal, state and local net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards State And Local License fee deductions Deferred Tax Assets License Fees Deductions Research and development tax credits Deferred Tax Assets Tax Credit Carryforwards Research Stock-based compensation deductions Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Accrued expenses Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Gross deferred tax assets Deferred Tax Assets Gross Less: valuation allowance Deferred Tax Assets Valuation Allowance Total deferred tax assets Deferred Tax Assets Net Deferred tax liabilities: Deferred Tax Liabilities Net [Abstract] Deferred tax liabilities, gross Deferred Income Tax Liabilities Net deferred tax assets Deferred Tax Assets Liabilities Net Income tax disclosure. Income tax disclosure. Income Tax Disclosure [Table] Income Tax Disclosure [Table] Income Tax Authority Income Tax Authority [Axis] Income Tax Authority Income Tax Authority [Domain] Federal. Federal Federal [Member] Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Increase in valuation allowance Valuation Allowance Deferred Tax Asset Change In Amount Deferred tax assets operating loss carryforwards federal. Deferred tax assets operating loss carryforwards state. Deferred tax assets operating loss carryforwards local. Operating loss carryforwards federal commencement of expiration date. Operating loss carryforwards state commencement of expiration date. Deferred tax assets tax credit carryforwards commencement of expiration date. Operating loss carryforwards local commencement of expiration date. Deferred tax assets operating loss carryforwards federal Deferred Tax Assets Operating Loss Carryforwards Federal Deferred tax assets operating loss carryforwards state Deferred Tax Assets Operating Loss Carryforwards State Deferred tax assets operating loss carryforwards local Deferred Tax Assets Operating Loss Carryforwards Local Deferred tax assets, operating loss carryforwards, not subject to expiration Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration Deferred tax assets, operating loss carryforwards, subject to expiration Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration Operating loss carryforwards federal commencement of expiration date Operating Loss Carryforwards Federal Commencement Of Expiration Date Operating loss carryforwards state commencement of expiration date Operating Loss Carryforwards State Commencement Of Expiration Date Operating loss carryforwards local commencement of expiration date Operating Loss Carryforwards Local Commencement Of Expiration Date Deferred tax assets tax credit carryforwards commencement of expiration date Deferred Tax Assets Tax Credit Carryforwards Commencement Of Expiration Date Open tax year Open Tax Year Percentage of eligible tax positions for recognition. Percentage of eligible tax positions for recognition Percentage Of Eligible Tax Positions For Recognition Unrecognized income tax benefits that would affect effective tax rate Unrecognized Tax Benefits That Would Impact Effective Tax Rate Earning per share basic and diluted. Earnings per share basic and diluted. Earnings Per Share Basic And Diluted [Table] Earnings Per Share Basic And Diluted [Table] Earning Per Share Basic And Diluted [Line Items] Earning Per Share Basic And Diluted [Line Items] Basic net loss per share: Earnings Per Share Basic [Abstract] Allocation of undistributed losses attributable to common stockholders Undistributed Earnings Loss Available To Common Shareholders Basic Weighted average number of shares used in basic per share computation Weighted Average Number Of Shares Outstanding Basic Net loss per share, basic Earnings Per Share Basic Diluted net loss per share: Earnings Per Share Diluted [Abstract] Allocation of undistributed losses for basic computation Undistributed Earnings Loss Allocated To Participating Securities Basic Reallocation of undistributed losses as a result of conversion of non-voting to voting common shares Dilutive Securities Effect On Basic Earnings Per Share Other Allocation of undistributed losses Undistributed Earnings Loss Allocated To Participating Securities Diluted Add: Conversion of non-voting to voting common shares outstanding Weighted Average Number Diluted Shares Outstanding Adjustment Weighted average number of shares used in diluted per share computation Weighted Average Number Of Diluted Shares Outstanding Net loss per share, diluted Earnings Per Share Diluted Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Stock Options to Purchase Common Stock Non-vested common stock member. Non-vested Common Stock Non Vested Common Stock [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive shares have been excluded from calculation of diluted net loss per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Defined contribution plan, contribution amount Defined Contribution Plan Cost Recognized Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Defined Contribution Plan Employer Matching Contribution Percent Defined Contribution Plan, Employer Matching Contribution, Percent of Match Defined Contribution Plan Employer Matching Contribution Percent Of Match Subsequent Event [Table] Subsequent Event [Table] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] WuXi Advanced Therapies. WuXi Advanced Therapies Wu Xi Advanced Therapies [Member] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Events Subsequent Event [Member] Development and manufacturing services agreement. Wuxi Agreement Development And Manufacturing Services Agreement [Member] Children’s Hospital of Philadelphia. CHOP Children S Hospital Of Philadelphia [Member] Research service agreement. Research Service Agreement Research Service Agreement [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Early termination fee Liabilities Subject To Compromise Early Contract Termination Fees Expected research service agreement cost. Total cost Expected Research Service Agreement Cost EX-101.PRE 32 caba-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 33 R1.htm IDEA: XBRL DOCUMENT v3.20.4

Document and Entity Information - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2020

Mar. 10, 2021

Jun. 30, 2020

Cover [Abstract]

Document Type 10-K

Amendment Flag false

Document Period End Date Dec. 31, 2020

Document Fiscal Year Focus 2020

Document Fiscal Period Focus FY

Trading Symbol CABA

Entity Registrant Name CABALETTA BIO, INC.

Entity Current Reporting Status Yes

Entity Central Index Key 0001759138

Entity Voluntary Filers No

Current Fiscal Year End Date --12-31

Entity Filer Category Non-accelerated Filer

Entity Well-known Seasoned Issuer No

Entity Shell Company false

Entity Small Business true

Entity Emerging Growth Company true

Entity Ex Transition Period false

ICFR Auditor Attestation Flag false

Entity Common Stock, Shares Outstanding 24,062,775

Entity Public Float $ 214

Entity File Number 001-39103

Entity Tax Identification Number 82-1685768

Entity Address, Address Line One 2929 Arch Street

Entity Address, Address Line Two Suite 600

Entity Address, City or Town Philadelphia

Entity Address, State or Province PA

Entity Address, Postal Zip Code 19104

City Area Code 267

Local Phone Number 759-3100

Entity Interactive Data Current Yes

Title of 12(b) Security Common Stock, par value $0.00001 per share

Security Exchange Name NASDAQ

Entity Incorporation, State or Country Code DE

Document Annual Report true

Document Transition Report false

Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE

Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant’s definitive Proxy Statement for its 2021 annual meeting of shareholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year end of December 31, 2020. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Area code of city
+ References
No definition available.
+ Details

Name: dei_CityAreaCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cover page.
+ References
No definition available.
+ Details

Name: dei_CoverAbstract

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true only for a form used as an annual report.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 10-K
-Number 249
-Section 310

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 20-F
-Number 249
-Section 220
-Subsection f

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 40-F
-Number 249
-Section 240
-Subsection f
+ Details

Name: dei_DocumentAnnualReport

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true only for a form used as a transition report.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Forms 10-K, 10-Q, 20-F
-Number 240
-Section 13
-Subsection a-1
+ Details

Name: dei_DocumentTransitionReport

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
Documents incorporated by reference.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-23
+ Details

Name: dei_DocumentsIncorporatedByReferenceTextBlock

Namespace Prefix: dei_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine1

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine2

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the City or Town
+ References
No definition available.
+ Details

Name: dei_EntityAddressCityOrTown

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details

Name: dei_EntityAddressPostalZipCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the state or province.
+ References
No definition available.
+ Details

Name: dei_EntityAddressStateOrProvince

Namespace Prefix: dei_

Data Type: dei:stateOrProvinceItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details

Name: dei_EntityExTransitionPeriod

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityTaxIdentificationNumber

Namespace Prefix: dei_

Data Type: dei:employerIdItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 10-K
-Number 249
-Section 310

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 20-F
-Number 249
-Section 220
-Subsection f

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form 40-F
-Number 249
-Section 240
-Subsection f
+ Details

Name: dei_IcfrAuditorAttestationFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Local phone number for entity.
+ References
No definition available.
+ Details

Name: dei_LocalPhoneNumber

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details

Name: dei_Security12bTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details

Name: dei_SecurityExchangeName

Namespace Prefix: dei_

Data Type: dei:edgarExchangeCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

XML 34 R2.htm IDEA: XBRL DOCUMENT v3.20.4

Balance Sheets - USD ($)
$ in Thousands

Dec. 31, 2020

Dec. 31, 2019

Current assets:

Cash and cash equivalents $ 101,429 $ 136,204

Short-term investments 7,233

Prepaid expenses and other current assets 4,873 4,348

Total current assets 113,535 140,552

Property, plant and equipment, net 890 815

Other assets 299 101

Total Assets 114,724 141,468

Current liabilities:

Accounts payable 1,243 920

Accrued and other current liabilities 3,937 2,227

Total current liabilities 5,180 3,147

Commitments and contingencies (see Note 7)

Stockholders’ equity:

Preferred stock, $0.00001 par value: 10,000,000 shares authorized as of December 31, 2020 and 2019, respectively; no shares issued or outstanding at December 31, 2020 and 2019, respectively

Voting and non-voting common stock, $0.00001 par value: 150,000,000 (143,590,481 voting and 6,409,519 non-voting) shares authorized as of December 31, 2020 and 2019, respectively; 24,062,775 (19,387,160 voting and 4,675,615 non-voting) shares issued and outstanding as of December 31, 2020 and 24,034,022 (17,624,503 voting and 6,409,519 non-voting) issued and outstanding as of December 31, 2019, respectively 0 0

Additional paid-in capital 175,836 171,280

Accumulated other comprehensive income 6

Accumulated deficit (66,298) (32,959)

Total stockholders’ equity 109,544 138,321

Total liabilities and stockholders’ equity $ 114,724 $ 141,468

X

- Definition
Accrued liabilities and other liabilities current.
+ References
No definition available.
+ Details

Name: caba_AccruedLiabilitiesAndOtherLiabilitiesCurrent

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(4))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(3))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(4))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(g))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R3.htm IDEA: XBRL DOCUMENT v3.20.4

Balance Sheets (Parenthetical) - $ / shares

Dec. 31, 2020

Dec. 31, 2019

Preferred stock, par value $ 0.00001 $ 0.00001

Preferred stock, authorized shares 10,000,000 10,000,000

Preferred stock, issued shares 0 0

Preferred stock, outstanding shares 0 0

Common stock, authorized shares 150,000,000 150,000,000

Common stock, issued shares 24,062,775 24,034,022

Common stock, outstanding shares 24,062,775 24,034,022

Voting Common Stock

Common stock, par value $ 0.00001 $ 0.00001

Common stock, authorized shares 143,590,481 143,590,481

Common stock, issued shares 19,387,160 17,624,503

Common stock, outstanding shares 19,387,160 17,624,503

Non-voting Common Stock

Common stock, par value $ 0.00001 $ 0.00001

Common stock, authorized shares 6,409,519 6,409,519

Common stock, issued shares 4,675,615 6,409,519

Common stock, outstanding shares 4,675,615 6,409,519

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=caba_VotingCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 36 R4.htm IDEA: XBRL DOCUMENT v3.20.4

Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Operating expenses:

Research and development $ 21,376 $ 11,671

General and administrative 12,457 7,012

Total operating expenses 33,833 18,683

Loss from operations (33,833) (18,683)

Other income:

Interest income 494 1,740

Net loss (33,339) (16,943)

Deemed dividend (5,326)

Net loss attributable to common stockholders (33,339) (22,269)

Other comprehensive income:

Net unrealized gain on available-for-sale investments, net of tax 6

Net comprehensive loss $ (33,333) $ (22,269)

Net loss per voting and non-voting share, basic and diluted $ (1.44) $ (4.07)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(22))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(24))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(26))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 405
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817
+ Details

Name: us-gaap_Dividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(b))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599
+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 37 R5.htm IDEA: XBRL DOCUMENT v3.20.4

Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity - USD ($)
$ in Thousands

Total

Initial Public Offering

Convertible Preferred Stock

Common Stock

Common Stock

Initial Public Offering

Additional Paid-in Capital

Additional Paid-in Capital

Initial Public Offering

Accumulated Other Comprehensive Income

Accumulated Deficit

Beginning balance at Dec. 31, 2018 $ (10,690) $ 1,762 $ (12,452)

Beginning balance, Shares at Dec. 31, 2018 12,393,047

Beginning balance at Dec. 31, 2018 $ 43,921

Beginning balance, Shares at Dec. 31, 2018 3,848,320

Issuance of convertible preferred stock, net of issuance costs $ 48,707

Issuance of convertible preferred stock, net of issuance cost, Shares 6,963,788

Issuance of common stock $ 71,020 $ 71,020

Issuance of common stock, Shares 7,275,501

Issuance of common stock in conjunction with exercise of stock options 6 6

Issuance of common stock in conjunction with exercise of stock options, Shares 5,667

Exchange of convertible preferred stock, including deemed dividend (5,326) $ 5,326 (1,762) (3,564)

Conversion of convertible preferred stock into common stock 97,954 97,954

Conversion of convertible preferred stock into common stock, Shares (19,356,835)

Conversion of convertible preferred stock into common stock $ (97,954)

Conversion of convertible preferred stock into common stock, Shares 12,904,534

Stock-based compensation 2,300 2,300

Net loss (16,943) (16,943)

Ending balance at Dec. 31, 2019 $ 138,321 171,280 (32,959)

Ending balance, Shares at Dec. 31, 2019 0

Ending balance, Shares at Dec. 31, 2019 24,034,022 24,034,022

Issuance of common stock in conjunction with exercise of stock options $ 139 139

Issuance of common stock in conjunction with exercise of stock options, Shares 25,611

Issuance of common stock under employee stock purchase plan 29 29

Issuance of common stock under employee stock purchase plan, Shares 3,142

Net unrealized gains on available-for-sale securities 6 $ 6

Stock-based compensation 4,388 4,388

Net loss (33,339) (33,339)

Ending balance at Dec. 31, 2020 $ 109,544 $ 175,836 $ 6 $ (66,298)

Ending balance, Shares at Dec. 31, 2020 0

Ending balance, Shares at Dec. 31, 2020 24,062,775 24,062,775

X

- Definition
Stock issued during period share stock options exercised.
+ References
No definition available.
+ Details

Name: caba_StockIssuedDuringPeriodShareStockOptionsExercised

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity converted into common stock value.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityConvertedIntoCommonStockValue

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Temporary equity stock converted into common stock.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityStockConvertedIntoCommonStock

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity stock issued during period share new issues.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityStockIssuedDuringPeriodShareNewIssues

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity stock issued during period value new issues net of issuance costs.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityStockIssuedDuringPeriodValueNewIssuesNetOfIssuanceCosts

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
No definition available.
+ Details

Name: us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=120519210&loc=d3e90193-114008

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764
+ Details

Name: us-gaap_ReclassificationsOfTemporaryToPermanentEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period as a result of an employee stock purchase plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueConversionOfUnits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
+ References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityCarryingAmountAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27)(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_TemporaryEquitySharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 38 R6.htm IDEA: XBRL DOCUMENT v3.20.4

Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Parenthetical)
$ in Thousands
12 Months Ended

Dec. 31, 2019

USD ($)

Issuance costs $ 1,293

Convertible Preferred Stock

Issuance costs $ 1,293

Convertible preferred stock conversion basis 1.5 for 1 basis

Initial Public Offering

Issuance costs $ 3,408

X

- Definition
The cash outflow for cost incurred directly with the issuance of an equity security.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockConversionBasis

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R7.htm IDEA: XBRL DOCUMENT v3.20.4

Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Cash flows from operating activities:

Net loss $ (33,339) $ (16,943)

Adjustments to reconcile net loss to net cash used in operating activities:

Stock-based compensation 4,388 2,300

Amortization of premium on investments 119

Depreciation 354 104

Changes in operating assets and liabilities:

Prepaid expenses and other current assets (524) (3,372)

Other assets (198) (101)

Accounts payable 555 246

Accrued and other current liabilities 1,875 1,721

Net cash used in operating activities (26,770) (16,045)

Cash flows from investing activities:

Purchases of property and equipment (635) (693)

Purchases of investments (11,097)

Proceeds from maturities of investments 3,751

Net cash used in investing activities (7,981) (693)

Cash flows from financing activities:

Proceeds from issuance of common stock, net of issuance costs (192) 71,212

Proceeds from issuance of convertible preferred stock 50,000

Issuance costs of convertible preferred stock (1,293)

Proceeds from issuance of common stock in connection with the exercise of stock options 139 6

Proceeds from the issuance of common stock under employee stock purchase plan 29

Net cash (used in) provided by financing activities (24) 119,925

Net (decrease) increase in cash and cash equivalents (34,775) 103,187

Cash and cash equivalents—beginning of year 136,204 33,017

Cash and cash equivalents—end of year 101,429 136,204

Supplemental disclosures of non-cash investing and financing activities:

Conversion of convertible preferred stock into common stock 97,954

Exchange of convertible preferred stock, including deemed dividend 10,090

Deferred offering costs in accounts payable and accrued and other current liabilities 192

Property and equipment purchases included in accounts payable $ 20 $ 226

X

- Definition
Deferred offering costs in accounts payable and accrued and other current liabilities.
+ References
No definition available.
+ Details

Name: caba_DeferredOfferingCostsInAccountsPayableAndAccruedAndOtherCurrentLiabilities

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Exchange of convertible preferred stock, including deemed dividend.
+ References
No definition available.
+ Details

Name: caba_ExchangeOfConvertiblePreferredStockIncludingDeemedDividend

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Future cash outflow to pay for purchases of fixed assets that have occurred.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586
+ Details

Name: us-gaap_CapitalExpendituresIncurredButNotYetPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586
+ Details

Name: us-gaap_ConversionOfStockAmountConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in accrued expenses, and obligations classified as other.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in operating assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for cost incurred directly with the issuance of an equity security.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfStockIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562
+ Details

Name: us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901
+ Details

Name: us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of option under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of noncash expense for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 40 R8.htm IDEA: XBRL DOCUMENT v3.20.4

Basis of Presentation
12 Months Ended

Dec. 31, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation
1. Basis of Presentation

Cabaletta Bio, Inc. (the Company or Cabaletta) was incorporated in April 2017 in the State of Delaware as Tycho Therapeutics, Inc. and, in August 2018, changed its name to Cabaletta Bio, Inc. The Company is headquartered in Philadelphia, Pennsylvania. Cabaletta is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.

Principal operations commenced in April 2018, when the Company executed two sponsored research agreements with the Trustees of the University of Pennsylvania (Penn).

On October 16, 2019, the Company effected a 1-for-1.5 reverse split of the Company’s issued and outstanding shares of common stock, par value $0.00001 per share (Common Stock). Upon the effectiveness of the reverse stock split: (i) all shares of outstanding Common Stock were adjusted; (ii) the conversion price of the Series A convertible preferred stock (Series A Preferred), Series A-1 convertible preferred stock (Series A-1 Preferred), Series A-2 convertible preferred stock (Series A-2 Preferred) and Series B convertible preferred stock (Series B Preferred; collectively, the Preferred Shares) was adjusted; (iii) the number of shares of Common Stock for which each outstanding option to purchase Common Stock is exercisable was adjusted; and (iv) the exercise price of each outstanding option to purchase Common Stock was adjusted. All of the outstanding Common Stock share numbers (including shares of Common Stock subject to the Company’s options and as converted for the outstanding convertible preferred stock shares), share prices, exercise prices and per share amounts contained in the financial statements have been retroactively adjusted in the financial statements to reflect this reverse stock split for all periods presented. The par value per share and the authorized number of shares of Common Stock and convertible preferred stock were not adjusted as a result of the reverse stock split.

On October 29, 2019, the Company completed its initial public offering (IPO) of 6,800,000 shares of Common Stock at an offering price of $11.00 per share. The Company received net proceeds of $66,156 after deducting underwriting discounts, commissions and estimated offering expenses. In connection with the IPO, the Company’s outstanding shares of convertible preferred stock were automatically converted into 12,904,534 shares of Common Stock. In November 2019, the underwriters partially exercised their option and purchased an additional 475,501 shares of Common Stock resulting in net proceeds to the Company of $4,864, after deducting underwriting discounts and commissions.

Risks and Uncertainties

The Company does not expect to generate revenue from sales of engineered T cell therapies for B cell-mediated autoimmune diseases or any other revenue unless and until the Company completes preclinical and clinical development and obtains regulatory approval for one or more product candidates. If the Company seeks to obtain regulatory approval for any of its product candidates, the Company expects to incur significant commercialization expenses.

The Company is subject to risks common to companies in the biotechnology industry including, but not limited to, new technological innovations, protection of proprietary technology, dependence on key personnel, compliance with government regulations and the need to obtain additional financing. As a result, the Company is unable to predict the timing or amount of increased expenses or when or if the Company will be able to achieve or maintain profitability. Further, the Company is currently dependent on University of Pennsylvania (Penn) for much of its preclinical research, clinical research and development activities and initial manufacturing activities (Note 6). Product candidates currently under development will require significant additional research and development efforts, including extensive preclinical and clinical testing and regulatory approval, prior to commercialization. Even if the Company is able to generate revenues from the sale of its product candidates, if approved, it may not become profitable. If the Company fails to become profitable or is unable to sustain profitability on a continuing basis, then it may be unable to continue its operations at planned levels and be forced to reduce its operations.

In December 2019, a novel strain of coronavirus surfaced in Wuhan, China and has since reached multiple other regions and countries. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures, which have delayed the commencement of non-COVID-19-related clinical trials, among other restrictions. The Company’s financial results for the year ended December 31, 2020 were not significantly impacted by COVID-19, however, the Company cannot at this time predict the specific extent, duration, or full impact that the COVID-19 pandemic, including new information that may emerge concerning the severity of COVID-19, the impact of new strains of the virus, the effectiveness and availability of vaccines and the actions to contain COVID-19 or treat its impact will have on its financial condition, operations, and business plans, including its ability to raise additional capital, the timing and enrollment of patients in its ongoing and planned clinical trials, future financings and other expected milestones of its product candidates.

Liquidity

The Company has sustained annual operating losses since inception and expects to continue to generate operating losses for the foreseeable future. The Company’s ultimate success depends on the outcome of its research and development activities. The Company had cash and cash equivalents and investments of $108,662 as of December 31, 2020. Through December 31, 2020, the Company has incurred an accumulated deficit of $66,298. Management expects to incur additional losses in the future as it continues its research and development and will need to raise additional capital to fully implement its business plan and to fund its operations.

The Company intends to raise such additional capital through a combination of equity offerings, debt financings, government funding arrangements, strategic alliances or other sources. However, if such financing is not available at adequate levels and on a timely basis, or such agreements are not available on favorable terms, or at all, as and when needed, the Company will need to reevaluate its operating plan and may be required to delay or discontinue the development of one or more of its product candidates or operational initiatives. The Company expects that its cash, cash equivalents and investments as of December 31, 2020 will be sufficient to fund its projected operations for at least 12 months from the date the Company’s Annual Report on Form 10-K is filed with the Securities and Exchange Commission (SEC).

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R9.htm IDEA: XBRL DOCUMENT v3.20.4

Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include but are not limited to the fair value of common stock, stock-based compensation and the valuation allowance on the Company’s deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.

Off-Balance Sheet Risk and Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, which are primarily invested in U.S. treasury-based money market funds, and available-for-sale debt securities, which are invested in investment grade corporate bonds with high credit quality issuers. These investments have maturities in 2021. A portion of the Company’s cash is maintained at a federally insured financial institution. The deposits held at this institution are in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held. The cash in this account is swept daily into U.S. treasury-based and U.S. government-based money market funds. The Company has no off‑balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market accounts.

Investments

Investments are available-for-sale and carried at estimated fair value. The Company’s valuations of available-for-sale debt securities are generally derived from independent pricing services based upon quoted prices in active markets for similar securities, with prices adjusted for yield and number of days to maturity, or based on industry models using data inputs, such as interest rates and prices that can be directly observed or corroborated in active markets. Management determines the appropriate classification of its investments in debt securities at the time of purchase and at the end of each reporting period. Investments with original maturities beyond three months at the date of purchase and which mature at, or less than, twelve months from the balance sheet date are classified as current.

Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive income. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors including the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or if more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other-than-temporary, if any, on available-for-sale securities are included in interest and other income, net. The cost of investments sold is based on the specific-identification method. Interest income on investments as well as amortization of discount or premium is included in interest income.

Property, Plant and Equipment

Property, plant and equipment are recorded at cost less accumulated depreciation. Cost includes the acquisition costs and all costs necessary to bring the asset to the location and working condition necessary for its intended use. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the accompanying statements of operations. Expenditures for normal, recurring or periodic repairs and maintenance related to property and equipment are charged to expense as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if it will result in future economic benefits.

Estimated useful lives for property and equipment are as follows:

Property and equipment

Estimated useful life

Laboratory equipment

Three years

Furniture and fixtures

Three years

Computer equipment

Three years

Leasehold improvements

Lesser of estimated useful life or remaining lease term

Fair Value Measurement

Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:

Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2—Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Research and Development Expenses

Research and development costs include costs incurred for internal and external research and development activities and are expensed as incurred in the accompanying statements of operations. Research and development costs consist of salaries and benefits, including associated stock-based compensation, and laboratory supplies and facility costs, as well as fees paid to entities that conduct certain research and development activities on the Company’s behalf.

The Company records accrued liabilities for estimated costs of research and development activities conducted by service providers, which include activities under agreements with Penn (Note 6), the conduct of sponsored research, preclinical studies and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes these costs in accrued and other current liabilities and prepaid expenses and other current assets in the accompanying balance sheets and within research and development expense in the accompanying statements of operations. Non-refundable advance payments made for goods or services that will be used or rendered for future research and development activities are deferred and capitalized and recognized as expense as the goods are received or the related services are rendered.

The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with service providers. The Company makes significant judgments and estimates in determining the accrued liabilities and prepaid expenses in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities and prepaid expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred since its inception.

Stock-based Compensation

The Company measures its stock-based awards granted to employees and non-employees based on the estimated fair values of the awards on the respective grant dates. The Company uses the Black-Scholes option-pricing model (Black-Scholes) to estimate the fair value of its stock-based awards. The Company recognizes compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company accounts for forfeitures of stock option awards as they occur.

Prior to the Company’s IPO, the assumptions used in the Company's Black-Scholes option-pricing model represented management's best estimates and involve a number of variables, uncertainties and assumptions and the application of management's judgment, as they are inherently subjective.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company’s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more-likely-than-not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.

Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more-likely-than-not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.

Net Loss Per Share

The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. The Company has voting and non-voting common stock. The rights, including the liquidation and dividend rights, of the holders of the voting and non-voting common stock are identical, except with respect to voting. Each share of non-voting common stock may be converted at any time into one share of voting common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. The Company also considers its unvested shares of common stock held by the Company’s founders and, prior to its conversion to common stock, its convertible preferred stock to be participating securities as, in the event a dividend is paid on common stock, the holders of convertible preferred stock and unvested shares of common stock would be entitled to receive dividends on a basis consistent with the common stockholders.

Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock, which excludes unvested shares of common stock. The undistributed loss for each year is allocated to common stockholders based on the contractual participation rights of the voting and non-voting common stock as if the losses for the year had been distributed. As the liquidation and dividend rights are identical, the undistributed losses are allocated on a proportionate basis. Net loss attributable to common stockholders for the year ended December 31, 2019 is calculated by adjusting the net loss of the Company for the deemed dividend associated with the exchange of Series A-2 Preferred for Series B Preferred. Diluted net loss per share attributable to common stockholders is computed under the if-converted method and assumes that all non-voting common stock has been converted to common stock. Since the Company was in a loss position for all periods presented, the effects of the other potentially dilutive securities are antidilutive.

Segments

Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one reportable segment.

Related Party Transactions

The Company engaged a firm controlled by a former executive (until February 2019) of the Company for professional services related to accounting, finance and other administrative functions. For the years ended December 31, 2020 and 2019, the costs incurred under this arrangement totaled $311 and $601, respectively. These amounts were recorded as general and administrative expense in the accompanying statements of operations. As of December 31, 2020 and 2019, amounts owed under this arrangement totaled $13 and $36, respectively, and are included in accounts payable in the accompanying balance sheets.

Emerging Growth Company Status

The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.

Recently Issued Accounting Pronouncements Not Yet Adopted

In February 2016, the Financial Accounting Standards Board (FASB) issued ASU 2016-02, Leases (Topic 842), with guidance regarding the accounting for and disclosure of leases. The update requires lessees to recognize the liabilities related all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will be effective for public companies for annual and interim periods beginning after December 15, 2018. For all other entities, including Emerging Growth Companies, this standard is effective for annual reporting periods beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. As an Emerging Growth Company, the Company expects to adopt Topic 842 for its annual period ending December 31, 2021 and has not yet finalized the assessment of the impact that ASU 2016-02 will have on its financial statements or financial statement disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R10.htm IDEA: XBRL DOCUMENT v3.20.4

Fair Value Measurements
12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements
3. Fair Value Measurements

As of December 31, 2020 and 2019, the Company’s financial instruments included cash and cash equivalents, available-for-sale debt securities, accounts payable and accrued expenses. The carrying amounts for cash and cash equivalents, accounts payable and accrued expenses reported in the Company’s financial statements for these instruments approximate their respective fair values because of the short-term nature of these instruments.

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:

December 31, 2020

Total

Quoted

Prices in

Active Markets

for Identical

Assets (Level 1)

Significant

Other

Observable

Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Financial assets

Cash and cash equivalents:

Money market funds

$

101,429

$

101,429

$

—

$

—

Short-term investments:

Corporate bonds

7,233

—

7,233

—

Total

$

108,662

$

101,429

$

7,233

$

—

December 31, 2019

Total

Quoted Prices in Active Markets for Identical Assets (Level 1)

Significant Other Observable Inputs (Level 2)

Significant Unobservable Inputs (Level 3)

Financial assets

Cash equivalents:

Money market funds

$

136,204

$

136,204

$

—

$

—

Total

$

136,204

$

136,204

$

—

$

—

Money market funds are measured at fair value on a recurring basis using quoted prices and are classified as Level 1. Investments are measured at fair value based on inputs other than quoted prices that are derived from observable market data and are classified as Level 2 inputs. There were no transfers of assets between the fair value measurement levels during the years ended December 31, 2020 or 2019.

For debt securities classified as available-for-sale investments, the Company records unrealized gains or losses resulting from changes in fair value between measurement dates as a component of other comprehensive income. The Company did not hold any available-for-sale securities as of December 31, 2019.

December 31, 2020

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair value

Financial assets

Money market funds

Included in cash and cash equivalents

$

101,429

$

—

$

—

$

101,429

Corporate bonds - due in one year or less

Included in short-term investments

7,227

6

—

7,233

Total

$

108,656

$

6

$

—

$

108,662

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R11.htm IDEA: XBRL DOCUMENT v3.20.4

Property, Plant and Equipment
12 Months Ended

Dec. 31, 2020

Property Plant And Equipment [Abstract]

Property, Plant and Equipment
4. Property, Plant and Equipment

Property plant and equipment consists of the following:

December 31,

2020

2019

Laboratory equipment

$

961

$

544

Furniture and fixtures

277

277

Leasehold improvements

57

57

Computer equipment

53

41

Total property, plant and equipment

1,348

919

Less: accumulated depreciation

(458

)

(104

)

Property, plant and equipment, net

$

890

$

815

Depreciation expense was $354 and $104 for the years ended December 31, 2020 and 2019, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R12.htm IDEA: XBRL DOCUMENT v3.20.4

Accrued and Other Current Liabilities
12 Months Ended

Dec. 31, 2020

Payables And Accruals [Abstract]

Accrued and Other Current Liabilities
5. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following:

December 31,

2020

2019

Research and development services

$

1,294

$

231

General and administrative services

160

297

Compensation expense

2,445

1,522

Other

38

177

$

3,937

$

2,227

X

- Definition
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R13.htm IDEA: XBRL DOCUMENT v3.20.4

Collaborations, Licensing Agreements and other Agreements
12 Months Ended

Dec. 31, 2020

Collaborations Licensing Agreements And Other Agreements [Abstract]

Collaborations, Licensing Agreements and other Agreements
6. Collaborations, Licensing Agreements and other Agreements

Amended and Restated License Agreement with the Trustees of the University of Pennsylvania and Children’s Hospital of Philadelphia

In August 2018, the Company entered into a license agreement with Penn, as amended and restated in July 2019 to include CHOP as a party, and as amended in May 2020 (the License Agreement) pursuant to which the Company obtained (a) a non-exclusive, non-sublicensable worldwide license to certain of Penn’s intellectual property to conduct research, product development, clinical trials, cell manufacturing and other activities, and (b) an exclusive, worldwide, royalty-bearing right and license, with a right to sublicense, on a target-by-target basis, under certain of Penn’s intellectual property to make, use, sell, offer for sale, import, and otherwise commercialize products for the treatment of autoimmune and alloimmune diseases.

Unless earlier terminated, the License Agreement expires on the expiration or abandonment or other termination of the last valid claim in Penn’s intellectual property licensed by the Company. The Company may terminate the License Agreement at any time for convenience upon 60 days written notice. In the event of an uncured, material breach, Penn may terminate the License Agreement upon 60 days written notice.

Under the terms of the License Agreement, the Company was obligated to pay $2,000 annually for three years beginning August 2018 for funding to the laboratories of each of Drs. Milone and Payne (see Sponsored Research Agreements). During the term of the License Agreement until the first commercial sale of the first product, the Company is obligated to pay Penn a non-refundable, non-creditable annual license maintenance fee of $10. In May 2020, the Company paid Penn an additional, non-refundable, non-creditable license fee of $33 under the amended License Agreement.

The Company is required to pay certain milestone payments upon the achievement of specified clinical and commercial milestones. Milestone payments are reduced by a certain percentage for the second product that achieves a milestone, by an additional percentage for the third product that achieves a milestone, and so on, for each subsequent product that achieves a milestone. In the event that the Company is able to successfully develop and launch multiple products under the License Agreement, total milestone payments could be approximately $21,000. Penn is also eligible to receive tiered royalties at percentage rates in the low single-digits, subject to an annual minimum royalty, on annual worldwide net sales of any products that are commercialized by the Company or its sublicensees that contain or incorporate, or are covered by, the intellectual property licensed by the Company. To the extent the Company sublicenses its license rights under the License Agreement, Penn would be eligible to receive tiered sublicense income at percentage rates in the mid-single to low double-digits. There were no amounts due under the License Agreement as of December 31, 2020.

 Sponsored Research Agreements

The Company has sponsored research agreements with two faculty members at Penn, who are also scientific co-founders of the Company and members of the Company’s scientific advisory board. In May 2020, one of the agreements was amended to expand the scope of sponsored research. In August 2020, this agreement was further amended to extend the term of the original research plan.

Under the amended agreements, the Company has committed to funding a defined research plan through February 2023. The total estimated cost of $11,781 under the agreements satisfies the Company’s annual obligation under the License Agreement (see Amended and Restated License Agreement with the Trustees of the University of Pennsylvania above). As of December 31, 2020, $7,090 of cost has been incurred pursuant to these agreements. For the years ended December 31, 2020 and 2019, the Company recognized research and development expense of $2,995 and $2,137, respectively, related to these agreements in the accompanying statements of operations. As of December 31, 2020 and 2019, $1,851 and $1,588 respectively, of advance payments are included in Prepaid expenses and other current assets in the accompanying balance sheets and there was $217 included in Accrued and other current liabilities in the accompanying balance sheets as of December 31, 2020.

Master Translational Research Services Agreement

In October 2018, the Company entered into a services agreement (the Services Agreement) with Penn for additional research and development services from various laboratories within Penn. The research and development activities are detailed in separately executed Penn organization-specific addenda. In May 2020, the Company amended its Addendum with the Center for Advanced Retinal and Ocular Therapeutics (CAROT) to expand access to vector manufacturing.

Research and development expense related to executed addenda under the master translational research service agreement with Penn recognized in the accompanying statements of operations for the years ended December 31, 2020 and 2019 was $2,474 and $2,355, respectively. The Company may incur additional expenses up to $1,360 through the remaining term of the CAROT Amended Addendum.

Subscription and Technology Transfer Agreement

In July 2019, the Company entered into a subscription and technology transfer agreement pursuant to which the Company owed Penn an upfront subscription fee, which was paid in 2019, and a nominal non-refundable royalty on the net sales of products, a portion of which will be credited toward milestone payments and royalties, respectively, under the Amended License Agreement. Technology transfer activities will be at the Company’s cost and subject to agreement as to the technology to be transferred. Under this agreement, the Company recognized $250 of research and development expense for the year ended December 31, 2019. No expense was recognized under this agreement for the year ended December 31, 2020.

Collaboration and License Agreement

In July 2020, the Company entered into a collaboration and license agreement with Artisan Bio, Inc. (Artisan), wherein the Company and Artisan agreed to collaborate to potentially enhance certain pipeline products of the Company at specific targets using Artisan’s gene editing and engineering technology. If the Artisan technology is applied to any of the Company’s products, the Company will be responsible for the development, manufacturing, and commercialization of any such products. Under the terms of the agreement, the Company was required to pay Artisan a nominal upfront fee, as well as costs associated with research and development activities. Artisan is eligible to receive future research, development and regulatory milestones, and is also eligible to receive sales milestones and tiered royalties on net sales of products that incorporate the Artisan technology. The Company can terminate the agreement at will upon advance written notice with payment of a nominal cancellation fee.

X

- Definition
Collaborations licensing agreements and other agreements.
+ References
No definition available.
+ Details

Name: caba_CollaborationsLicensingAgreementsAndOtherAgreementsAbstract

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Collaborations licensing agreements and other agreement.
+ References
No definition available.
+ Details

Name: caba_CollaborationsLicensingAgreementsAndOtherAgreementsDisclosureTextBlock

Namespace Prefix: caba_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R14.htm IDEA: XBRL DOCUMENT v3.20.4

Commitments and Contingencies
12 Months Ended

Dec. 31, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies
7. Commitments and Contingencies

Operating Lease Agreement

In February 2019, the Company entered into an operating lease agreement for new office space in Philadelphia, Pennsylvania. The lease term commenced in May 2019 and will expire in July 2022. The initial annual base rent is $261, and such amount will increase by 2% annually on each anniversary of the commencement date. The Company records rent expense on a straight-line basis over the lease term. Rent expense related to this lease agreement recognized in the accompanying statement of operations was $266 and $178 for the years ended December 31, 2020 and 2019.

As of December 31, 2020, the future minimum payments for operating leases are as follows:

2021

$

268

2022

158

Thereafter

—

$

426

Other Purchase Commitments

In the normal course of business, the Company enters into various purchase commitments with third-party contract manufacturers for the manufacture and processing of its product candidates and related raw materials, contracts with contract research organizations for clinical trials and agreements with vendors for other services and products for operating purposes. These agreements generally provide for termination or cancellation, other than for costs already incurred.

Indemnification

The Company enters into certain types of contracts that contingently requires the Company to indemnify various parties against claims from third parties. These contracts primarily relate to (i) the Company’s bylaws, under which the Company must indemnify directors and executive officers, and may indemnify other officers and employees, for liabilities arising out of their relationship, (ii) contracts under which the Company must indemnify directors and certain officers and consultants for liabilities arising out of their relationship, (iii) contracts under which the Company may be required to indemnify partners against certain claims, including claims from third parties asserting, among other things, infringement of their intellectual property rights, and (iv) procurement, consulting, or license agreements under which the Company may be required to indemnify vendors, consultants or licensors for certain claims, including claims that may be brought against them arising from the Company’s acts or omissions with respect to the supplied products, technology or services. From time to time, the Company may receive indemnification claims under these contracts in the normal course of business. In addition, under these contracts, the Company may have to modify the accused infringing intellectual property and/or refund amounts received.

In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R15.htm IDEA: XBRL DOCUMENT v3.20.4

Convertible Preferred Stock
12 Months Ended

Dec. 31, 2020

Temporary Equity Disclosure [Abstract]

Convertible Preferred Stock
8. Convertible Preferred Stock

Preferred Stock

Preferred Stock

The Company has 10,000,000 shares of authorized preferred stock as of December 31, 2020, none of which is issued or outstanding. The preferred stock is not redeemable and does not have a stated voting, dividend or liquidation preference.

Convertible Preferred Stock

The Company has issued Series A Preferred, Series A-1 Preferred, Series A-2 Preferred, and Series B Preferred of Convertible Preferred Stock. The Company classified Convertible Preferred Stock outside of stockholders’ equity (deficit) because the shares contained deemed liquidation rights that were a contingent redemption feature not solely within the control of the Company.

Series A Preferred

Series A-1 Preferred

Series A-2 Preferred

Series B Preferred

Total Convertible

Preferred Stock

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Balance—December 31, 2018

3,146,551

12,575

7,372,719

24,994

1,873,777

6,352

—

—

12,393,047

43,921

Issuance

—

—

—

—

—

—

6,963,788

50,000

6,963,788

50,000

Exchange, including

 deemed dividend

—

—

—

—

(1,405,332

)

(4,764

)

1,405,332

10,090

—

5,326

Issuance costs

—

—

—

—

—

—

—

(1,293

)

—

(1,293

)

Conversion to common

 stock

(3,146,551

)

(12,575

)

(7,372,719

)

(24,994

)

(468,445

)

(1,588

)

(8,369,120

)

(58,797

)

(19,356,835

)

(97,954

)

Balance—December 31, 2019

—

$

—

—

$

—

—

$

—

—

$

—

—

$

—

In January 2019, the Company’s certificate of incorporation was amended to increase the authorized shares of Convertible Preferred Stock to 20,762,168 shares, and the Company issued 6,963,788 shares of Series B Preferred, resulting in gross proceeds of $50,000. In connection, the Company issued a further 1,405,332 shares of Series B Preferred in exchange for 1,405,332 shares of Series A-2 Preferred. The Company determined the terms of the Series B Preferred to be materially, qualitatively different than the terms of the Series A-2 Preferred and, as such, applied extinguishment accounting with respect to the Series A-2 Preferred received in the exchange resulting in removal of the carrying amount of the Series A-2 Preferred received ($4,764), the addition of the Series B Preferred issued at fair value determined with reference to the contemporaneous issuance of Series B Preferred ($10,090) and the difference ($5,326) determined to be a deemed dividend recorded to additional paid-in capital (to the extent of paid-in capital) and accumulated deficit within stockholders’ deficit on the balance sheet.

The shares of Convertible Preferred Stock had various rights, including voting and dividend rights, preferences and privileges, including optional and mandatory conversion rights.

In October 2019, the Convertible Preferred Stock was converted into 12,904,534 shares of Common Stock. Certain holders of the Company’s Convertible Preferred Stock elected to have such shares convert into 6,409,519 shares of non-voting Common Stock following the closing of the Company’s IPO. The non-voting shares of Common Stock have the same rights and preferences as the Common Stock but are non-voting. No Convertible Preferred Stock was outstanding as of December 31, 2020 or 2019.

X

- Definition
The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762
+ Details

Name: us-gaap_PreferredStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R16.htm IDEA: XBRL DOCUMENT v3.20.4

Common Stock
12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Common Stock
9. Common Stock

Common Stock

Pursuant to the Company’s Third Amended and Restated Certificate of Incorporation filed in October 2019, the Company is authorized to issue 143,590,481 shares of voting common stock and 6,409,519 shares of non-voting common stock. Holders of voting common stock shall have the exclusive right to vote for the election of directors of the Company and on all other matters requiring stockholder action. Each share of the Company’s non-voting common stock may be converted at any time into one share of common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. In August 2020, 1,733,904 shares of non-voting common stock were converted to voting common stock.

At-The-Market Offering Sales Agreement

On November 10, 2020, the Company filed a Shelf Registration Statement in relation to the registration of common stock, preferred stock, debt securities, warrants and/or units of any combination thereof for the purposes of selling, from time to time, the Company’s common stock, debt securities or other equity securities in one or more offerings. The Company also simultaneously entered into a Sales Agreement with Cowen and Company, LLC, to provide for the offering, issuance and sale of up to an aggregate amount of $75.0 million of the Company’s common stock from time to time in “at-the-market” offerings under the Shelf Registration Statement and subject to the limitations thereof. No shares have been sold under the Sales Agreement as of December 31, 2020.

Share-based Payment Awards

In May 2018, several of the Company’s founders agreed to modify their shares of common stock outstanding to include vesting provisions that require continued service to the Company in order to vest in those shares. As such, the 2,904,000 modified shares of common stock became compensatory upon such modification. The fair value of the awards on the modification date was determined to be $0.74 per share of common stock, based on the issuance of convertible notes in May 2018, considering the maximum conversion price and the seniority of the notes. The total compensation cost resulting from the modification was $2,126. The total compensation cost is being recognized over the three-year vesting term attendant to the founders’ common shares.

During the year ended December 31, 2020, the Company recognized $495 and $177 of this amount in research and development expense and general and administrative expense, respectively. During the year ended December 31, 2019, the Company recognized $529 and $177 of this amount in research and development expense and general and administrative expense, respectively.

2018 Stock Option and Grant Plan

In September 2018, the Company adopted the 2018 stock option and grant plan (the 2018 Plan), which provided for the Company to sell or issue common stock, or other stock-based awards, to employees, members of the board of directors and consultants of the Company. The Company generally granted stock-based awards with service conditions only (service-based awards), although there was one grant with performance conditions. As of December 31, 2020, there are no unvested options with performance conditions. Stock options granted under the 2018 Plan generally vest over three to four years. There were 1,959,411 options granted under the 2018 Plan prior to the Company’s IPO in October 2019. No further grants may be made under the 2018 Plan subsequent to the IPO.

2019 Stock Option and Incentive Plan

The 2019 Stock Option and Incentive Plan (2019 Plan) was approved by the Company’s board of directors on October 14, 2019, and became effective on October 23, 2019. The 2019 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock units, restricted stock awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to the Company’s officers, employees, directors and consultants. The number of shares initially reserved for issuance under the 2019 Plan was 2,342,288, which will be increased each January 1 thereafter by 4% of the number of shares of the Company’s common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by the Company’s board of directors or compensation committee of the board of directors. On January 1, 2021, the total number of shares under the 2019 Plan was increased by 962,511 shares. As of December 31, 2020, there were 2,314,303 shares remaining available for issuance.

A summary of the stock option activity is presented below:

Number of

Shares

Weighted

Average

Exercise Price

Weighted

Average

Remaining

Contractual

Term (years)

Aggregate

Intrinsic

Value

Outstanding as of January 1, 2019

971,353

$

1.01

9.8

$

4,051

Granted

1,340,839

7.97

Exercised

(5,667

)

1.01

Cancelled

(176,893

)

4.22

Outstanding as of December 31, 2019

2,129,632

5.12

9.2

$

18,844

Granted

813,172

13.03

Exercised

(25,611

)

5.44

183

Forfeited

(16,714

)

6.30

Outstanding as of December 31, 2020

2,900,479

$

7.33

8.5

$

16,303

Options Exercisable at December 31, 2020

1,068,675

$

4.04

8.1

$

9,059

The aggregate intrinsic value of options granted is calculated as the difference between the exercise price of the options and the estimated fair value of the Company’s common stock. The weighted average grant-date fair value of stock options granted during the year ended December 31, 2020 and 2019 was $8.31 and $5.24, respectively.

The fair value of each award is estimated using Black-Scholes based on the following assumptions:

For the Year Ended December 31,

2020

2019

Risk-free interest rate

0.28%—1.48%

1.39%—2.59%

Expected term

5.7—6.1 years

0.3—6.1 years

Expected volatility

70%—79%

70%—76%

Expected dividend yield

0%

0%

Black-Scholes requires the use of subjective assumptions which determine the fair value of stock-based awards. These assumptions include:

Fair value of common stock—Prior to the Company’s IPO in October 2019, the fair value of the Company’s common stock underlying stock-based awards was estimated on each grant date by the Company’s board of directors. In order to determine the fair value of the Company’s common stock underlying stock-based awards, the Company’s board of directors considered, among other things, a valuation of the Company’s common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.

Expected term—The expected term represents the period that stock-based awards are expected to be outstanding. The expected term for option grants is determined using the simplified method, which is the midpoint between the vesting period and the contractual term of the option.

Expected volatility—As a privately held company prior to the Company’s IPO in October 2019, the Company has limited trading history for its common stock and, as such, the expected volatility is estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock-based awards. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available.

Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of a stock-based award.

Expected dividend—The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.

Stock-based Compensation

The Company has recorded stock-based compensation in the accompanying statements of operations as follows:

For the Year Ended December 31,

2020

2019

Research and development

$

1,989

$

1,304

General and administrative

2,399

996

Total

$

4,388

$

2,300

As of December 31, 2020, there was $9,809 of unrecognized compensation cost related to unvested option awards, which is expected to be recognized over a weighted-average period of 2.8 years. As of December 31, 2020, there was $239 of unrecognized compensation cost related to unvested founder stock awards, which is expected to be recognized over a weighted-average period of 0.3 years.

2019 Employee Stock Purchase Plan

The 2019 Employee Stock Purchase Plan (2019 ESPP) was approved by the Company’s board of directors on October 14, 2019, and became effective on October 23, 2019. A total of 234,229 shares of common stock were initially reserved for issuance under the 2019 ESPP, and will be increased each January 1 thereafter through January 1, 2029 by the least of (i) 234,229 shares of common stock, (ii) 1% of the number of shares of the Company’s common stock outstanding on the immediately preceding December 31 or (iii) such lesser number of shares determined by the 2019 ESPP’s administrator. On January 1, 2021, the total number of shares under the 2019 ESPP was increased by 234,229 shares.

Employee contributions are made through payroll deductions of up to 15% of eligible compensation over the offering period. A participant may not accrue rights to purchase more than $25 worth of the Company’s common stock for each calendar year in which such right is outstanding. At the end of each offering period, shares of the Company’s common stock may be purchased at 85% of the lesser of the Company’s common stock on (i) the first trading day of the relevant offering period and (ii) the last trading day of the relevant offering period. The first offering period commenced on July 1, 2020 and ended on November 30, 2020. Thereafter, offerings will be six months in duration and will commence on each December 1 and June 1. The Company recognized stock-based compensation expense of $18 during the year ended December 31, 2020 related to the 2019 ESPP.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938
+ Details

Name: us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R17.htm IDEA: XBRL DOCUMENT v3.20.4

Income Taxes
12 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes
10. Income Taxes

The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate is as follows:

For the Year Ended December 31,

2020

2019

Expected income tax benefit at the federal statutory rate

21.0

%

21.0

%

State and local taxes, net of federal benefit

12.5

13.1

Research and development credit, net

2.6

2.3

Non-deductible items and other

(0.8

)

(3.3

)

Change in valuation allowance

(35.3

)

(33.1

)

Total

0.0

%

0.0

%

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The principal components of the Company’s deferred tax assets consisted of the following:

December 31,

2020

2019

Deferred tax assets:

Federal, state and local net operating loss carryforwards

$

15,241

$

5,688

License fee deductions

340

362

Research and development tax credits

1,317

452

Stock-based compensation deductions

1,243

264

Accrued expenses

837

457

Gross deferred tax assets

18,978

7,223

Less: valuation allowance

(18,978

)

(7,223

)

Total deferred tax assets

—

—

Deferred tax liabilities:

—

—

$

—

$

—

Net deferred tax assets

$

—

$

—

The Company increased its valuation allowance by $11,755 for the year ended December 31, 2020 in order to maintain a full valuation allowance against its deferred tax assets. Based on the Company’s history of losses, the Company recorded a full valuation allowance against its deferred tax assets as of December 31, 2020. The Company intends to maintain a valuation allowance until sufficient positive evidence exists to support a reversal of the allowance.

As of December 31, 2020, the Company had federal, state and local net operating loss carryforwards of $45,550, $47,735 and $38,645, respectively; $45,301 of the federal amounts do not expire, and the remaining $249 expire in 2037. The state net operating losses begin to expire in 2037. The local net operating losses begin to expire in 2039. As of December 31, 2020, the Company had federal research and development tax credit carryforwards of $1,317, which begin to expire in 2038. Under the provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the IRC), these net operating losses, credit carryforwards and other tax attributes may be subject to limitation based on previous significant changes in ownership and upon future significant changes in ownership of the Company, as defined by the IRC.

The Company files income tax returns in the U.S. federal jurisdiction as well as in Pennsylvania and Philadelphia. The tax years 2019, 2018 and 2017 remain open to examination by the jurisdictions where the Company is subject to tax.

The Company evaluates tax positions for recognition using a more-likely-than-not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. As of December 31, 2020, the Company had no unrecognized income tax benefits that would affect the Company’s effective tax rate if recognized.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R18.htm IDEA: XBRL DOCUMENT v3.20.4

Net Loss Per Share
12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Net Loss Per Share
11. Net Loss Per Share

The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. For the years ended December 31, 2020 and 2019, the Company had voting and non-voting common stock outstanding. Since the rights of the voting and non-voting common stock are identical, except with respect to voting, the undistributed losses of the Company have been allocated on a proportionate basis to the two classes. Diluted net loss per share is calculated using the if-converted method, which assumes conversion of all non-voting common stock to voting common stock.

Year ended December 31, 2020

Voting common stock

Non-voting common stock

Basic net loss per share:

Numerator

Allocation of undistributed losses attributable to common stockholders

$

(25,090

)

$

(8,249

)

Denominator

Weighted average number of shares used in basic per share computation

17,417,900

5,727,327

Net loss per share, basic

$

(1.44

)

$

(1.44

)

Diluted net loss per share:

Numerator

Allocation of undistributed losses for basic computation

$

(25,090

)

$

(8,249

)

Reallocation of undistributed losses as a result of conversion of

 non-voting to voting common shares

(8,249

)

—

Allocation of undistributed losses

$

(33,339

)

$

(8,249

)

Denominator

Weighted average number of shares used in basic per share computation

17,417,900

5,727,327

Add: Conversion of non-voting to voting common shares outstanding

5,727,327

—

Weighted average number of shares used in diluted per share computation

23,145,227

5,727,327

Net loss per share, diluted

$

(1.44

)

$

(1.44

)

Year ended December 31, 2019

Voting common stock

Non-voting common stock

Basic net loss per share:

Numerator

Allocation of undistributed losses attributable to common stockholders

$

(17,693

)

$

(4,576

)

Denominator

Weighted average number of shares used in basic per share computation

4,345,530

1,123,861

Net loss per share, basic

$

(4.07

)

$

(4.07

)

Diluted net loss per share:

Numerator

Allocation of undistributed losses for basic computation

$

(17,693

)

$

(4,576

)

Reallocation of undistributed losses as a result of conversion of

 non-voting to voting common shares

(4,576

)

—

Allocation of undistributed losses

$

(22,269

)

$

(4,576

)

Denominator

Weighted average number of shares used in basic per share computation

4,345,530

1,123,861

Add: Conversion of non-voting to voting common shares outstanding

1,123,861

—

Weighted average number of shares used in diluted per share computation

5,469,391

1,123,861

Net loss per share, diluted

$

(4.07

)

$

(4.07

)

The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive:

For the Year Ended December 31,

2020

2019

Stock options to purchase common stock

2,900,479

2,129,632

Non-vested founder stock

465,801

1,388,977

Total

3,366,280

3,518,609

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-URI http://asc.fasb.org/topic&trid=2144383

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R19.htm IDEA: XBRL DOCUMENT v3.20.4

401(k) Savings Plan
12 Months Ended

Dec. 31, 2020

Compensation And Retirement Disclosure [Abstract]

401(k) Savings Plan
12. 401(k) Savings Plan

The Company maintains a defined-contribution savings plan under Section 401(k) of the IRC, or the 401(k) Plan. The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis. In 2019, the Company made a safe harbor nonelective contribution of 3% of eligible compensation on behalf of all employees. Effective January 1, 2020, the Plan provided for matching contributions on a portion of participant contributions pursuant to the 401(k) Savings Plan’s matching formula, up to 4% of eligible compensation. All matching contributions and participant contributions vest immediately. Contributions totaled $203 and $74 for the years ended December 31, 2020 and 2019, respectively, and have been recorded in the statements of operations.

X

- Definition
The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 712
-URI http://asc.fasb.org/topic&trid=2197446

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-URI http://asc.fasb.org/topic&trid=2127225

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017
+ Details

Name: us-gaap_CompensationAndEmployeeBenefitPlansTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R20.htm IDEA: XBRL DOCUMENT v3.20.4

Subsequent Events
12 Months Ended

Dec. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

13. Subsequent Events

In January 2021, the Company entered into a Development and Manufacturing Services Agreement (Wuxi Agreement) with WuXi Advanced Therapies (Wuxi) to serve as the Company’s cell processing manufacturing partner for the anticipated MuSK-CAART Phase 1 clinical trial. The Company has the right to terminate the Wuxi Agreement for convenience or other reasons specified in the Wuxi Agreement upon prior written notice. If the Company terminates the Wuxi Agreement, it will be obligated to pay an early termination fee of $1,500.

In February 2021, the Company entered into a research service agreement with CHOP for vector manufacturing, with a total cost of $670, expected to be incurred during 2021.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R21.htm IDEA: XBRL DOCUMENT v3.20.4

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include but are not limited to the fair value of common stock, stock-based compensation and the valuation allowance on the Company’s deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.

Off-Balance Sheet Risk and Concentrations of Credit Risk
Off-Balance Sheet Risk and Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, which are primarily invested in U.S. treasury-based money market funds, and available-for-sale debt securities, which are invested in investment grade corporate bonds with high credit quality issuers. These investments have maturities in 2021. A portion of the Company’s cash is maintained at a federally insured financial institution. The deposits held at this institution are in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held. The cash in this account is swept daily into U.S. treasury-based and U.S. government-based money market funds. The Company has no off‑balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.

Cash and Cash Equivalents
Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market accounts.

Investments

Investments

Investments are available-for-sale and carried at estimated fair value. The Company’s valuations of available-for-sale debt securities are generally derived from independent pricing services based upon quoted prices in active markets for similar securities, with prices adjusted for yield and number of days to maturity, or based on industry models using data inputs, such as interest rates and prices that can be directly observed or corroborated in active markets. Management determines the appropriate classification of its investments in debt securities at the time of purchase and at the end of each reporting period. Investments with original maturities beyond three months at the date of purchase and which mature at, or less than, twelve months from the balance sheet date are classified as current.

Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive income. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors including the severity and duration of the unrealized loss as well as the Company’s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or if more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other-than-temporary, if any, on available-for-sale securities are included in interest and other income, net. The cost of investments sold is based on the specific-identification method. Interest income on investments as well as amortization of discount or premium is included in interest income.

Property, Plant and Equipment
Property, Plant and Equipment

Property, plant and equipment are recorded at cost less accumulated depreciation. Cost includes the acquisition costs and all costs necessary to bring the asset to the location and working condition necessary for its intended use. Depreciation expense is recognized using the straight-line method over the estimated useful life of each asset. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the accompanying statements of operations. Expenditures for normal, recurring or periodic repairs and maintenance related to property and equipment are charged to expense as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if it will result in future economic benefits.

Estimated useful lives for property and equipment are as follows:

Property and equipment

Estimated useful life

Laboratory equipment

Three years

Furniture and fixtures

Three years

Computer equipment

Three years

Leasehold improvements

Lesser of estimated useful life or remaining lease term

Fair Value Measurement
Fair Value Measurement

Assets and liabilities recorded at fair value on a recurring basis in the balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:

Level 1—Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2—Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Research and Development Expenses
Research and Development Expenses

Research and development costs include costs incurred for internal and external research and development activities and are expensed as incurred in the accompanying statements of operations. Research and development costs consist of salaries and benefits, including associated stock-based compensation, and laboratory supplies and facility costs, as well as fees paid to entities that conduct certain research and development activities on the Company’s behalf.

The Company records accrued liabilities for estimated costs of research and development activities conducted by service providers, which include activities under agreements with Penn (Note 6), the conduct of sponsored research, preclinical studies and contract manufacturing activities. The Company records the estimated costs of research and development activities based upon the estimated amount of services provided and includes these costs in accrued and other current liabilities and prepaid expenses and other current assets in the accompanying balance sheets and within research and development expense in the accompanying statements of operations. Non-refundable advance payments made for goods or services that will be used or rendered for future research and development activities are deferred and capitalized and recognized as expense as the goods are received or the related services are rendered.

The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with service providers. The Company makes significant judgments and estimates in determining the accrued liabilities and prepaid expenses in each reporting period. As actual costs become known, the Company adjusts its accrued liabilities and prepaid expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred since its inception.

Stock-based Compensation
Stock-based Compensation

The Company measures its stock-based awards granted to employees and non-employees based on the estimated fair values of the awards on the respective grant dates. The Company uses the Black-Scholes option-pricing model (Black-Scholes) to estimate the fair value of its stock-based awards. The Company recognizes compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The Company accounts for forfeitures of stock option awards as they occur.

Prior to the Company’s IPO, the assumptions used in the Company's Black-Scholes option-pricing model represented management's best estimates and involve a number of variables, uncertainties and assumptions and the application of management's judgment, as they are inherently subjective.

Income Taxes
Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax base. Deferred tax assets and liabilities, which relate primarily to the carrying amount of the Company’s property and equipment and its net operating loss carryforwards, are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax expense or benefit is the result of changes in the deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets where, based upon the available evidence, the Company concludes that it is more-likely-than-not that the deferred tax assets will not be realized. In evaluating its ability to recover deferred tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. Because of the uncertainty of the realization of deferred tax assets, the Company has recorded a full valuation allowance against its deferred tax assets.

Reserves are provided for tax benefits for which realization is uncertain. Such benefits are only recognized when the underlying tax position is considered more-likely-than-not to be sustained on examination by a taxing authority, assuming they possess full knowledge of the position and facts. Interest and penalties related to uncertain tax positions are recognized in the provision of income taxes; however, the Company currently has no interest or penalties related to uncertain income tax benefits.

Net Loss Per Share
Net Loss Per Share

The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. The Company has voting and non-voting common stock. The rights, including the liquidation and dividend rights, of the holders of the voting and non-voting common stock are identical, except with respect to voting. Each share of non-voting common stock may be converted at any time into one share of voting common stock at the option of its holder by providing written notice to the Company, subject to the limitations provided for in the amended and restated certificate of incorporation. The Company also considers its unvested shares of common stock held by the Company’s founders and, prior to its conversion to common stock, its convertible preferred stock to be participating securities as, in the event a dividend is paid on common stock, the holders of convertible preferred stock and unvested shares of common stock would be entitled to receive dividends on a basis consistent with the common stockholders.

Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock, which excludes unvested shares of common stock. The undistributed loss for each year is allocated to common stockholders based on the contractual participation rights of the voting and non-voting common stock as if the losses for the year had been distributed. As the liquidation and dividend rights are identical, the undistributed losses are allocated on a proportionate basis. Net loss attributable to common stockholders for the year ended December 31, 2019 is calculated by adjusting the net loss of the Company for the deemed dividend associated with the exchange of Series A-2 Preferred for Series B Preferred. Diluted net loss per share attributable to common stockholders is computed under the if-converted method and assumes that all non-voting common stock has been converted to common stock. Since the Company was in a loss position for all periods presented, the effects of the other potentially dilutive securities are antidilutive.

Segments
Segments

Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one reportable segment.

Related Party Transactions
Related Party Transactions

The Company engaged a firm controlled by a former executive (until February 2019) of the Company for professional services related to accounting, finance and other administrative functions. For the years ended December 31, 2020 and 2019, the costs incurred under this arrangement totaled $311 and $601, respectively. These amounts were recorded as general and administrative expense in the accompanying statements of operations. As of December 31, 2020 and 2019, amounts owed under this arrangement totaled $13 and $36, respectively, and are included in accounts payable in the accompanying balance sheets.

Emerging Growth Company Status
Emerging Growth Company Status

The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.

Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Issued Accounting Pronouncements Not Yet Adopted

In February 2016, the Financial Accounting Standards Board (FASB) issued ASU 2016-02, Leases (Topic 842), with guidance regarding the accounting for and disclosure of leases. The update requires lessees to recognize the liabilities related all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. This guidance will be effective for public companies for annual and interim periods beginning after December 15, 2018. For all other entities, including Emerging Growth Companies, this standard is effective for annual reporting periods beginning after December 15, 2020, and interim periods within annual periods beginning after December 15, 2021. Early adoption is permitted. As an Emerging Growth Company, the Company expects to adopt Topic 842 for its annual period ending December 31, 2021 and has not yet finalized the assessment of the impact that ASU 2016-02 will have on its financial statements or financial statement disclosures.

X

- Definition
Emerging growth company status.
+ References
No definition available.
+ Details

Name: caba_EmergingGrowthCompanyStatusPolicyTextBlock

Namespace Prefix: caba_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Recently issued accounting pronouncements not yet adopted.
+ References
No definition available.
+ Details

Name: caba_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock

Namespace Prefix: caba_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Related party transactions.
+ References
No definition available.
+ Details

Name: caba_RelatedPartyTransactionsPolicyTextBlock

Namespace Prefix: caba_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investment in financial asset.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(3)(b))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_InvestmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of accounting policies and methodologies used to estimate the entity's liability for off-balance sheet credit exposures and related charges for those credit exposures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121611835&loc=d3e5144-111524

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121599337&loc=SL82919272-210447
+ Details

Name: us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 958
-SubTopic 360
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpensePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for segment reporting.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599
+ Details

Name: us-gaap_SegmentReportingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R22.htm IDEA: XBRL DOCUMENT v3.20.4

Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Schedule of Estimated Useful Lives for Property and Equipment
Estimated useful lives for property and equipment are as follows:

Property and equipment

Estimated useful life

Laboratory equipment

Three years

Furniture and fixtures

Three years

Computer equipment

Three years

Leasehold improvements

Lesser of estimated useful life or remaining lease term

X

- Definition
Schedule of estimated useful lives of property and equipment.
+ References
No definition available.
+ Details

Name: caba_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock

Namespace Prefix: caba_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R23.htm IDEA: XBRL DOCUMENT v3.20.4

Fair Value Measurements (Tables)
12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Financial Assets Measured at Fair Value on Recurring Basis
The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values:

December 31, 2020

Total

Quoted

Prices in

Active Markets

for Identical

Assets (Level 1)

Significant

Other

Observable

Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Financial assets

Cash and cash equivalents:

Money market funds

$

101,429

$

101,429

$

—

$

—

Short-term investments:

Corporate bonds

7,233

—

7,233

—

Total

$

108,662

$

101,429

$

7,233

$

—

December 31, 2019

Total

Quoted Prices in Active Markets for Identical Assets (Level 1)

Significant Other Observable Inputs (Level 2)

Significant Unobservable Inputs (Level 3)

Financial assets

Cash equivalents:

Money market funds

$

136,204

$

136,204

$

—

$

—

Total

$

136,204

$

136,204

$

—

$

—

Schedule of Debt Securities Classified as Available-for-Sale Investments

December 31, 2020

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair value

Financial assets

Money market funds

Included in cash and cash equivalents

$

101,429

$

—

$

—

$

101,429

Corporate bonds - due in one year or less

Included in short-term investments

7,227

6

—

7,233

Total

$

108,656

$

6

$

—

$

108,662

X

- Definition
Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-URI http://asc.fasb.org/topic&trid=2196928
+ Details

Name: us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 56 R24.htm IDEA: XBRL DOCUMENT v3.20.4

Property, Plant and Equipment (Tables)
12 Months Ended

Dec. 31, 2020

Property Plant And Equipment [Abstract]

Schedule of Property Plant and Equipment
Property plant and equipment consists of the following:

December 31,

2020

2019

Laboratory equipment

$

961

$

544

Furniture and fixtures

277

277

Leasehold improvements

57

57

Computer equipment

53

41

Total property, plant and equipment

1,348

919

Less: accumulated depreciation

(458

)

(104

)

Property, plant and equipment, net

$

890

$

815

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R25.htm IDEA: XBRL DOCUMENT v3.20.4

Accrued and Other Current Liabilities (Tables)
12 Months Ended

Dec. 31, 2020

Payables And Accruals [Abstract]

Schedule of Accrued and Other Current Liabilities
Accrued and other current liabilities consist of the following:

December 31,

2020

2019

Research and development services

$

1,294

$

231

General and administrative services

160

297

Compensation expense

2,445

1,522

Other

38

177

$

3,937

$

2,227

X

- Definition
Accrued expenses and other current liabilities.
+ References
No definition available.
+ Details

Name: caba_AccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock

Namespace Prefix: caba_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 58 R26.htm IDEA: XBRL DOCUMENT v3.20.4

Commitments and Contingencies (Tables)
12 Months Ended

Dec. 31, 2020

Commitments And Contingencies Disclosure [Abstract]

Schedule of Future Minimum Payments for Operating Leases
As of December 31, 2020, the future minimum payments for operating leases are as follows:

2021

$

268

2022

158

Thereafter

—

$

426

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R27.htm IDEA: XBRL DOCUMENT v3.20.4

Convertible Preferred Stock (Tables)
12 Months Ended

Dec. 31, 2020

Partners Capital [Abstract]

Summary of Convertible Preferred Stock

Series A Preferred

Series A-1 Preferred

Series A-2 Preferred

Series B Preferred

Total Convertible

Preferred Stock

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Balance—December 31, 2018

3,146,551

12,575

7,372,719

24,994

1,873,777

6,352

—

—

12,393,047

43,921

Issuance

—

—

—

—

—

—

6,963,788

50,000

6,963,788

50,000

Exchange, including

 deemed dividend

—

—

—

—

(1,405,332

)

(4,764

)

1,405,332

10,090

—

5,326

Issuance costs

—

—

—

—

—

—

—

(1,293

)

—

(1,293

)

Conversion to common

 stock

(3,146,551

)

(12,575

)

(7,372,719

)

(24,994

)

(468,445

)

(1,588

)

(8,369,120

)

(58,797

)

(19,356,835

)

(97,954

)

Balance—December 31, 2019

—

$

—

—

$

—

—

$

—

—

$

—

—

$

—

X

- References
No definition available.
+ Details

Name: us-gaap_PartnersCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (27)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764
+ Details

Name: us-gaap_TemporaryEquityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 60 R28.htm IDEA: XBRL DOCUMENT v3.20.4

Common Stock (Tables)
12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Summary of Stock Option Activity
A summary of the stock option activity is presented below:

Number of

Shares

Weighted

Average

Exercise Price

Weighted

Average

Remaining

Contractual

Term (years)

Aggregate

Intrinsic

Value

Outstanding as of January 1, 2019

971,353

$

1.01

9.8

$

4,051

Granted

1,340,839

7.97

Exercised

(5,667

)

1.01

Cancelled

(176,893

)

4.22

Outstanding as of December 31, 2019

2,129,632

5.12

9.2

$

18,844

Granted

813,172

13.03

Exercised

(25,611

)

5.44

183

Forfeited

(16,714

)

6.30

Outstanding as of December 31, 2020

2,900,479

$

7.33

8.5

$

16,303

Options Exercisable at December 31, 2020

1,068,675

$

4.04

8.1

$

9,059

Schedule of Assumptions Used to Estimate Fair Value of Stock Options
The fair value of each award is estimated using Black-Scholes based on the following assumptions:

For the Year Ended December 31,

2020

2019

Risk-free interest rate

0.28%—1.48%

1.39%—2.59%

Expected term

5.7—6.1 years

0.3—6.1 years

Expected volatility

70%—79%

70%—76%

Expected dividend yield

0%

0%

Summary of Stock-Based Compensation
The Company has recorded stock-based compensation in the accompanying statements of operations as follows:

For the Year Ended December 31,

2020

2019

Research and development

$

1,989

$

1,304

General and administrative

2,399

996

Total

$

4,388

$

2,300

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901
+ Details

Name: us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 R29.htm IDEA: XBRL DOCUMENT v3.20.4

Income Taxes (Tables)
12 Months Ended

Dec. 31, 2020

Income Tax Disclosure [Abstract]

Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate
The reconciliation of federal statutory income tax rate to the Company’s effective income tax rate is as follows:

For the Year Ended December 31,

2020

2019

Expected income tax benefit at the federal statutory rate

21.0

%

21.0

%

State and local taxes, net of federal benefit

12.5

13.1

Research and development credit, net

2.6

2.3

Non-deductible items and other

(0.8

)

(3.3

)

Change in valuation allowance

(35.3

)

(33.1

)

Total

0.0

%

0.0

%

Summary of Principal Components of Company's Deferred Tax Assets The principal components of the Company’s deferred tax assets consisted of the following:

December 31,

2020

2019

Deferred tax assets:

Federal, state and local net operating loss carryforwards

$

15,241

$

5,688

License fee deductions

340

362

Research and development tax credits

1,317

452

Stock-based compensation deductions

1,243

264

Accrued expenses

837

457

Gross deferred tax assets

18,978

7,223

Less: valuation allowance

(18,978

)

(7,223

)

Total deferred tax assets

—

—

Deferred tax liabilities:

—

—

$

—

$

—

Net deferred tax assets

$

—

$

—

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 R30.htm IDEA: XBRL DOCUMENT v3.20.4

Net Loss Per Share (Tables)
12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earnings Per Share

Year ended December 31, 2020

Voting common stock

Non-voting common stock

Basic net loss per share:

Numerator

Allocation of undistributed losses attributable to common stockholders

$

(25,090

)

$

(8,249

)

Denominator

Weighted average number of shares used in basic per share computation

17,417,900

5,727,327

Net loss per share, basic

$

(1.44

)

$

(1.44

)

Diluted net loss per share:

Numerator

Allocation of undistributed losses for basic computation

$

(25,090

)

$

(8,249

)

Reallocation of undistributed losses as a result of conversion of

 non-voting to voting common shares

(8,249

)

—

Allocation of undistributed losses

$

(33,339

)

$

(8,249

)

Denominator

Weighted average number of shares used in basic per share computation

17,417,900

5,727,327

Add: Conversion of non-voting to voting common shares outstanding

5,727,327

—

Weighted average number of shares used in diluted per share computation

23,145,227

5,727,327

Net loss per share, diluted

$

(1.44

)

$

(1.44

)

Year ended December 31, 2019

Voting common stock

Non-voting common stock

Basic net loss per share:

Numerator

Allocation of undistributed losses attributable to common stockholders

$

(17,693

)

$

(4,576

)

Denominator

Weighted average number of shares used in basic per share computation

4,345,530

1,123,861

Net loss per share, basic

$

(4.07

)

$

(4.07

)

Diluted net loss per share:

Numerator

Allocation of undistributed losses for basic computation

$

(17,693

)

$

(4,576

)

Reallocation of undistributed losses as a result of conversion of

 non-voting to voting common shares

(4,576

)

—

Allocation of undistributed losses

$

(22,269

)

$

(4,576

)

Denominator

Weighted average number of shares used in basic per share computation

4,345,530

1,123,861

Add: Conversion of non-voting to voting common shares outstanding

1,123,861

—

Weighted average number of shares used in diluted per share computation

5,469,391

1,123,861

Net loss per share, diluted

$

(4.07

)

$

(4.07

)

Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share
The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive:

For the Year Ended December 31,

2020

2019

Stock options to purchase common stock

2,900,479

2,129,632

Non-vested founder stock

465,801

1,388,977

Total

3,366,280

3,518,609

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 63 R31.htm IDEA: XBRL DOCUMENT v3.20.4

Basis of Presentation - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended

Oct. 29, 2019

USD ($)

$ / shares

shares

Oct. 16, 2019

$ / shares

Nov. 30, 2019

USD ($)

shares

Dec. 31, 2020

USD ($)

Dec. 31, 2019

USD ($)

Basis Of Presentation [Line Items]

Reverse stock split description 1-for-1.5 reverse split

Reverse stock split ratio 0.67

Common stock, par value | $ / shares $ 0.00001

Cash and cash equivalents and investments | $ $ 108,662

Accumulated deficit | $ $ (66,298) $ (32,959)

Initial Public Offering

Basis Of Presentation [Line Items]

Issuance of common stock, shares | shares 6,800,000

Common stock issued, per share | $ / shares $ 11.00

Net proceeds from initial public offering | $ $ 66,156 $ 4,864

Conversion of convertible preferred stock to common stock | shares 12,904,534

Number of additional common stock purchased by underwriters upon partial exercise of option | shares 475,501

X

- Definition
Basis of presentation.
+ References
No definition available.
+ Details

Name: caba_BasisOfPresentationLineItems

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of additional common stock purchased by underwriters upon partial exercise of option.
+ References
No definition available.
+ Details

Name: caba_NumberOfAdditionalCommonStockPurchasedByUnderwritersUponPartialExerciseOfOption

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CashCashEquivalentsAndShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued for each share of convertible preferred stock that is converted.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644
+ Details

Name: us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770
+ Details

Name: us-gaap_StockholdersEquityNoteStockSplitConversionRatio1

Namespace Prefix: us-gaap_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770
+ Details

Name: us-gaap_StockholdersEquityReverseStockSplit

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R32.htm IDEA: XBRL DOCUMENT v3.20.4

Summary of Significant Accounting Policies - Additional Information (Details)
12 Months Ended

Dec. 31, 2020

USD ($)

Segment

Dec. 31, 2019

USD ($)

Summary of Significant Accounting Policies [Line Items]

Investments maturity year 2021

Interest or penalties related to uncertain income tax benefits $ 0

Number of operating segment | Segment 1

Number of reportable segment | Segment 1

Amounts due to related party $ 13,000 $ 36,000

Professional Services

Summary of Significant Accounting Policies [Line Items]

Costs incurred under the arrangement recorded as general and administrative expense $ 311,000 $ 601,000

X

- Definition
Investments maturity year.
+ References
No definition available.
+ Details

Name: caba_InvestmentsMaturityYear

Namespace Prefix: caba_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Summary of significant accounting policies.
+ References
No definition available.
+ Details

Name: caba_SummaryOfSignificantAccountingPoliciesLineItems

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
+ Details

Name: us-gaap_DueToRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599
+ Details

Name: us-gaap_NumberOfOperatingSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportingUnits

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.
+ References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RelatedPartyTransactionAxis=caba_ProfessionalServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R33.htm IDEA: XBRL DOCUMENT v3.20.4

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives for Property and Equipment (Details)
12 Months Ended

Dec. 31, 2020

Laboratory Equipment

Property Plant And Equipment [Line Items]

Estimated useful life 3 years

Furniture and Fixtures

Property Plant And Equipment [Line Items]

Estimated useful life 3 years

Computer Equipment

Property Plant And Equipment [Line Items]

Estimated useful life 3 years

Leasehold Improvements

Property Plant And Equipment [Line Items]

Estimated useful life Lesser of estimated useful life or remaining lease term

X

- Definition
Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 35
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=caba_LaboratoryEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R34.htm IDEA: XBRL DOCUMENT v3.20.4

Fair Value Measurements - Financial Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands

Dec. 31, 2020

Dec. 31, 2019

Short-term investments:

Short-term investments $ 7,233

Fair Value, Measurements, Recurring

Financial assets

Total 108,662 $ 136,204

Fair Value, Measurements, Recurring | Money Market Funds

Cash and cash equivalents:

Money market funds 101,429 136,204

Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)

Financial assets

Total 101,429 136,204

Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money Market Funds

Cash and cash equivalents:

Money market funds 101,429 $ 136,204

Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)

Financial assets

Total 7,233

Fair Value, Measurements, Recurring | Short-term Investments - Corporate Bonds

Short-term investments:

Short-term investments 7,233

Fair Value, Measurements, Recurring | Short-term Investments - Corporate Bonds | Significant Other Observable Inputs (Level 2)

Short-term investments:

Short-term investments $ 7,233

X

- Definition
Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(4))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(g))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R35.htm IDEA: XBRL DOCUMENT v3.20.4

Fair Value Measurements - Additional Information (Details) - USD ($)
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Fair Value Disclosures [Abstract]

Fair value, assets, level 1 to level 2 transfers, amount $ 0 $ 0

Fair value, assets, level 2 to level 1 transfers, amount 0 0

Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net 0 0

Available-for-sale securities $ 108,662,000 $ 0

X

- Definition
Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 68 R36.htm IDEA: XBRL DOCUMENT v3.20.4

Fair Value Measurements - Schedule of Debt Securities Classified as Available-for-Sale Investments (Details) - USD ($)

Dec. 31, 2020

Dec. 31, 2019

Schedule Of Available For Sale Securities [Line Items]

Amortized Cost $ 108,656,000

Gross Unrealized Gains 6,000

Fair value 108,662,000 $ 0

Money Market Funds Included in Cash and Cash Equivalents

Schedule Of Available For Sale Securities [Line Items]

Amortized Cost 101,429,000

Fair value 101,429,000

Corporate Bonds - due in One Year or Less

Schedule Of Available For Sale Securities [Line Items]

Amortized Cost 7,227,000

Gross Unrealized Gains 6,000

Fair value $ 7,233,000

X

- Definition
Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454
+ Details

Name: us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 69 R37.htm IDEA: XBRL DOCUMENT v3.20.4

Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) - USD ($)
$ in Thousands

Dec. 31, 2020

Dec. 31, 2019

Property Plant And Equipment [Line Items]

Total property, plant and equipment $ 1,348 $ 919

Less: accumulated depreciation (458) (104)

Property, plant and equipment, net 890 815

Laboratory Equipment

Property Plant And Equipment [Line Items]

Total property, plant and equipment 961 544

Furniture and Fixtures

Property Plant And Equipment [Line Items]

Total property, plant and equipment 277 277

Leasehold Improvements

Property Plant And Equipment [Line Items]

Total property, plant and equipment 57 57

Computer Equipment

Property Plant And Equipment [Line Items]

Total property, plant and equipment $ 53 $ 41

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R38.htm IDEA: XBRL DOCUMENT v3.20.4

Property, Plant and Equipment - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Property Plant And Equipment [Abstract]

Depreciation expense $ 354 $ 104

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 71 R39.htm IDEA: XBRL DOCUMENT v3.20.4

Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands

Dec. 31, 2020

Dec. 31, 2019

Payables And Accruals [Abstract]

Research and development services $ 1,294 $ 231

General and administrative services 160 297

Compensation expense 2,445 1,522

Other 38 177

Accrued and other current liabilities $ 3,937 $ 2,227

X

- Definition
Accrued general and administrative services current.
+ References
No definition available.
+ Details

Name: caba_AccruedGeneralAndAdministrativeServicesCurrent

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accrued liabilities and other liabilities current.
+ References
No definition available.
+ Details

Name: caba_AccruedLiabilitiesAndOtherLiabilitiesCurrent

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accrued research and development services current.
+ References
No definition available.
+ Details

Name: caba_AccruedResearchAndDevelopmentServicesCurrent

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_PayablesAndAccrualsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 72 R40.htm IDEA: XBRL DOCUMENT v3.20.4

Collaborations, Licensing Agreements and other Agreements - Additional Information (Details)
1 Months Ended 12 Months Ended

May 31, 2020

USD ($)

Dec. 31, 2020

USD ($)

Faculty

Dec. 31, 2019

USD ($)

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Research and development expense $ 21,376,000 $ 11,671,000

License Agreement

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Obligation to be paid $ 2,000,000

Payment term 3 years

Payment commencement date 2018-08

License maintenance fee $ 33,000 $ 10,000

Total milestone payments 21,000,000

Amounts due to agreement 0

Sponsored Research Agreements | Penn

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Obligation to be paid $ 11,781,000

Number of faculty member | Faculty 2

Funding term end date 2023-02

Cost incurred $ 7,090,000

Research and development expense 2,995,000 2,137,000

Sponsored Research Agreements | Penn | Prepaid Expenses and Other Current Assets

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Advance payments 1,851,000 1,588,000

Sponsored Research Agreements | Penn | Accrued and Other Current Liabilities

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Obligation to be paid 217,000

Master Translational Research Services Agreement

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Research and development expense 2,474,000 2,355,000

Maximum research and development additional expense incurred 1,360,000

Subscription and Technology Transfer Agreement

Collaborations, Licensing Agreements And Other Agreements [Line Items]

Expense related to agreement $ 0 $ 250,000

X

- Definition
Advance payments.
+ References
No definition available.
+ Details

Name: caba_AdvancePayments

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Collaborations licensing agreements and other agreements.
+ References
No definition available.
+ Details

Name: caba_CollaborationsLicensingAgreementsAndOtherAgreementsLineItems

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Collaborative agreement payments due.
+ References
No definition available.
+ Details

Name: caba_CollaborativeAgreementPaymentsDue

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual cost incurred.
+ References
No definition available.
+ Details

Name: caba_ContractualCostIncurred

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Contractual expenses.
+ References
No definition available.
+ Details

Name: caba_ContractualExpenses

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Funding term ending date.
+ References
No definition available.
+ Details

Name: caba_FundingTermEndingDate

Namespace Prefix: caba_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition
License maintenance fee.
+ References
No definition available.
+ Details

Name: caba_LicenseMaintenanceFee

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Maximum research and development additional expense due in remaining term.
+ References
No definition available.
+ Details

Name: caba_MaximumResearchAndDevelopmentAdditionalExpenseDueInRemainingTerm

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Milestone payments.
+ References
No definition available.
+ Details

Name: caba_MilestonePayments

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of faculty.
+ References
No definition available.
+ Details

Name: caba_NumberOfFaculty

Namespace Prefix: caba_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Obligation to be paid, commencement date.
+ References
No definition available.
+ Details

Name: caba_ObligationToBePaidCommencementDate

Namespace Prefix: caba_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition
Payment of obligation, term.
+ References
No definition available.
+ Details

Name: caba_PaymentOfObligationTerm

Namespace Prefix: caba_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.
+ References
No definition available.
+ Details

Name: us-gaap_ContractualObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_LicenseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_SponsoredResearchAgreementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=caba_RegentsOfUniversityOfCaliforniaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=caba_AccruedAndOtherCurrentLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_MasterTranslationalResearchServicesAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_SubscriptionAndTechnologyTransferAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R41.htm IDEA: XBRL DOCUMENT v3.20.4

Commitments and Contingencies - Additional Information (Details) - Operating Lease Agreement - USD ($)
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Commitments and Contingencies [Line Items]

Operating lease, description The lease term commenced in May 2019 and will expire in July 2022.

Lease commencement period 2019-05

Lease expiration period 2022-07

Initial annual base rent $ 261,000

Percentage of annual increase of base rent 2.00%

Rent expense $ 266,000 $ 178,000

X

- Definition
Annual increase percentage of base rent.
+ References
No definition available.
+ Details

Name: caba_AnnualIncreasePercentageOfBaseRent

Namespace Prefix: caba_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Commitments and contingencies disclosure.
+ References
No definition available.
+ Details

Name: caba_CommitmentsAndContingenciesDisclosureLineItems

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Lease commencement month and year.
+ References
No definition available.
+ Details

Name: caba_LeaseCommencementMonthAndYear

Namespace Prefix: caba_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition
Lease expiration month and year.
+ References
No definition available.
+ Details

Name: caba_LeaseExpirationMonthAndYear

Namespace Prefix: caba_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition
Rent expense.
+ References
No definition available.
+ Details

Name: caba_RentExpense

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Description of lessee's operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 25
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121595440&loc=d3e34039-112682

Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717
+ Details

Name: us-gaap_OperatingLeasesRentExpenseMinimumRentals

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_OperatingLeaseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R42.htm IDEA: XBRL DOCUMENT v3.20.4

Commitments and Contingencies - Schedule of Future Minimum Payments for Operating Leases (Details)
$ in Thousands

Dec. 31, 2020

USD ($)

Commitments And Contingencies Disclosure [Abstract]

2021 $ 268

2022 158

Total $ 426

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of lessee's undiscounted obligation for lease payment for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 75 R43.htm IDEA: XBRL DOCUMENT v3.20.4

Convertible Preferred Stock - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended

Oct. 31, 2019

Jan. 31, 2019

Dec. 31, 2019

Dec. 31, 2020

Dec. 31, 2018

Temporary Equity [Line Items]

Preferred stock, authorized shares 10,000,000 10,000,000

Preferred stock, issued shares 0 0

Preferred stock, outstanding shares 0 0

Convertible preferred stock, authorized shares 20,762,168

Gross proceeds from convertible preferred stock $ 50,000

Preferred stock exchange including deemed dividend $ (5,326)

Convertible preferred stock convert into common stock 12,904,534

Convertible preferred stock convert into non-voting common stock 6,409,519

Series B Preferred Stock

Temporary Equity [Line Items]

Issuance, shares 6,963,788 6,963,788

Gross proceeds from convertible preferred stock $ 50,000

Number of preferred shares in exchange 1,405,332 1,405,332

Preferred stock exchange including deemed dividend $ (10,090) $ (10,090)

Series A-2 Preferred

Temporary Equity [Line Items]

Number of preferred shares in exchange (1,405,332) (1,405,332)

Preferred stock exchange including deemed dividend $ (4,764) $ 4,764

Convertible preferred stock, outstanding shares 1,873,777

Convertible Preferred Stock

Temporary Equity [Line Items]

Issuance, shares 6,963,788

Preferred stock exchange including deemed dividend $ (5,326)

Convertible preferred stock, outstanding shares 0 0 12,393,047

X

- Definition
Convertible preferred stock convert into non-voting common stock.
+ References
No definition available.
+ Details

Name: caba_ConvertiblePreferredStockConvertIntoNonVotingCommonStock

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Convertible preferred stock convert into voting common stock.
+ References
No definition available.
+ Details

Name: caba_ConvertiblePreferredStockConvertIntoVotingCommonStock

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity shares exchange including deemed dividend.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquitySharesExchangeIncludingDeemedDividend

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity stock issued during period, shares, new issues.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity value exchange including deemed dividend.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityValueExchangeIncludingDeemedDividend

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27)(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_TemporaryEquitySharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27)(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_TemporaryEquitySharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=caba_SeriesA2PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 76 R44.htm IDEA: XBRL DOCUMENT v3.20.4

Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended

Jan. 31, 2019

Dec. 31, 2019

Temporary Equity [Line Items]

Exchange, including deemed dividend $ 5,326

Series A Preferred

Temporary Equity [Line Items]

Beginning balance $ 12,575 $ 12,575

Beginning balance, Shares 3,146,551 3,146,551

Conversion to common stock $ (12,575)

Conversion to common stock, shares (3,146,551)

Series A-1 Preferred

Temporary Equity [Line Items]

Beginning balance $ 24,994 $ 24,994

Beginning balance, Shares 7,372,719 7,372,719

Conversion to common stock $ (24,994)

Conversion to common stock, shares (7,372,719)

Series A-2 Preferred

Temporary Equity [Line Items]

Beginning balance $ 6,352 $ 6,352

Beginning balance, Shares 1,873,777 1,873,777

Exchange, including deemed dividend $ 4,764 $ (4,764)

Exchange, including deemed dividend, Shares (1,405,332) (1,405,332)

Conversion to common stock $ (1,588)

Conversion to common stock, shares (468,445)

Series B Preferred Stock

Temporary Equity [Line Items]

Issuance $ 50,000

Issuance, shares 6,963,788 6,963,788

Exchange, including deemed dividend $ 10,090 $ 10,090

Exchange, including deemed dividend, Shares 1,405,332 1,405,332

Issuance costs $ (1,293)

Conversion to common stock $ (58,797)

Conversion to common stock, shares (8,369,120)

Convertible Preferred Stock

Temporary Equity [Line Items]

Beginning balance $ 43,921 $ 43,921

Beginning balance, Shares 12,393,047 12,393,047

Issuance $ 50,000

Issuance, shares 6,963,788

Exchange, including deemed dividend $ 5,326

Issuance costs (1,293)

Conversion to common stock $ (97,954)

Conversion to common stock, shares (19,356,835)

X

- Definition
Temporary equity conversion of stock shares for common stock.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityConversionOfStockSharesForCommonStock

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity conversion of stock value for common stock.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityConversionOfStockValueForCommonStock

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Temporary equity issuance costs.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityIssuanceCosts

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Temporary equity shares exchange including deemed dividend.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquitySharesExchangeIncludingDeemedDividend

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity stock issued during period, shares, new issues.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Temporary equity value exchange including deemed dividend.
+ References
No definition available.
+ Details

Name: caba_TemporaryEquityValueExchangeIncludingDeemedDividend

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
+ References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityCarryingAmountAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27)(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_TemporaryEquitySharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Value of new stock classified as temporary equity issued during the period.
+ References
No definition available.
+ Details

Name: us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=caba_SeriesA1PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=caba_SeriesA2PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 77 R45.htm IDEA: XBRL DOCUMENT v3.20.4

Common Stock - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended

Oct. 23, 2019

May 31, 2018

Dec. 31, 2020

Dec. 31, 2019

Aug. 31, 2020

Jan. 01, 2020

Oct. 31, 2019

Class Of Stock [Line Items]

Common stock, authorized shares 150,000,000 150,000,000

Conversion of non-voting common stock to voting common stock 1,733,904

Common stock shares modified 2,904,000

Fair value of common stock shares modified $ 0.74

Total compensation cost of common stock shares modified $ 2,126

Unrecognized compensation cost, period for recognition 3 years 2 years 9 months 18 days

Unrecognized compensation cost related to unvested stock-based awards $ 9,809

Stock Options

Class Of Stock [Line Items]

Compensation cost recognized $ 4,388 $ 2,300

Founders

Class Of Stock [Line Items]

Unrecognized compensation cost, period for recognition 3 months 18 days

Unrecognized compensation cost related to unvested stock-based awards $ 239

Research and Development | Stock Options

Class Of Stock [Line Items]

Compensation cost recognized 1,989 1,304

Research and Development | Founders

Class Of Stock [Line Items]

Compensation cost recognized 495 529

General and Administrative Expense | Stock Options

Class Of Stock [Line Items]

Compensation cost recognized 2,399 996

General and Administrative Expense | Founders

Class Of Stock [Line Items]

Compensation cost recognized 177 $ 177

At-The-Market Offering Sales Agreement

Class Of Stock [Line Items]

Issuance of common stock $ 75,000

Issuance of common stock, Shares 0

Two Thousand Eighteen Stock Option And Grant Plan | Stock Options

Class Of Stock [Line Items]

Share-based compensation unvested number of shares 0

Number of options granted 1,959,411

Two Thousand Eighteen Stock Option And Grant Plan | Stock Options | Minimum

Class Of Stock [Line Items]

Share-based compensation, vesting period 3 years

Two Thousand Eighteen Stock Option And Grant Plan | Stock Options | Maximum

Class Of Stock [Line Items]

Share-based compensation, vesting period 4 years

2019 Plan

Class Of Stock [Line Items]

Shares reserved for issuance 2,342,288 962,511

Increase in share reserved percentage 4.00%

Share-based compensation, number of shares available for grant 2,314,303

2019 Plan | Stock Options

Class Of Stock [Line Items]

Number of options granted 813,172 1,340,839

Weighted average grant-date fair value of stock options granted $ 8.31 $ 5.24

2019 ESPP

Class Of Stock [Line Items]

Compensation cost recognized $ 18

Shares reserved for issuance 234,229 234,229

2019 ESPP | Minimum

Class Of Stock [Line Items]

Shares reserved for issuance 234,229

Increase in share reserved percentage 1.00%

2019 ESPP | Maximum

Class Of Stock [Line Items]

Payroll deduction percentage of eligible compensation 15.00%

Employee stock purchase plan maximum annual rights to purchase common stock $ 25

Percentage of shares to be purchased 85.00%

Voting Common Stock

Class Of Stock [Line Items]

Common stock, authorized shares 143,590,481 143,590,481 143,590,481

Non-voting Common Stock

Class Of Stock [Line Items]

Common stock, authorized shares 6,409,519 6,409,519 6,409,519

X

- Definition
Conversion of non voting common stock to voting common stock shares converted.
+ References
No definition available.
+ Details

Name: caba_ConversionOfNonVotingCommonStockToVotingCommonStockSharesConverted

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Employee stock purchase plan maximum annual rights to purchase common stock.
+ References
No definition available.
+ Details

Name: caba_EmployeeStockPurchasePlanMaximumAnnualRightsToPurchaseCommonStock

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Increase in share reserved percentage.
+ References
No definition available.
+ Details

Name: caba_IncreaseInShareReservedPercentage

Namespace Prefix: caba_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of payroll deduction on eligible compensation.
+ References
No definition available.
+ Details

Name: caba_PercentageOfPayrollDeductionOnEligibleCompensation

Namespace Prefix: caba_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of shares purchased at fair market value of common stock.
+ References
No definition available.
+ Details

Name: caba_PercentageOfSharesPurchasedAtFairMarketValueOfCommonStock

Namespace Prefix: caba_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Share based compensation arrangement by share based payment award common stock shares modified
+ References
No definition available.
+ Details

Name: caba_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonStockSharesModified

Namespace Prefix: caba_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share based compensation arrangement by share based payment award common stock shares modified fair value.
+ References
No definition available.
+ Details

Name: caba_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommonStockSharesModifiedFairValue

Namespace Prefix: caba_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share based compensation arrangement by share based payment award modified common stock shares compensation cost.
+ References
No definition available.
+ Details

Name: caba_ShareBasedCompensationArrangementByShareBasedPaymentAwardModifiedCommonStockSharesCompensationCost

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ClassOfStockLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of cost not yet recognized for nonvested award under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=caba_FoundersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=caba_AtTheMarketOfferingSalesAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=caba_TwoThousandEighteenStockOptionAndGrantPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=caba_TwoThousandNineteenStockOptionAndIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=caba_TwoThousandNineteenEmployeeStockPurchasePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=caba_VotingCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 78 R46.htm IDEA: XBRL DOCUMENT v3.20.4

Common Stock - Summary of Stock Option Activity (Details) - Stock Options - 2019 Plan - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Number of Shares

Number of Shares, Beginning Balance 2,129,632 971,353

Number of Shares, Granted 813,172 1,340,839

Number of Shares, Exercised (25,611) (5,667)

Number of shares, Forfeited/Cancelled (16,714) (176,893)

Number of Shares, Ending Balance 2,900,479 2,129,632 971,353

Number of Shares, Options Exercisable 1,068,675

Weighted Average Exercise Price

Weighted Average Exercise Price, Beginning Balance $ 5.12 $ 1.01

Weighted Average Exercise Price, Granted 13.03 7.97

Weighted Average Exercise Price, Exercised 5.44 1.01

Weighted Average Exercise Price, Forfeited/Cancelled 6.30 4.22

Weighted Average Exercise Price, Ending Balance 7.33 $ 5.12 $ 1.01

Weighted Average Exercise Price, Options Exercisable $ 4.04

Weighted Average Remaining Contractual Term (years)

Term (years) 8 years 6 months 9 years 2 months 12 days 9 years 9 months 18 days

Weighted Average Remaining Contractual Term (years), Options Exercisable 8 years 1 month 6 days

Aggregate Intrinsic Value

Aggregate Intrinsic Value, Beginning Balance $ 18,844 $ 4,051

Aggregate Intrinsic Value, Exercised 183

Aggregate Intrinsic Value, Ending Balance 16,303 $ 18,844 $ 4,051

Aggregate Intrinsic Value, Options Exercisable $ 9,059

X

- Definition
Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value.
+ References
No definition available.
+ Details

Name: caba_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term.
+ References
No definition available.
+ Details

Name: caba_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=caba_TwoThousandNineteenStockOptionAndIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R47.htm IDEA: XBRL DOCUMENT v3.20.4

Common Stock - Schedule of Assumptions Used to Estimate Fair Value of Stock Options (Details)
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Risk-free interest rate, minimum 0.28% 1.39%

Risk-free interest rate, maximum 1.48% 2.59%

Expected volatility, minimum 70.00% 70.00%

Expected volatility, maximum 79.00% 76.00%

Expected dividend yield 0.00% 0.00%

Minimum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Expected term 5 years 8 months 12 days 3 months 18 days

Maximum

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Expected term 6 years 1 month 6 days 6 years 1 month 6 days

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 80 R48.htm IDEA: XBRL DOCUMENT v3.20.4

Common Stock - Summary of Stock-Based Compensation (Details) - Stock Options - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Stock-based compensation $ 4,388 $ 2,300

Research and Development

Stock-based compensation 1,989 1,304

General and Administrative Expense

Stock-based compensation $ 2,399 $ 996

X

- Definition
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R49.htm IDEA: XBRL DOCUMENT v3.20.4

Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details)
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Expected income tax benefit at the federal statutory rate 21.00% 21.00%

State and local taxes, net of federal benefit 12.50% 13.10%

Research and development credit, net 2.60% 2.30%

Non-deductible items and other (0.80%) (3.30%)

Change in valuation allowance (35.30%) (33.10%)

Total 0.00% 0.00%

X

- Definition
Effective income tax rate reconciliation nondeductible items and other.
+ References
No definition available.
+ Details

Name: caba_EffectiveIncomeTaxRateReconciliationNondeductibleItemsAndOther

Namespace Prefix: caba_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.Fact.4)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.Fact.4)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.Fact.4)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.Fact.4)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 82 R50.htm IDEA: XBRL DOCUMENT v3.20.4

Income Taxes - Summary of Principal Components of Company's Deferred Tax Assets (Details) - USD ($)
$ in Thousands

Dec. 31, 2020

Dec. 31, 2019

Deferred tax assets:

Federal, state and local net operating loss carryforwards $ 15,241 $ 5,688

License fee deductions 340 362

Research and development tax credits 1,317 452

Stock-based compensation deductions 1,243 264

Accrued expenses 837 457

Gross deferred tax assets 18,978 7,223

Less: valuation allowance (18,978) (7,223)

Deferred tax liabilities:

Net deferred tax assets $ 0 $ 0

X

- Definition
Deferred tax assets license fees deductions.
+ References
No definition available.
+ Details

Name: caba_DeferredTaxAssetsLicenseFeesDeductions

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 83 R51.htm IDEA: XBRL DOCUMENT v3.20.4

Income Taxes - Additional Information (Details) - USD ($)
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Income Tax Disclosure [Line Items]

Increase in valuation allowance $ 11,755,000

Deferred tax assets operating loss carryforwards federal 45,550,000

Deferred tax assets operating loss carryforwards state 47,735,000

Deferred tax assets operating loss carryforwards local 38,645,000

Deferred tax assets, operating loss carryforwards, not subject to expiration 45,301,000

Deferred tax assets, operating loss carryforwards, subject to expiration $ 249,000

Operating loss carryforwards federal commencement of expiration date 2037

Operating loss carryforwards state commencement of expiration date 2037

Operating loss carryforwards local commencement of expiration date 2039

Research and development tax credits $ 1,317,000 $ 452,000

Open tax year 2017 2018 2019

Percentage of eligible tax positions for recognition 50.00%

Unrecognized income tax benefits that would affect effective tax rate $ 0

Federal

Income Tax Disclosure [Line Items]

Research and development tax credits $ 1,317,000

Deferred tax assets tax credit carryforwards commencement of expiration date 2038

X

- Definition
Deferred tax assets operating loss carryforwards federal.
+ References
No definition available.
+ Details

Name: caba_DeferredTaxAssetsOperatingLossCarryforwardsFederal

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Deferred tax assets operating loss carryforwards local.
+ References
No definition available.
+ Details

Name: caba_DeferredTaxAssetsOperatingLossCarryforwardsLocal

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Deferred tax assets operating loss carryforwards state.
+ References
No definition available.
+ Details

Name: caba_DeferredTaxAssetsOperatingLossCarryforwardsState

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Deferred tax assets tax credit carryforwards commencement of expiration date.
+ References
No definition available.
+ Details

Name: caba_DeferredTaxAssetsTaxCreditCarryforwardsCommencementOfExpirationDate

Namespace Prefix: caba_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Income tax disclosure.
+ References
No definition available.
+ Details

Name: caba_IncomeTaxDisclosureLineItems

Namespace Prefix: caba_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating loss carryforwards federal commencement of expiration date.
+ References
No definition available.
+ Details

Name: caba_OperatingLossCarryforwardsFederalCommencementOfExpirationDate

Namespace Prefix: caba_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating loss carryforwards local commencement of expiration date.
+ References
No definition available.
+ Details

Name: caba_OperatingLossCarryforwardsLocalCommencementOfExpirationDate

Namespace Prefix: caba_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Operating loss carryforwards state commencement of expiration date.
+ References
No definition available.
+ Details

Name: caba_OperatingLossCarryforwardsStateCommencementOfExpirationDate

Namespace Prefix: caba_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of eligible tax positions for recognition.
+ References
No definition available.
+ Details

Name: caba_PercentageOfEligibleTaxPositionsForRecognition

Namespace Prefix: caba_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Tax year that remains open to examination under enacted tax laws, in CCYY format.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_OpenTaxYear

Namespace Prefix: us-gaap_

Data Type: us-types:gYearListItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=caba_FederalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 84 R52.htm IDEA: XBRL DOCUMENT v3.20.4

Net Loss Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Voting Common Stock

Basic net loss per share:

Allocation of undistributed losses attributable to common stockholders $ (25,090) $ (17,693)

Weighted average number of shares used in basic per share computation 17,417,900 4,345,530

Net loss per share, basic $ (1.44) $ (4.07)

Diluted net loss per share:

Allocation of undistributed losses for basic computation $ (25,090) $ (17,693)

Reallocation of undistributed losses as a result of conversion of non-voting to voting common shares (8,249) (4,576)

Allocation of undistributed losses $ (33,339) $ (22,269)

Weighted average number of shares used in basic per share computation 17,417,900 4,345,530

Add: Conversion of non-voting to voting common shares outstanding 5,727,327 1,123,861

Weighted average number of shares used in diluted per share computation 23,145,227 5,469,391

Net loss per share, diluted $ (1.44) $ (4.07)

Non-voting Common Stock

Basic net loss per share:

Allocation of undistributed losses attributable to common stockholders $ (8,249) $ (4,576)

Weighted average number of shares used in basic per share computation 5,727,327 1,123,861

Net loss per share, basic $ (1.44) $ (4.07)

Diluted net loss per share:

Allocation of undistributed losses for basic computation $ (8,249) $ (4,576)

Allocation of undistributed losses $ (8,249) $ (4,576)

Weighted average number of shares used in basic per share computation 5,727,327 1,123,861

Weighted average number of shares used in diluted per share computation 5,727,327 1,123,861

Net loss per share, diluted $ (1.44) $ (4.07)

X

- Definition
Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.
+ References
No definition available.
+ Details

Name: us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 65
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 66
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256
+ Details

Name: us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.
+ References
Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 65
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 66
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256
+ Details

Name: us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of undistributed earnings (loss) allocated to common stock as if earnings had been distributed. Excludes distributed earnings.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 66
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256
+ Details

Name: us-gaap_UndistributedEarningsLossAvailableToCommonShareholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=caba_VotingCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_NonvotingCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 85 R53.htm IDEA: XBRL DOCUMENT v3.20.4

Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]

Antidilutive shares have been excluded from calculation of diluted net loss per share 3,366,280 3,518,609

Stock Options to Purchase Common Stock

Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]

Antidilutive shares have been excluded from calculation of diluted net loss per share 2,900,479 2,129,632

Non-vested Common Stock

Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]

Antidilutive shares have been excluded from calculation of diluted net loss per share 465,801 1,388,977

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=caba_NonVestedCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 86 R54.htm IDEA: XBRL DOCUMENT v3.20.4

401 (k) Savings Plan - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Compensation And Retirement Disclosure [Abstract]

Defined contribution plan, contribution amount $ 203 $ 74

Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 3.00%

Defined Contribution Plan, Employer Matching Contribution, Percent of Match 4.00%

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cost for defined contribution plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942
+ Details

Name: us-gaap_DefinedContributionPlanCostRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage employer matches of the employee's percentage contribution matched.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

XML 87 R55.htm IDEA: XBRL DOCUMENT v3.20.4

Subsequent Events - Additional Information (Details) - Subsequent Events - USD ($)
$ in Thousands
1 Months Ended

Feb. 28, 2021

Jan. 31, 2021

WuXi Advanced Therapies | Wuxi Agreement

Subsequent Event [Line Items]

Early termination fee $ 1,500

CHOP | Research Service Agreement

Subsequent Event [Line Items]

Total cost $ 670

X

- Definition
Expected research service agreement cost.
+ References
No definition available.
+ Details

Name: caba_ExpectedResearchServiceAgreementCost

Namespace Prefix: caba_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of early contract termination fees included in liabilities subject to compromise.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56145-112766

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=116635682&loc=d3e55717-112764

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120604989&loc=d3e56015-112765
+ Details

Name: us-gaap_LiabilitiesSubjectToCompromiseEarlyContractTerminationFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: srt_CounterpartyNameAxis=caba_WuXiAdvancedTherapiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_DevelopmentAndManufacturingServicesAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CounterpartyNameAxis=caba_ChildrenSHospitalOfPhiladelphiaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SupplyCommitmentAxis=caba_ResearchServiceAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 89 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 147 359 1 false 50 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Balance Sheets Sheet http://www.cabalettabio.com/20201231/taxonomy/role/StatementBalanceSheets Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Balance Sheets (Parenthetical) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Statements of Operations and Comprehensive Loss Sheet http://www.cabalettabio.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity Sheet http://www.cabalettabio.com/20201231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersDeficitEquity Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity Statements 5 false false R6.htm 100050 - Statement - Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Parenthetical) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/StatementStatementsOfConvertiblePreferredStockAndStockholdersDeficitEquityParenthetical Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Statements of Cash Flows Sheet http://www.cabalettabio.com/20201231/taxonomy/role/StatementStatementsOfCashFlows Statements of Cash Flows Statements 7 false false R8.htm 100070 - Disclosure - Basis of Presentation Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureBasisOfPresentation Basis of Presentation Notes 8 false false R9.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Fair Value Measurements Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100100 - Disclosure - Property, Plant and Equipment Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosurePropertyPlantAndEquipment Property, Plant and Equipment Notes 11 false false R12.htm 100110 - Disclosure - Accrued and Other Current Liabilities Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilities Accrued and Other Current Liabilities Notes 12 false false R13.htm 100120 - Disclosure - Collaborations, Licensing Agreements and other Agreements Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCollaborationsLicensingAgreementsAndOtherAgreements Collaborations, Licensing Agreements and other Agreements Notes 13 false false R14.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100140 - Disclosure - Convertible Preferred Stock Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureConvertiblePreferredStock Convertible Preferred Stock Notes 15 false false R16.htm 100150 - Disclosure - Common Stock Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStock Common Stock Notes 16 false false R17.htm 100160 - Disclosure - Income Taxes Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 17 false false R18.htm 100170 - Disclosure - Net Loss Per Share Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 18 false false R19.htm 100180 - Disclosure - 401(k) Savings Plan Sheet http://www.cabalettabio.com/20201231/taxonomy/role/Disclosure401KSavingsPlan 401(k) Savings Plan Notes 19 false false R20.htm 100190 - Disclosure - Subsequent Events Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 20 false false R21.htm 100200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 100210 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 100220 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureFairValueMeasurements 23 false false R24.htm 100230 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosurePropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosurePropertyPlantAndEquipment 24 false false R25.htm 100240 - Disclosure - Accrued and Other Current Liabilities (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesTables Accrued and Other Current Liabilities (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilities 25 false false R26.htm 100250 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingencies 26 false false R27.htm 100260 - Disclosure - Convertible Preferred Stock (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureConvertiblePreferredStockTables Convertible Preferred Stock (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureConvertiblePreferredStock 27 false false R28.htm 100270 - Disclosure - Common Stock (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStockTables Common Stock (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStock 28 false false R29.htm 100280 - Disclosure - Income Taxes (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureIncomeTaxes 29 false false R30.htm 100290 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureNetLossPerShare 30 false false R31.htm 100300 - Disclosure - Basis of Presentation - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformationDetails Basis of Presentation - Additional Information (Details) Details 31 false false R32.htm 100310 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 32 false false R33.htm 100320 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives for Property and Equipment (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives for Property and Equipment (Details) Details 33 false false R34.htm 100330 - Disclosure - Fair Value Measurements - Financial Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Financial Assets Measured at Fair Value on Recurring Basis (Details) Details 34 false false R35.htm 100340 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 35 false false R36.htm 100350 - Disclosure - Fair Value Measurements - Schedule of Debt Securities Classified as Available-for-Sale Investments (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfDebtSecuritiesClassifiedAsAvailableForSaleInvestmentsDetails Fair Value Measurements - Schedule of Debt Securities Classified as Available-for-Sale Investments (Details) Details 36 false false R37.htm 100360 - Disclosure - Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentDetails Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) Details 37 false false R38.htm 100370 - Disclosure - Property, Plant and Equipment - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails Property, Plant and Equipment - Additional Information (Details) Details 38 false false R39.htm 100380 - Disclosure - Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfAccruedAndOtherCurrentLiabilitiesDetails Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) Details 39 false false R40.htm 100390 - Disclosure - Collaborations, Licensing Agreements and other Agreements - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCollaborationsLicensingAgreementsAndOtherAgreementsAdditionalInformationDetails Collaborations, Licensing Agreements and other Agreements - Additional Information (Details) Details 40 false false R41.htm 100400 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 41 false false R42.htm 100410 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments for Operating Leases (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumPaymentsForOperatingLeasesDetails Commitments and Contingencies - Schedule of Future Minimum Payments for Operating Leases (Details) Details 42 false false R43.htm 100420 - Disclosure - Convertible Preferred Stock - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetails Convertible Preferred Stock - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureConvertiblePreferredStockSummaryOfConvertiblePreferredStockDetails Convertible Preferred Stock - Summary of Convertible Preferred Stock (Details) Details 44 false false R45.htm 100440 - Disclosure - Common Stock - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails Common Stock - Additional Information (Details) Details 45 false false R46.htm 100450 - Disclosure - Common Stock - Summary of Stock Option Activity (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStockSummaryOfStockOptionActivityDetails Common Stock - Summary of Stock Option Activity (Details) Details 46 false false R47.htm 100460 - Disclosure - Common Stock - Schedule of Assumptions Used to Estimate Fair Value of Stock Options (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStockScheduleOfAssumptionsUsedToEstimateFairValueOfStockOptionsDetails Common Stock - Schedule of Assumptions Used to Estimate Fair Value of Stock Options (Details) Details 47 false false R48.htm 100470 - Disclosure - Common Stock - Summary of Stock-Based Compensation (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureCommonStockSummaryOfStockBasedCompensationDetails Common Stock - Summary of Stock-Based Compensation (Details) Details 48 false false R49.htm 100480 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToCompanySEffectiveIncomeTaxRateDetails Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details) Details 49 false false R50.htm 100490 - Disclosure - Income Taxes - Summary of Principal Components of Company's Deferred Tax Assets (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfPrincipalComponentsOfCompanySDeferredTaxAssetsDetails Income Taxes - Summary of Principal Components of Company's Deferred Tax Assets (Details) Details 50 false false R51.htm 100500 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 51 false false R52.htm 100510 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails Net Loss Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) Details 52 false false R53.htm 100520 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails Net Loss Per Share - Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share (Details) Details 53 false false R54.htm 100530 - Disclosure - 401 (k) Savings Plan - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/Disclosure401KSavingsPlanAdditionalInformationDetails 401 (k) Savings Plan - Additional Information (Details) Details http://www.cabalettabio.com/20201231/taxonomy/role/Disclosure401KSavingsPlan 54 false false R55.htm 100540 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.cabalettabio.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 55 false false All Reports Book All Reports caba-20201231.xml caba-20201231.xsd caba-20201231_cal.xml caba-20201231_def.xml caba-20201231_lab.xml caba-20201231_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 93 0001564590-21-013329-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-013329-xbrl.zip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end

	Year Ended December 31,
	2020		2019		Change
	(in thousands)
Sponsored research activities	$	3,062	$	2,228	$	834
License of intellectual property and subscription fee		143		268		(125	)
Manufacturing of preclinical and clinical supplies		4,652		2,382		2,270
Clinical trials		1,202		441		761
Personnel		7,827		4,006		3,821
Development services		4,350		2,146		2,204
Other		140		200		(60	)
	$	21,376	$	11,671	$	9,705

		Page
Report of Independent Registered Public Accounting Firm		F-2
Balance Sheets as of December 31, 2020 and 2019		F-3
Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2020 and 2019		F-4
Statements of Convertible Preferred Stock and Stockholders’ (Deficit) Equity for the Years Ended December 31, 2020 and 2019		F-5
Statements of Cash Flows for the Years Ended December 31, 2020 and 2019		F-6
Notes to Financial Statements		F-7


Property and equipment		Estimated useful life
Laboratory equipment		Three years
Furniture and fixtures		Three years
Computer equipment		Three years
Leasehold improvements		Lesser of estimated useful life or remaining lease term

	December 31, 2020
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Financial assets
Cash and cash equivalents:
Money market funds	$	101,429	$	101,429	$	—	$	—
Short-term investments:
Corporate bonds		7,233		—		7,233		—
Total	$	108,662	$	101,429	$	7,233	$	—

	December 31, 2019
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Financial assets
Cash equivalents:
Money market funds	$	136,204	$	136,204	$	—	$	—
Total	$	136,204	$	136,204	$	—	$	—

	December 31, 2020
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair value
Financial assets
Money market funds
Included in cash and cash equivalents	$	101,429	$	—	$	—	$	101,429
Corporate bonds - due in one year or less
Included in short-term investments		7,227		6		—		7,233
Total	$	108,656	$	6	$	—	$	108,662

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2020	Mar. 10, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Trading Symbol	CABA
Entity Registrant Name	CABALETTA BIO, INC.
Entity Current Reporting Status	Yes
Entity Central Index Key	0001759138
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Common Stock, Shares Outstanding		24,062,775
Entity Public Float			$ 214
Entity File Number	001-39103
Entity Tax Identification Number	82-1685768
Entity Address, Address Line One	2929 Arch Street
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19104
City Area Code	267
Local Phone Number	759-3100
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock, par value $0.00001 per share
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	DE
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant’s definitive Proxy Statement for its 2021 annual meeting of shareholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year end of December 31, 2020. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.

Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 101,429	$ 136,204
Short-term investments	7,233
Prepaid expenses and other current assets	4,873	4,348
Total current assets	113,535	140,552
Property, plant and equipment, net	890	815
Other assets	299	101
Total Assets	114,724	141,468
Current liabilities:
Accounts payable	1,243	920
Accrued and other current liabilities	3,937	2,227
Total current liabilities	5,180	3,147
Commitments and contingencies (see Note 7)
Stockholders’ equity:
Preferred stock, $0.00001 par value: 10,000,000 shares authorized as of December 31, 2020 and 2019, respectively; no shares issued or outstanding at December 31, 2020 and 2019, respectively
Voting and non-voting common stock, $0.00001 par value: 150,000,000 (143,590,481 voting and 6,409,519 non-voting) shares authorized as of December 31, 2020 and 2019, respectively; 24,062,775 (19,387,160 voting and 4,675,615 non-voting) shares issued and outstanding as of December 31, 2020 and 24,034,022 (17,624,503 voting and 6,409,519 non-voting) issued and outstanding as of December 31, 2019, respectively	0	0
Additional paid-in capital	175,836	171,280
Accumulated other comprehensive income	6
Accumulated deficit	(66,298)	(32,959)
Total stockholders’ equity	109,544	138,321
Total liabilities and stockholders’ equity	$ 114,724	$ 141,468

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Common stock, authorized shares	150,000,000	150,000,000
Common stock, issued shares	24,062,775	24,034,022
Common stock, outstanding shares	24,062,775	24,034,022
Voting Common Stock
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, authorized shares	143,590,481	143,590,481
Common stock, issued shares	19,387,160	17,624,503
Common stock, outstanding shares	19,387,160	17,624,503
Non-voting Common Stock
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, authorized shares	6,409,519	6,409,519
Common stock, issued shares	4,675,615	6,409,519
Common stock, outstanding shares	4,675,615	6,409,519

Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
Research and development	$ 21,376	$ 11,671
General and administrative	12,457	7,012
Total operating expenses	33,833	18,683
Loss from operations	(33,833)	(18,683)
Other income:
Interest income	494	1,740
Net loss	(33,339)	(16,943)
Deemed dividend		(5,326)
Net loss attributable to common stockholders	(33,339)	(22,269)
Other comprehensive income:
Net unrealized gain on available-for-sale investments, net of tax	6
Net comprehensive loss	$ (33,333)	$ (22,269)
Net loss per voting and non-voting share, basic and diluted	$ (1.44)	$ (4.07)

Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity - USD ($) $ in Thousands	Total	Initial Public Offering	Convertible Preferred Stock	Common Stock	Common Stock Initial Public Offering	Additional Paid-in Capital	Additional Paid-in Capital Initial Public Offering	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance at Dec. 31, 2018	$ (10,690)					$ 1,762			$ (12,452)
Beginning balance, Shares at Dec. 31, 2018			12,393,047
Beginning balance at Dec. 31, 2018			$ 43,921
Beginning balance, Shares at Dec. 31, 2018				3,848,320
Issuance of convertible preferred stock, net of issuance costs			$ 48,707
Issuance of convertible preferred stock, net of issuance cost, Shares			6,963,788
Issuance of common stock		$ 71,020					$ 71,020
Issuance of common stock, Shares					7,275,501
Issuance of common stock in conjunction with exercise of stock options	6					6
Issuance of common stock in conjunction with exercise of stock options, Shares				5,667
Exchange of convertible preferred stock, including deemed dividend	(5,326)		$ 5,326			(1,762)			(3,564)
Conversion of convertible preferred stock into common stock	97,954					97,954
Conversion of convertible preferred stock into common stock, Shares			(19,356,835)
Conversion of convertible preferred stock into common stock			$ (97,954)
Conversion of convertible preferred stock into common stock, Shares				12,904,534
Stock-based compensation	2,300					2,300
Net loss	(16,943)								(16,943)
Ending balance at Dec. 31, 2019	$ 138,321					171,280			(32,959)
Ending balance, Shares at Dec. 31, 2019			0
Ending balance, Shares at Dec. 31, 2019	24,034,022			24,034,022
Issuance of common stock in conjunction with exercise of stock options	$ 139					139
Issuance of common stock in conjunction with exercise of stock options, Shares				25,611
Issuance of common stock under employee stock purchase plan	29					29
Issuance of common stock under employee stock purchase plan, Shares				3,142
Net unrealized gains on available-for-sale securities	6							$ 6
Stock-based compensation	4,388					4,388
Net loss	(33,339)								(33,339)
Ending balance at Dec. 31, 2020	$ 109,544					$ 175,836		$ 6	$ (66,298)
Ending balance, Shares at Dec. 31, 2020			0
Ending balance, Shares at Dec. 31, 2020	24,062,775			24,062,775

Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($)
Issuance costs	$ 1,293
Convertible Preferred Stock
Issuance costs	$ 1,293
Convertible preferred stock conversion basis	1.5 for 1 basis
Initial Public Offering
Issuance costs	$ 3,408

Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
Statements of Cash Flows - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (33,339)	$ (16,943)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	4,388	2,300
Amortization of premium on investments	119
Depreciation	354	104
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(524)	(3,372)
Other assets	(198)	(101)
Accounts payable	555	246
Accrued and other current liabilities	1,875	1,721
Net cash used in operating activities	(26,770)	(16,045)
Cash flows from investing activities:
Purchases of property and equipment	(635)	(693)
Purchases of investments	(11,097)
Proceeds from maturities of investments	3,751
Net cash used in investing activities	(7,981)	(693)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	(192)	71,212
Proceeds from issuance of convertible preferred stock		50,000
Issuance costs of convertible preferred stock		(1,293)
Proceeds from issuance of common stock in connection with the exercise of stock options	139	6
Proceeds from the issuance of common stock under employee stock purchase plan	29
Net cash (used in) provided by financing activities	(24)	119,925
Net (decrease) increase in cash and cash equivalents	(34,775)	103,187
Cash and cash equivalents—beginning of year	136,204	33,017
Cash and cash equivalents—end of year	101,429	136,204
Supplemental disclosures of non-cash investing and financing activities:
Conversion of convertible preferred stock into common stock		97,954
Exchange of convertible preferred stock, including deemed dividend		10,090
Deferred offering costs in accounts payable and accrued and other current liabilities		192
Property and equipment purchases included in accounts payable	$ 20	$ 226

Basis of Presentation - Additional Information (Details) $ / shares in Units, $ in Thousands			1 Months Ended	12 Months Ended
	Oct. 29, 2019 USD ($) $ / shares shares	Oct. 16, 2019 $ / shares	Nov. 30, 2019 USD ($) shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Basis Of Presentation [Line Items]
Reverse stock split description				1-for-1.5 reverse split
Reverse stock split ratio		0.67
Common stock, par value \| $ / shares		$ 0.00001
Cash and cash equivalents and investments \| $				$ 108,662
Accumulated deficit \| $				$ (66,298)	$ (32,959)
Initial Public Offering
Basis Of Presentation [Line Items]
Issuance of common stock, shares \| shares	6,800,000
Common stock issued, per share \| $ / shares	$ 11.00
Net proceeds from initial public offering \| $	$ 66,156		$ 4,864
Conversion of convertible preferred stock to common stock \| shares	12,904,534
Number of additional common stock purchased by underwriters upon partial exercise of option \| shares			475,501

Summary of Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Dec. 31, 2020 USD ($) Segment	Dec. 31, 2019 USD ($)
Summary of Significant Accounting Policies [Line Items]
Investments maturity year	2021
Interest or penalties related to uncertain income tax benefits	$ 0
Number of operating segment \| Segment	1
Number of reportable segment \| Segment	1
Amounts due to related party	$ 13,000	$ 36,000
Professional Services
Summary of Significant Accounting Policies [Line Items]
Costs incurred under the arrangement recorded as general and administrative expense	$ 311,000	$ 601,000

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives for Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2020
Laboratory Equipment
Property Plant And Equipment [Line Items]
Estimated useful life	3 years
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Estimated useful life	3 years
Computer Equipment
Property Plant And Equipment [Line Items]
Estimated useful life	3 years
Leasehold Improvements
Property Plant And Equipment [Line Items]
Estimated useful life	Lesser of estimated useful life or remaining lease term

Fair Value Measurements - Financial Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Short-term investments:
Short-term investments	$ 7,233
Fair Value, Measurements, Recurring
Financial assets
Total	108,662	$ 136,204
Fair Value, Measurements, Recurring \| Money Market Funds
Cash and cash equivalents:
Money market funds	101,429	136,204
Fair Value, Measurements, Recurring \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Financial assets
Total	101,429	136,204
Fair Value, Measurements, Recurring \| Quoted Prices in Active Markets for Identical Assets (Level 1) \| Money Market Funds
Cash and cash equivalents:
Money market funds	101,429	$ 136,204
Fair Value, Measurements, Recurring \| Significant Other Observable Inputs (Level 2)
Financial assets
Total	7,233
Fair Value, Measurements, Recurring \| Short-term Investments - Corporate Bonds
Short-term investments:
Short-term investments	7,233
Fair Value, Measurements, Recurring \| Short-term Investments - Corporate Bonds \| Significant Other Observable Inputs (Level 2)
Short-term investments:
Short-term investments	$ 7,233

Fair Value Measurements - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Fair value, assets, level 1 to level 2 transfers, amount	$ 0	$ 0
Fair value, assets, level 2 to level 1 transfers, amount	0	0
Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net	0	0
Available-for-sale securities	$ 108,662,000	$ 0

Fair Value Measurements - Schedule of Debt Securities Classified as Available-for-Sale Investments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	$ 108,656,000
Gross Unrealized Gains	6,000
Fair value	108,662,000	$ 0
Money Market Funds Included in Cash and Cash Equivalents
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	101,429,000
Fair value	101,429,000
Corporate Bonds - due in One Year or Less
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	7,227,000
Gross Unrealized Gains	6,000
Fair value	$ 7,233,000

Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 1,348	$ 919
Less: accumulated depreciation	(458)	(104)
Property, plant and equipment, net	890	815
Laboratory Equipment
Property Plant And Equipment [Line Items]
Total property, plant and equipment	961	544
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Total property, plant and equipment	277	277
Leasehold Improvements
Property Plant And Equipment [Line Items]
Total property, plant and equipment	57	57
Computer Equipment
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 53	$ 41

Property, Plant and Equipment - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Abstract]
Depreciation expense	$ 354	$ 104

Accrued and Other Current Liabilities - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Payables And Accruals [Abstract]
Research and development services	$ 1,294	$ 231
General and administrative services	160	297
Compensation expense	2,445	1,522
Other	38	177
Accrued and other current liabilities	$ 3,937	$ 2,227

Collaborations, Licensing Agreements and other Agreements - Additional Information (Details)	1 Months Ended	12 Months Ended
	May 31, 2020 USD ($)	Dec. 31, 2020 USD ($) Faculty	Dec. 31, 2019 USD ($)
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Research and development expense		$ 21,376,000	$ 11,671,000
License Agreement
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Obligation to be paid		$ 2,000,000
Payment term		3 years
Payment commencement date		2018-08
License maintenance fee	$ 33,000	$ 10,000
Total milestone payments		21,000,000
Amounts due to agreement		0
Sponsored Research Agreements \| Penn
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Obligation to be paid		$ 11,781,000
Number of faculty member \| Faculty		2
Funding term end date		2023-02
Cost incurred		$ 7,090,000
Research and development expense		2,995,000	2,137,000
Sponsored Research Agreements \| Penn \| Prepaid Expenses and Other Current Assets
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Advance payments		1,851,000	1,588,000
Sponsored Research Agreements \| Penn \| Accrued and Other Current Liabilities
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Obligation to be paid		217,000
Master Translational Research Services Agreement
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Research and development expense		2,474,000	2,355,000
Maximum research and development additional expense incurred		1,360,000
Subscription and Technology Transfer Agreement
Collaborations, Licensing Agreements And Other Agreements [Line Items]
Expense related to agreement		$ 0	$ 250,000

Commitments and Contingencies - Additional Information (Details) - Operating Lease Agreement - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies [Line Items]
Operating lease, description	The lease term commenced in May 2019 and will expire in July 2022.
Lease commencement period	2019-05
Lease expiration period	2022-07
Initial annual base rent	$ 261,000
Percentage of annual increase of base rent	2.00%
Rent expense	$ 266,000	$ 178,000

Commitments and Contingencies - Schedule of Future Minimum Payments for Operating Leases (Details) $ in Thousands	Dec. 31, 2020 USD ($)
Commitments And Contingencies Disclosure [Abstract]
2021	$ 268
2022	158
Total	$ 426

Convertible Preferred Stock - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Oct. 31, 2019	Jan. 31, 2019	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2018
Temporary Equity [Line Items]
Preferred stock, authorized shares			10,000,000	10,000,000
Preferred stock, issued shares			0	0
Preferred stock, outstanding shares			0	0
Convertible preferred stock, authorized shares		20,762,168
Gross proceeds from convertible preferred stock			$ 50,000
Preferred stock exchange including deemed dividend		$ (5,326)
Convertible preferred stock convert into common stock	12,904,534
Convertible preferred stock convert into non-voting common stock	6,409,519
Series B Preferred Stock
Temporary Equity [Line Items]
Issuance, shares		6,963,788	6,963,788
Gross proceeds from convertible preferred stock		$ 50,000
Number of preferred shares in exchange		1,405,332	1,405,332
Preferred stock exchange including deemed dividend		$ (10,090)	$ (10,090)
Series A-2 Preferred
Temporary Equity [Line Items]
Number of preferred shares in exchange		(1,405,332)	(1,405,332)
Preferred stock exchange including deemed dividend		$ (4,764)	$ 4,764
Convertible preferred stock, outstanding shares					1,873,777
Convertible Preferred Stock
Temporary Equity [Line Items]
Issuance, shares			6,963,788
Preferred stock exchange including deemed dividend			$ (5,326)
Convertible preferred stock, outstanding shares			0	0	12,393,047

Common Stock - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	12 Months Ended
	Oct. 23, 2019	May 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Aug. 31, 2020	Jan. 01, 2020	Oct. 31, 2019
Class Of Stock [Line Items]
Common stock, authorized shares			150,000,000	150,000,000
Conversion of non-voting common stock to voting common stock					1,733,904
Common stock shares modified		2,904,000
Fair value of common stock shares modified		$ 0.74
Total compensation cost of common stock shares modified		$ 2,126
Unrecognized compensation cost, period for recognition		3 years	2 years 9 months 18 days
Unrecognized compensation cost related to unvested stock-based awards			$ 9,809
Stock Options
Class Of Stock [Line Items]
Compensation cost recognized			$ 4,388	$ 2,300
Founders
Class Of Stock [Line Items]
Unrecognized compensation cost, period for recognition			3 months 18 days
Unrecognized compensation cost related to unvested stock-based awards			$ 239
Research and Development \| Stock Options
Class Of Stock [Line Items]
Compensation cost recognized			1,989	1,304
Research and Development \| Founders
Class Of Stock [Line Items]
Compensation cost recognized			495	529
General and Administrative Expense \| Stock Options
Class Of Stock [Line Items]
Compensation cost recognized			2,399	996
General and Administrative Expense \| Founders
Class Of Stock [Line Items]
Compensation cost recognized			177	$ 177
At-The-Market Offering Sales Agreement
Class Of Stock [Line Items]
Issuance of common stock			$ 75,000
Issuance of common stock, Shares			0
Two Thousand Eighteen Stock Option And Grant Plan \| Stock Options
Class Of Stock [Line Items]
Share-based compensation unvested number of shares			0
Number of options granted			1,959,411
Two Thousand Eighteen Stock Option And Grant Plan \| Stock Options \| Minimum
Class Of Stock [Line Items]
Share-based compensation, vesting period			3 years
Two Thousand Eighteen Stock Option And Grant Plan \| Stock Options \| Maximum
Class Of Stock [Line Items]
Share-based compensation, vesting period			4 years
2019 Plan
Class Of Stock [Line Items]
Shares reserved for issuance	2,342,288					962,511
Increase in share reserved percentage	4.00%
Share-based compensation, number of shares available for grant			2,314,303
2019 Plan \| Stock Options
Class Of Stock [Line Items]
Number of options granted			813,172	1,340,839
Weighted average grant-date fair value of stock options granted			$ 8.31	$ 5.24
2019 ESPP
Class Of Stock [Line Items]
Compensation cost recognized			$ 18
Shares reserved for issuance	234,229					234,229
2019 ESPP \| Minimum
Class Of Stock [Line Items]
Shares reserved for issuance	234,229
Increase in share reserved percentage	1.00%
2019 ESPP \| Maximum
Class Of Stock [Line Items]
Payroll deduction percentage of eligible compensation			15.00%
Employee stock purchase plan maximum annual rights to purchase common stock			$ 25
Percentage of shares to be purchased			85.00%
Voting Common Stock
Class Of Stock [Line Items]
Common stock, authorized shares			143,590,481	143,590,481			143,590,481
Non-voting Common Stock
Class Of Stock [Line Items]
Common stock, authorized shares			6,409,519	6,409,519			6,409,519

Common Stock - Schedule of Assumptions Used to Estimate Fair Value of Stock Options (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate, minimum	0.28%	1.39%
Risk-free interest rate, maximum	1.48%	2.59%
Expected volatility, minimum	70.00%	70.00%
Expected volatility, maximum	79.00%	76.00%
Expected dividend yield	0.00%	0.00%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term	5 years 8 months 12 days	3 months 18 days
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term	6 years 1 month 6 days	6 years 1 month 6 days

Income Taxes - Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Expected income tax benefit at the federal statutory rate	21.00%	21.00%
State and local taxes, net of federal benefit	12.50%	13.10%
Research and development credit, net	2.60%	2.30%
Non-deductible items and other	(0.80%)	(3.30%)
Change in valuation allowance	(35.30%)	(33.10%)
Total	0.00%	0.00%

Income Taxes - Summary of Principal Components of Company's Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets:
Federal, state and local net operating loss carryforwards	$ 15,241	$ 5,688
License fee deductions	340	362
Research and development tax credits	1,317	452
Stock-based compensation deductions	1,243	264
Accrued expenses	837	457
Gross deferred tax assets	18,978	7,223
Less: valuation allowance	(18,978)	(7,223)
Deferred tax liabilities:
Net deferred tax assets	$ 0	$ 0

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Line Items]
Increase in valuation allowance	$ 11,755,000
Deferred tax assets operating loss carryforwards federal	45,550,000
Deferred tax assets operating loss carryforwards state	47,735,000
Deferred tax assets operating loss carryforwards local	38,645,000
Deferred tax assets, operating loss carryforwards, not subject to expiration	45,301,000
Deferred tax assets, operating loss carryforwards, subject to expiration	$ 249,000
Operating loss carryforwards federal commencement of expiration date	2037
Operating loss carryforwards state commencement of expiration date	2037
Operating loss carryforwards local commencement of expiration date	2039
Research and development tax credits	$ 1,317,000	$ 452,000
Open tax year	2017 2018 2019
Percentage of eligible tax positions for recognition	50.00%
Unrecognized income tax benefits that would affect effective tax rate	$ 0
Federal
Income Tax Disclosure [Line Items]
Research and development tax credits	$ 1,317,000
Deferred tax assets tax credit carryforwards commencement of expiration date	2038